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Preface 
 
This PhD thesis is based on the experimental work performed at the island of Lindholm which 
is a part of the National Veterinary Institute at the Technical University of Denmark (DTU-
Vet). It was conducted from December 2014 to December 2017 under the supervision of 
Professor Graham J. Belsham with co-supervision from Senior Researcher Thomas B. 
Rasmussen. The studies were supported by core funds within DTU-Vet. 
The thesis is organized in three parts: Part 1 consist of a general introduction which provides 
a review surrounding the different aspects of the molecular biology of FMDV with a focus on 
the viral life cycle and the conserved elements within the viral genome which influence it. Part 
2 describes the results achieved during this study presented as three manuscripts listed below: 
 
I. Kjær J., Belsham G. J. (2018) Modifications to the foot-and-mouth disease virus 2A 
peptide; influence on polyprotein processing and virus replication. Submitted.   
 
II. Kjær J., Belsham G. J. (2017). Selection of functional 2A sequences within foot-and-
mouth disease virus; requirements for the NPGP motif with a distinct codon bias. RNA. 
DOI: 10.1261/rna.063339.117 
 
III. Kjær J., Belsham G. J. The influence of conserved RNA structures in the 2B, 3C and 
3D coding region of the foot-and-mouth disease virus on virus replication. Manuscript 
in preparation.   
 
Part 3 provides a Discussion of the achieved results and future perspectives for continued 
research.
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Objectives and Summary 
 
Foot-and-mouth disease (FMD) is caused by a highly contagious virus infection of cloven-
hoofed farm animals with high financial importance for countries, such as Denmark, which 
rely on a significant trade in agricultural products. At present, FMD is exotic to the cloven 
hoofed livestock in Denmark. However, outbreaks of FMD have previously been detected in 
other parts of Europe (United Kingdom) during the last decade, thus an introduction of FMD 
remains a continuing threat to the highly industrialized pig production in Denmark.  
Several conserved elements within the genome of the foot-and-mouth disease virus (FMDV) 
have been identified, e.g. the IRES. Such elements can be crucial for the efficient replication 
of the genomic RNA. A better understanding of the influence of these elements is required to 
identify currently unrecognized interactions within the viruses which may be important for the 
development of anti-viral agents. 
SHAPE analysis of the entire FMDV genome (Poulsen, 2015) has identified three conserved 
RNA structures within the coding regions for 2B, 3C and 3D (RNA-dependent RNA 
polymerase) which might have an important role in virus replication. The FMDV 2A peptide, 
another conserved element, is responsible for the primary “cleavage” at its own C-terminus 
(2A/2B junction). It is believed that this “cleavage” is achieved by a protease-independent 
event termed ribosomal skipping or StopGo, in which the 2A peptide prevents the ribosome 
from linking the next amino acid to the growing polypeptide. The nature of this “cleavage” has 
so far not been investigated in the context of the full-length FMDV RNA within cells.  
The focus of this PhD thesis has been to characterize these elements and their influence on the 
FMDV replication. In order to fulfil the aims of this thesis a series of studies were performed 
and the scientific work is presented as three manuscripts.  
Manuscript 1 investigated the impact of 2A modifications within the conserved C-terminal 
D(V/I)E(S/T)NPG↓P motif on FMDV protein synthesis, polyprotein processing and virus 
viability. Certain amino acid substitutions (E14Q, S15I, S15F and N16H) that have been shown 
to severely (50-70%) reduce the cleavage activity at the 2A/2B junction compared to the wt, 
using in vitro assays, have been found to be tolerated within infectious FMDVs. In contrast, 
substitutions (N16A, P17A, G18A, P19A, and P19G) that inhibit cleavage by 89-100% in vitro, 
reverted to the wt sequence in the rescued viruses. The 2A substitutions impaired the replication 
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of a FMDV replicon, however surprisingly the viable 2A mutant viruses did not exhibit an 
attenuation of virus growth in cell culture. Expression of cDNAs encoding a truncated FMDV 
polyprotein, without any viral proteinases showed that certain amino acid substitutions at 
residues E14, S15, N16 and P19 resulted in partial “cleavage” indicating that these specific 
residues are not essential for co-translational “cleavage”. This shows that the StopGo function 
at the 2A/2B junction is necessary for efficient virus replication. However, maximal cleavage 
activity does not appear to be essential for the viability of FMDV.  
Manuscript 2 sought to identify which codons at each position of the coding sequence for the 
conserved NPG↓P motif at the 2A/2B junction would produce viable progeny viruses. This was 
achieved using a reverse genetics system with highly degenerate primers with all possible 
codons present for each of the amino acids individually within the NPG↓P motif. This generated 
pools of modified plasmids for each codon position from which RNA transcripts were made 
which were subsequently introduced into cells in culture. The rescued viruses all encoded the 
NPG↓P motif, confirming the importance of this amino acid sequence. However, at passage 
two, these four residues were found to be encoded by all possible codons (14 in total) within 
the rescued pools. Subsequent passages in cell culture revealed a distinct codon bias. 
Remarkably, this bias matches the codon bias observed within naturally occurring FMDV 
strains. Interestingly, the codons selected are different for P17 and P19. Residue P17 is 
preferentially encoded by CCU while P19 is preferentially encoded by CCC. However, a single 
prolyl-tRNA species recognizes both of these two codons in cattle and pigs, which are the 
major hosts for FMDV, and suggests a role for the RNA sequence itself.  
Manuscript 3 examines the influence of three conserved RNA structures within the genome 
of FMDV on viral protein synthesis and virus viability. Poulsen, (2015) previously identified 
these RNA structures within the coding regions for the FMDV 2B, 3C and 3D proteins using 
SHAPE probing. Interestingly, the structures had significant lower synonymous substitution 
rates compared to the remainder of the genome. However, introduction of synonymous 
substitutions which disrupted the structures but did not alter the amino acid sequence are 
tolerated and were retained after three passages in cell culture. The same substitutions did not 
impair the replication of a FMDV replicon either. This shows that the identified structures 
located in the coding region of 2B, 3C and 3D are not required for FMDV replication in BHK 
cells.  
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Formål og Sammenfatning 
 
Mund- og klovesyge (MKS) skyldes en meget smitsom virusinfektion hos klovbærende dyr, 
som har stor økonomisk betydning for lande som Danmark, der er afhængige af en betydelig 
handel med landbrugsprodukter. MKS betegnes i dag som eksotisk for besætninger med 
klovbærende dyr i Danmark. Udbrud af mund- og klovesyge har dog fundet sted i Europa 
(Storbritannien) i løbet af det sidste årti. Introduktionen af MKS er derfor en fortsat trussel mod 
den stærkt industrialiserede svineproduktion i Danmark. 
Flere konserverede elementer er blevet identificeret i genomet af mund- og klovesyge virus 
(MKSV), f.eks. IRES. Sådanne elementer kan være afgørende for en optimal replikation af det 
genomiske RNA. En bedre forståelse af betydningen af disse elementer er nødvendig for at 
identificere hidtil ukendte interaktioner i viruset, som kan være vigtige for udviklingen af 
antivirale midler. 
RNA strukturanalyse af hele MKSV genomet (Poulsen, 2015) har identificeret tre 
konserverede RNA strukturer i de kodende regioner for proteinerne 2B, 3C og 3D (den RNA-
afhængige RNA-polymerase), som kan have en vigtig rolle i virus replikationen. MKSV 2A 
peptidet, et andet konserveret element, er ansvarlig for den primære “kløvning” i sin egen C-
terminus (2A/2B-kløvningssitet). Det antages, at denne “kløvning” sker ved en protease 
uafhængig hændelse betegnet ribosomal skipping eller StopGo, hvor 2A peptidet forhindrer 
ribosomet i at forbinde den næste aminosyre med det voksende polyprotein. Denne “kløvning” 
har hidtil ikke været undersøgt ved brug af fuldlængde MKSV RNA i celler. 
Fokus for denne ph.d. afhandling har været at karakterisere disse elementer og deres 
indflydelse på MKSV replikationen. For at opfylde disse mål blev der udført en række af 
undersøgelser og det videnskabelige arbejde er præsenteret som tre manuskripter. 
Manuskript 1 undersøger effekten af modifikationer i 2A, i det konserverede C-
terminale D(V/I)E(S/T)NPG↓P motiv, på polyprotein-syntese og -bearbejdning samt 
levedygtighed af virus. Visse aminosyresubstitutioner (E14Q, S15I, S15F og N16H), der 
tidligere er vist at reducere (50-70%) kløvningsaktiviteten ved 2A/2B kløvningssitet, 
sammenlignet med vildtypen i et in vitro assay, blev tolereret i infektiøse MKSV. I modsætning 
til dette førte andre substitutioner (N16A, P17A, G18A, P19A og P19G), der hæmmer 
kløvningen med 89-100% in vitro, til reversion til vildtype sekvensen i de genererede virus. 2A 
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substitutionerne forringede replikationen af et MKSV replikon, men overraskende viste de 
levedygtige 2A mutanter ikke en svækkelse af væksten i cellekultur. Ekspression 
af cDNAer, der koder for et trunkeret MKSV polyprotein, uden de virale proteinaser, viste at 
visse aminosyre substitutioner ved E14, S15, N16 og P19 resulterede i delvis “kløvning” og 
indikerer at disse specifikke aminosyre ikke er essentielle for co-translationel “kløvning”. Dette 
viser at StopGo funktionen ved 2A/2B kløvningssitet er nødvendig for optimal virus 
replikation. Den maksimale kløvningsaktivitet synes imidlertid ikke at være afgørende for 
levedygtighed af MKSV. 
Manuskript 2 forsøger at identificere hvilke kodoner, i hver position af den kodende sekvens 
for det konserverede NPG↓P motiv ved 2A/2B kløvningssitet, som producerer levedygtige 
virus. Dette blev opnået ved anvendelse af et revers genetiksystem og degenererede primere, 
som kodede for alle potentielle kodoner for hver individuel aminosyre i NPG↓P motivet. Disse 
dannede en pool af modificerede plasmider for hver kodon position, hvorfra RNA transkripter 
blev fremstillet, som efterfølgende blev introduceret i cellekultur. De genererede virus kodede 
alle for NPG↓P motivet, hvilket bekræfter betydningen af denne aminosyresekvens. Efter to 
cellekulturpassager blev det vist at alle potentielle kodoner (14 i alt) blev fundet, som kodende 
for de fire aminosyrer. Efterfølgende passager i cellekultur viste en tydelig kodon-
bias. Bemærkelsesværdigt matcher denne bias den kodon-bias, der observeres i naturligt 
forekommende MKSV stammer, hvor f.eks. kodoner for henholdsvis P17 og P19 er 
forskellige. Aminosyre P17 er fortrinsvis kodet af CCU hvorimod P19 hovedsagelig er kodet af 
CCC. En enkelt prolyl-tRNA enhed genkender imidlertid begge disse to kodoner hos både 
kvæg og svin, som er de vigtigste værter for MKSV, hvilket antyder at RNA sekvensen også 
spiller en rolle. 
Manuskript 3 undersøger indflydelsen af tre konserverede RNA strukturer i genomet for 
MKSV på polyproteinsyntese og levedygtighed. Poulsen, (2015) har tidligere identificeret 
disse RNA strukturer i de kodende regioner for MKSV 2B, 3C og 3D proteinerne ved 
anvendelse af RNA strukturanalyse. Interessant nok havde strukturerne betydelige lavere 
synonyme substitutionsrater sammenlignet med den øvrige del af virusgenomet. Indsættelsen 
af synonyme substitutioner som ophævede strukturerne, men ikke ændrede 
aminosyresekvensen blev tolereret og blev bibeholdt efter tre passager i cellekultur. De samme 
substitutioner svækkede heller ikke replikationen af et MKSV replikon. Dette viser, at de 
identificerede konserverede RNA strukturer, der er lokaliseret i den kodende region af 2B, 3C 
og 3D ikke er nødvendige for MKSV replikation i BHK celler. 
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Part 1 · Introduction 
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Foot-and-mouth disease 
 
Foot-and-mouth disease: from past to present  
Foot-and-mouth disease virus (FMDV) is an animal pathogen responsible for the highly 
contagious and economically devastating foot-and-mouth disease (FMD). It affects cloven-
hoofed domestic and wild animals such as cattle, sheep, pigs, goats and about 70 species of 
wildlife e.g. African buffalo (reviewed in Jamal & Belsham, 2013). The origin of FMDV 
remains unclear; however, an Italian monk, Hieronymus Fracastorius first described the 
symptoms of a disease similar to that of FMD in cattle in Venice in 1514. Four centuries later, 
in 1897, Loeffler and Frosch demonstrated that the infectious causative agent of FMD was a 
virus by transmitting the disease from FMDV infected calves to other susceptible cloven-
hoofed animals through the use of filtered material (reviewed in Grubman & Baxt, 2004).  
The FMDV is the prototypic member of the Aphthovirus genus within the family 
Picornaviridae, which has approximately 30 genera including many important human and 
animal pathogens such as poliovirus (PV) and coxsackie B viruses (e.g. CVB3) (see Figure 1). 
The Aphthoviruses consist of FMDV, bovine rhinitis B virus (BRBV), equine rhinitis A virus 
(ERAV) and the recently identified bovine rhinitis A virus (BRAV) (Knowles et al., 2010). 
FMDV exists in seven serologically distinct serotypes (A, O, C, Asia 1 and Southern African 
Territories 1, 2 and 3), but with numerous subtypes within each serotype (Rweyemamu et al., 
2008).  
An outbreak of FMD in areas with high-density pig and cattle farming can cause great socio-
economic challenges as is evident from the 2001 and 2007 outbreaks of FMD in the United 
Kingdom (UK) (Cottam et al., 2008; Thompson et al., 2002). Even though the average 
mortality rate from FMD is only about 1 %, the morbidity within a herd can be close to 100% 
due to a very high transmission rate. The FMDV infected animals develop fever and vesicles 
in the mouth, muzzle, feet and/or teats, which has a severe effect on the productivity of the 
livestock. Dairy cattle not only experience a substantial fall in milk production of up to 40 % 
and loss of weight but also experience reduced mobility because of the lesions (reviewed in 
Grubman & Baxt, 2004). In the recent 2001 FMD UK epidemic, 2030 infected premises were 
identified across the country. This resulted in the culling of 6.5 million animals out of which 
only 1.3 million of these were on infected premises. These circumstances, as well as the costs 
associated with tourism and trade restrictions, contributed to the substantial financial losses. 
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The total financial cost of the UK FMD epidemic in 2001 was calculated to be 12.3-13.8 billion 
USD out of which 5.8 billion was associated with agriculture and food production and $5.1 to 
$6.0 billion in tourism-related business (Thompson et al., 2002).   
The preferred method for controlling a FMD outbreak in non-endemic countries is through 
restriction of animal movement, stamping out of all diseased and potentially infected herds 
with the subsequent incineration of their carcasses followed by quarantine (Paton et al., 2009). 
However, the pre-emptive culling of susceptible animals can, in countries with high cattle or 
pig populations (like the UK or Denmark), lead to the widespread slaughter of healthy animals. 
Emergency vaccination or systematic FMDV vaccination programs can therefore be an 
additional tool for disease control (Doel, 2003). Nevertheless, there are complex problems 
associated with the use of vaccination as a control measure. The current FMD vaccine is an 
inactivated virus, which does not provide long-lasting immunity and ideally needs to be 
administered every 6 months (Doel, 2003). Furthermore, the high mutation rate of FMDV 
provides the chance of antigenic changes, potentially producing a new subtype, which can 
reduce the effectiveness of the vaccine. In addition, the use of vaccination hinders the 
differentiation between infected and vaccinated animals. This blocks trade with other countries, 
as detection of anti-FMDV antibodies, although due to vaccination, is an admission of the 
existence of a FMD outbreak. This lead the EU, which until 1991 (except in Denmark, UK and 
Ireland) systematically vaccinated against FMDV, to stop this practice (Sutmoller et al., 2003). 
Countries with a status as “FMD-free without vaccination” have commercial advantages as 
they face less trade restrictions. In FMD endemic countries, primarily found in Asia and Africa, 
little or no effort has been made to control the spread of the disease. 
The worldwide distribution of FMDV mirrors economic development. Industrialised countries 
in Europe, North American and Australia have eradicated the disease and all of South America 
has been free of clinical disease since 2013 (but with vaccination). Developing countries, 
primarily found in Africa and Asia, lack the resources and infrastructure to initiate proper 
eradication programs and FMD has, during the last decades, been reported as either endemic 
or with sporadic outbreaks in domestic or wild cloven-hoofed animals species (Paton et al., 
2009; Rweyemamu et al., 2008). The seven FMDV serotypes are not distributed equally around 
the world. The serotype O, A and C viruses have had the widest distribution and have been 
responsible for outbreaks in Europe, America, Asia and Africa, whereas the SAT serotypes are 
normally restricted to sub-Saharan Africa. In Denmark, FMD has not been reported since the 
last outbreak in 1982 (Jamal & Belsham, 2013).  
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Figure 1: Phylogenetic tree of the Picornaviridae family. The tree depicts the genetic relationship 
based on the analysis of the P1 capsid precursor. The neighbour joining tree was produced using MEGA 
(Tamura et al., 2011). The branch lengths are proportional to the genetic difference where the distance 
scale corresponds to amino acid substitutions per position. Adapted from the ICTV 9th Report: Virus 
Taxonomy: The Classification and Nomenclature of Viruses.  
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Genome organization of foot-and-mouth 
disease virus 
 
Genome organisation 
The FMDV particle has an icosahedral protein shell (capsid) about 30 nm in diameter (Acharya 
et al., 1989; Fry et al., 2005). It consist of 60 copies of each of the four structural proteins VP1, 
VP2, VP3, and VP4 enclosing the viral genome. The capsid serves to protect the genome before 
the infection of the host cell, whereupon it is released into the cytoplasm. The FMDV genome 
consists of a positive-sense, single-stranded (+ss) RNA molecule approximately 8.3 kb long 
and includes a single, long, open reading frame (ORF) of about 7 kb (Martinez-Salas & 
Belsham, 2017). The RNA genome shares many characteristics with eukaryotic mRNAs as 
these also usually contain a single ORF followed by a 3΄-untranslated region (UTR) and a 
poly(A) tail. However, in contrast to cellular mRNAs, the viral RNA does not possess a 7-
methyl-G cap (m7GpppN) structure at its 5´-terminus which is normally required for translation 
initiation. The large ORF within the genome encodes a large polyprotein that is rapidly 
processed, largely by virus-encoded proteases, to generate 15 distinct mature proteins 
(Belsham, 2005). The FMDV viral polyproteins, with four primary precursor proteins is 
divided into a leader (Lpro) protein, the structural capsid proteins (P1-2A), and non-structural 
proteins (P2 and P3) associated with the replication of the viral genome (see Figure 2).  
 
The 5ʹ- and 3ʹ-untranslated regions 
The approximately 1,300 nucleotide 5ʹ-UTR of FMDV RNA accounts for ~16 % of the 
genome. The large size of this UTR is in contrast to the ~50-100 nt normally observed in 
eukaryotic mRNAs. This region contains extensive secondary structures and can be divided 
into five functional elements termed the S-fragment, poly(C) tract and pseudoknots, cis-acting 
replication element (cre) and the Internal Ribosome Entry Site (IRES) (Belsham, 2005; 
Grubman & Baxt, 2004). The 3ʹ-UTR of FMDV consists of a sequence of ca. 100 nt that is 
predicted to fold into two separate stem-loops (Witwer et al., 2001) followed by a poly(A) tract 
of varying length. These structures and their influence on the viral replication and translation 
are described in more detail in the section: Functional structural RNA elements within the 
FMDV genome.  
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Figure 2: Schematic diagram of the genome organization of FMDV. The FMDV genome RNA 
contains a single large ORF of about 7 kb. The ORF is flanked by a long 5ʹ-UTR and a short 3ʹ-UTR. 
3B (VPg) is covalently linked to the 5ʹ-terminus of the RNA. The ORF encodes a polyprotein which is 
never observed due to rapid co-translational processing by viral proteinases (Lpro and 3Cpro, indicated 
by black arrows) and by the translational recoding event (StopGo, ribosomal skipping) at the 2A/2B 
junction (indicated by a green arrow). The ORF is divided into four functional regions L, P1-2A 
(structural proteins), P2 and P3 (non-structural proteins) due to their distinct functions in the viral life 
cycle. Adapted from Jamal & Belsham, (Submitted). 
 
Leader protein 
Members of the Aphthovirus genus, are unusual in having a protease as the first component of 
the viral polyprotein. The FMDV Leader (Lpro) protein is a papain-like cysteine protease 
(Strebel & Beck, 1986). It cleaves itself from the polyprotein between its own C-terminus and 
the N-terminus of VP4 and it is also involved in repression of cap-dependent protein synthesis 
(host cell translation) by inducing cleavage of the translation initiation factor eIF4G (Devaney 
et al., 1988; Kirchweger et al., 1994; Medina et al., 1993). The Lpro protein is produced in two 
distinct forms, termed Lab and Lb. This is a result of two in-frame start codons, 84 nts apart, 
which are conserved in all natural FMDV isolates (Carrillo et al., 2005; Sangar et al., 1987). 
Despite the Lab proteins N-terminal extension of an additional 28 residues compared to Lb it 
has been demonstrated that each form of proteinase has indistinguishable proteolytic activity 
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and specificity (Medina et al., 1993). Interestingly, deletion of the Lb region does not affect 
virus viability within BHK cells (Piccone et al., 1995). Conversely, deletion of the entire Lab 
coding sequence is not tolerated (Belsham, 2013). Viable virus can also be produced from 
mutant FMDV genomes if the Lab start site is modified, however modification of the Lb 
initiation site hinders the production of viable progeny (Cao et al., 1995). Previously, it was 
suggested that the “spacer” region was required for activity unrelated to its coding function. 
However, Belsham, (2013) demonstrated that deletion of the “spacer” region between the two 
initiation codons can be tolerated.  
 
The structural proteins VP1-VP4 
The FMDV capsid is made up of 60 copies of the four structural proteins VP1 (1D), VP2 (1B), 
VP3 (1C) and VP4 (1A). VP1, VP2 and VP3 are surface-exposed and fold into eight-stranded 
antiparallel β-barrels that are a characteristic of picornavirus capsid proteins (Acharya et al., 
1989). VP4 is found within the interior of the mature virus particle and can until virion 
maturation be considered an N-terminal myristoylated extension of VP2. The stability of 
virions is dependent on the myristoylation of the N-terminal glycine residue generated during 
cleavage at the L/P1 junction (Chow et al., 1987). The virus encoded proteinase 3Cpro is 
responsible for processing of the P1/2A precursor. This generates protomers, consisting of one 
copy each of VP1, VP3, and VP0. During assembly, five protomers, associate into a pentamer, 
and 12 pentamers interact with a newly transcribed RNA molecule to form a mature infectious 
FMDV particle. 
 
2A 
The large polyprotein precursor produced during translation of FMDV RNA is proteolytically 
processed by the virus-encoded Lpro and 3Cpro proteins to produce multiple precursors 
(including P1-2A) and some 15 mature proteins (Belsham, 2005). Separation of the capsid 
precursor P1-2A from P2 at the 2A/2B junction occurs in a co-translational manner and is 
mediated by the short (18 residues long) 2A peptide (Belsham, 1993; Palmenberg et al., 1992; 
Ryan et al., 1989). The 2A peptide lacks any protease motifs but has a characteristic conserved 
C-terminal motif (D12(V/I)E(S/T)NPG↓P192B) shared with some other picornaviruses (e.g. 
encephalomyocarditis virus (EMCV) and Theiler’s murine encephalitis virus (TMEV)). The 
FMDV 2A-mediated cleavage occurs at its C-terminus using a non-proteolytic translational 
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recoding mechanism termed “ribosome skipping” or “StopGo”  (Ryan et al., 1989, 1991; 
Palmenberg et al., 1992). Mutational analysis has shown that the amino acid sequence, 
especially within the conserved NPG↓P motif, are critical for optimal ribosomal skipping 
(Donnelly et al., 2001a, b; Sharma et al., 2012). The function of 2A is described in more detail 
in the section: FMDV replication.  
 
2B 
2B proteins from some other picornaviruses (enterovirus 71, PV) have been characterized as 
hydrophobic transmembrane proteins termed viroporins (Agirre et al., 2002; Xie & Wang, 
2011). The hydrophobic domain of such proteins has been found to interact with the 
phospholipid bilayer of membranes. They are found to increase cell membrane permeability 
and promote the release of viral particles from the host cell (Nieva et al., 2012). Presently, little 
is known about the exact function of the FMDV 2B. The enterovirus 2B protein has been found 
to impair Golgi complex trafficking by decreasing the endoplasmic reticulum (ER) luminal 
Ca2+ content (Van Kuppeveld et al., 2005). Within FMDV infected cells and cells made to 
express 2B, the protein has been mainly located in the ER. The Ca2+ concentration in cells 
expressing the 2B protein increased resulting in autophagy in host cells (Ao et al., 2015). 
Expression of both 2B and 2C within BHK cells has shown the transport between the ER and 
Golgi apparatus to become blocked by the 2BC precursor protein or by 2B and 2C together but 
not by either 2B or 2C alone indicating a synergistic effect (Moffat et al., 2005, 2007).  
 
2C 
The exact biological function of the 2C protein is still unknown. Sequence analysis has shown 
that it is the most conserved viral protein within the FMDV genome (Gao et al., 2016). 2C-like 
proteins have also been observed in other RNA viruses (Gorbalenya & Koonin, 1989). It has 
been suggested that FMDV 2C shares the same function as other picornavirus 2C proteins and 
along with 2B is required for the facilitation of membrane rearrangement. An ATPase  domain, 
with documented ATPase activity, has been identified upstream of a predicted N-terminal 
amphipathic helix (Sweeney et al., 2010). Although, a helicase domain also has been identified, 
no evidence for helicase activity has so far been documented (Gorbalenya & Koonin, 1989). It 
has been established that guanidine inhibits the initiation of negative-strand PV synthesis 
within a cell-free replication system (Barton & Flanegan, 1997). Guanidine resistant mutants 
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of FMDV have amino acid substitutions within the 2C protein (Belsham & Normann, 2008; 
Saunders & King, 1982) and it is thus inferred that 2C has a role in this process.  
 
3A 
The FMDV 3A protein is considerable larger than other 3A proteins from within the 
picornavirus family. The N-terminus of 3A is highly conserved in all FMDV isolates and 
includes both hydrophilic and hydrophobic regions, by which the latter is capable of anchoring 
the protein to cellular membranes (Knowles et al., 2001). Immunofluorescence staining of 
FMDV-infected BHK cells using anti-3A antibodies showed that 3A associates with both the 
ER and the Golgi apparatus (García-Briones et al., 2006). PV 3A has been found to inhibit the 
protein trafficking from the ER to the Golgi, and it has been suggested that FMDV 3A could 
exhibit a similar function. However, as previously described, 2BC exerts this role in FMDV 
infected cells (Moffat et al., 2005). 3A is a potential virulence and host range determinant. 
Several passages of FMDV in chicken embryos produced attenuated strains with deletions in 
the less conserved C-terminus of 3A (He et al., 2011). FMDV isolated from outbreaks in 
Taiwan in 1997, which interestingly only infected swine and had an unusually high mortality 
rate, were also found to carry similar deletions in 3A (Beard & Mason, 2000). In addition, this 
strain also displayed restricted growth in bovine cells in vitro and significant attenuation in 
cattle in vivo (Pacheco et al., 2003, 2013). Núñez et al., (2001) also demonstrated that the 
mutation of a single residue within 3A mediated adaptation of FMDV to the guinea pig.  
 
3B 
The 3B (VPg) is covalently attached to the 5ʹ-terminus of both positive- and negative-sense 
FMDV RNA genomes. 3B serves as a primer for RNA synthesis and is attached to most viral 
RNA transcripts, although not those associated with polysomes. In contrast to other members 
of the picornavirus family that only encode a single copy of 3B, the FMDV genome encodes 
three non-identical copies of the 3B (termed 3B1,3B2, and 3B3) in tandem (Forss & Schaller, 
1982). Each distinct form of the 3B protein has been found attached to genomic RNA, and is 
believed to be functionally equivalent (Nayak et al., 2005). So far, all natural FMDV isolates 
have been reported to contain three copies of 3B, albeit not all three copies of FMDV 3B are 
required to maintain infectivity (Pacheco et al., 2003). Deletion of one or two FMDV 3B 
sequences can produce viable viruses, but the mutant viruses have a lower replication 
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efficiency than the wt virus. Using a replicon system it has been established that deletion of 
3B3 prevents replication but it could be restored by introducing substitutions at the C-terminus 
of 3B2 equivalent to that of the original sequence at the 3B3-3C cleavage site (Herod et al., 
2017). In vitro translation of plasmids expressing the wild-type FMDV P3 polyprotein showed 
that deletions of the 3B3 produced 3CD but no 3D.  
 
3C  
The FMDV 3Cpro is responsible for most of the polyprotein cleavages thereby generating most 
of the mature and intermediate protein products. It can exercise its function alone, in contrast 
to the PV 3C protease (Ypma-Wong et al., 1988), which requires the 3D sequences for some 
of its processing activities. 3Cpro is a member of the chymotrypsin-like family of serine 
proteases, although the active site serine is replaced by a cysteine (Birtley et al., 2005). The 
predominant function of FMDV 3Cpro is polyprotein processing but it has also been associated 
with inhibition of host cell transcription and translation (Belsham et al., 2000), RNA binding   
and it is required (as part of 3CD) for the uridylylation of VPg in vitro (Nayak et al., 2006). 
Like Lpro, 3Cpro is involved in eIF4G cleavage, although much later in the infection cycle and 
at an alternative site. It has also been reported to cleave eIF4A which is another component of 
the cap-binding complex with the function of an RNA helicase. Moreover, 3Cpro has been 
identified as the agent responsible for cleavage of histone H3 following FMDV infection (Falk 
et al., 1990). Precursors containing 3Cpro (P3, 3ABC, 3CD) have also been shown to retain 
catalytic activity in PV (Spear et al., 2015).  
 
3D 
The 3D protein is an RNA-dependent RNA polymerase (RdRp) catalysing the synthesis of 
positive- and negative-sense FMDV RNA genomes during viral replication (Robertson et al., 
1983a). The overall structure of the 3D resembles those of other RdRps by taking the 
appearance of  a cupped “right hand” consisting of “palm”, “fingers”, and “thumb” subdomains 
(Ferrer-Orta et al., 2006). The catalytic site of all RdRps is contained in the palm domain and 
includes a GDD motif which is conserved within the picornavirus family (Ferrer-Orta et al., 
2004). Uridylylated 3B (VPg) is required as a primer by 3D to initiate replication of either 
strand (Paul et al., 1998) and will be described in more detail in the section: FMDV replication.  
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Quasispecies and genetic diversity 
RNA viruses and, in particular FMDV, have extremely high mutation rates due to the lack of 
proofreading capabilities by their respective RdRps (Drake, 1993). The low replication fidelity 
leads to differences between FMDV replicated genomes compared to the original parental 
genome with 10-4 to 10-5 substitutions per nucleotide synthesized (Domingo & Holland, 1997; 
Drake & Holland, 1999). This is approximately 105 times higher than the mutational rate for 
the human DNA polymerase. For FMDV, the consequence of this significant high mutational 
rate is a 0.5 - 1.0% change in the consensus strain per year corresponding to 40-80 
nucleotides/year (Haydon et al., 2001a). Continuous error-prone nucleotide substitutions 
ultimately lead to a very heterogeneous viral population within the host cell, called a viral 
quasispecies (Manrubia & Lázaro, 2006). The significant genetic diversity allows the virus to 
rapidly adapt to dynamic environments thereby enabling it to evade the immune response of 
the host or evolve resistance to antiviral drugs. The quasispecies nature of the FMDV is a well-
known characteristic of the virus and has been studied in detail at the nucleotide level 
(Domingo et al., 1980, 2012). Studies have shown that non-synonymous mutations, which can 
lead to changes in the FMDV viral phenotype, represent about 50% of the total substitutions 
introduced during replication of the viral genome (Escarmis et al., 1996). The highest 
occurrence of codon change is observed in the capsid-coding region of the genome (P1) and 
can result in antigenic variation. Studies have shown that antigenic variation within field 
isolates increases with time and most likely arises as a result of immunological pressure placed 
on the virus by the infected host’s immune system (Domingo et al., 2003; Haydon et al., 
2001b). Interestingly, antigenic variation in FMDV has also been reported in cell cultures 
incapable of producing any immunological pressure, suggesting that antigenic sites on the 
capsid could be involved in other functions (Diez et al., 1989; Domingo et al., 1993; Fares et 
al., 2001). Non-synonymous mutations also occur within the P2 and P3 protein-coding regions 
of the genome but are observed less frequently possibly because these proteins are necessary 
for the viral replication and changes are more likely to result in deleterious phenotypes. A PV 
variant with an RdRp derivative possessing a 2-3-fold higher error rate has previously been 
found to move towards extinction more easily than wt in cell culture. The same virus also had 
a reduction in virulence in mouse, correlating with its inability to sustain replication in different 
cell types in which the wt virus can grow (Korboukh et al., 2014). 
Recombination is an alternative process, which can contribute to the genetic diversity in 
FMDV. It has been demonstrated that FMDV is able to undergo RNA recombination in cell 
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culture and that it was most likely to occur within the regions of the genome coding for the NS 
proteins (King et al., 1985; McCahon et al., 1985). However, Tosh et al., (2002) suggested that 
RNA recombination within the capsid-coding P1 region of the genome may contribute to 
genetic diversity in FMDVs isolated from the field. Regardless of the mechanism, analysis of 
both synonymous and non-synonymous mutations has been a valuable tool in epidemiological 
studies of FMDV outbreaks. 
 
Reverse genetics system  
It has been known for years that the genome of various + ssRNA viruses, including FMDV, is 
infectious when introduced into susceptible cells (Baltimore, 1971; Belsham & Bostock, 1988). 
Reverse genetics systems exploits this principle enabling the generation of genetically modified 
viruses and is today a cornerstone of molecular virus research. Full-length complementary 
DNA (cDNA) of a positive-strand RNA virus is inserted into a bacterial DNA plasmid under 
the influence of a suitable promoter, most often T7. These plasmids can be genetically 
manipulated either by restriction enzyme cloning or PCR mutagenesis after which the genomic 
viral RNA can be produced by in vitro transcription and introduced into cells. If the mutated 
RNA is infectious, then modified viruses are produced. This allows for determination of 
important viral properties such as virulence/attenuation, cell penetration, replication, host range 
and functions of coding or non-coding genomic regions. To date, few infectious cDNA clones 
of FMDV has been established (Ellard et al., 1999; Liu et al., 2004; Rieder et al., 1993; Zibert 
et al., 1990) which  are  based on the O1 Kaufbeuren and A12 strains respectively.  
 
Strategies to study viral replication  
Quantification of virus replication represents an important step in the characterization of the 
viral life cycle of wt or genetically modified virus. Accurate determination of virus 
concentration (virus titre) can be archived through various methods (see Figure 3), of which 
the tissue culture infective dose assay (TCID50) or virus plaque assay has been considered the 
“gold standard” for many years. In the last decade, RT-qPCR has also been increasingly used. 
The methods are well established but have disadvantages and limitations. The measurement of 
growth kinetics of viruses using TCID50 does not differentiate between the different elements 
of the viral life cycle. A decrease in growth characterises can thus be a result of other altered 
processes in the viral life cycle than only the replication. RT-qPCR which can be laborious 
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determines RNA production, and is dependent on primer specificity and an accurate standard 
curve (reference point). Recently, the use of fluorescently-tagged viruses as tools to 
characterize the viral life cycle has been investigated for various RNA viruses. The methods 
utilize the tagging of viral proteins which subsequently can be monitored over time. This has 
been demonstrated for various viruses within the picornavirus family such as FMDV, PV and 
coxsackievirus B3 (Mueller & Wimmer, 1998; Seago et al., 2013; Tong et al., 2011). The GFP 
coding sequence (700 nt) and Renilla luciferase (800 nt) for FMDV was inserted downstream 
of the structural proteins coding region, but was rapidly removed, presumably by 
recombination, following serial passage. In addition, insertion of GFP into the PV genome was 
shown to be detrimental for viral replication efficiency. This suggested that packaging limits 
of the viral capsid and stability of the RNA genome following GFP coding sequence insertion 
were contributing factors leading to the results seen by both groups. Insertion of the coding 
sequence for a smaller, alternative, fluorescent protein termed iLOV (400 nt) resulted in the 
production of a virus that displayed only a slightly reduced rate of growth compared to the 
parental virus in cell culture. The fluorescent-tagging of influenza virus and Marburg virus 
(Albariño et al., 2013) which both have negative-sense RNA genomes has also been 
demonstrated (Manicassamy et al., 2010).  
Advances in molecular biology, especially within the field of reverse genetics have enabled the 
development of replicon systems, which can be suitable for characterization of RNA 
replication. Replicons are defined as self-replicating but non-infectious RNAs. FMDV 
replicons can be generated using in-frame deletions within the region encoding the structural 
proteins (Khromykh, 2000). This abrogates capsid assembly making the virus unable to 
produce new infectious FMDV particles. In certain members of the picornaviruses family, this 
approach is not possible due to the presence of an essential RNA replication element, termed 
the cre, in the coding region for the structural proteins (McKnight & Lemon, 1996). This 
element is located in the non-coding region upstream of the IRES within the FMDV genome 
(Mason et al., 2002). Thus, a reporter protein in place of, or in frame with, viral coding 
sequences allows quantitative measurements of the viral replication efficiencies. The reporter 
protein can be either fluorescent or enzymatic in nature and both have previously been applied 
in FMDV replicon systems (Mason et al., 2002; McInerney et al., 2000; Tulloch et al., 2014). 
The use of FMDV replicon systems has provided an opportunity for research into FMDV 
replication, which had previously been restricted to high-security containment facilities. This 
is because they are unable to produce infectious virus particles and recombination with 
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circulating FMDV can be neglected if the laboratory is located within a FMD free region and 
otherwise does not conduct work with constructs harbouring the capsid coding region.  
The first reported FMDV replicon system with a detectable reporter protein was based on the 
genome of FMDV O1K and contained the chloramphenicol acetyl-transferase (CAT) protein 
(McInerney et al., 2000). It was a derivative of the infectious cDNA of FMDV, pT7S3, in 
which a majority of the Lpro (Lab and Lb) and structural protein coding sequences (VP4-VP3) 
were deleted and replaced by a sequence encoding the CAT protein. The deletion of most of 
the structural proteins was not detrimental for RNA replication consistent with later 
observations (that the cre is located in the 5ʹ-UTR and the Lpro is not essential for FMDV 
replication). Recently, a FMDV replicon encoding the Gaussia Luciferase (Gluc) reporter 
protein instead of the VP1-VP3 sequence has been generated (Kjær & Belsham, submitted, see 
Manuscript 1). This replicon was used to demonstrate the detrimental effect of amino acid 
substitutions within the 2A peptide on the translation/replication of the FMDV genome. Gluc 
is naturally secreted and thus has advantages to Renilla based replicons which require cell lysis 
prior to detection of the reporter protein. Fluorescent proteins like GFP, mCherry or DsRed can 
also be used in the investigation of FMDV replication. They possess several advantages over 
their enzymatic counterparts, since the intracellular accumulation can be directly observed in 
vivo over time and their expression can be measured for individual cells. A GFP replicon 
system has been generated for FMDV (Herod et al., 2015, 2016; Tulloch et al., 2014). The 
FMDV CAT replicon system reported by (McInerney et al., 2000) was modified by deleting 
the sequence encoding CAT and replacing it with the coding regions for a functional Lpro 
together with the fluorescent protein GFP linked to the puromycin resistance protein. The GFP 
replicon was replication competent and it was easily detected. However, the replication-
incompetent forms of the genome surprisingly produced a signal only 2-fold lower. 
Interestingly, a derivative of the GFP replicon, which did not contain the LPro, showed a 
significantly stronger fluorescence signal, which has been suggested to be the result of cleavage 
of the GFP protein by the Lpro. The co-transfection of a helper-replicon containing a fluorescent 
reporter protein detectable at another wavelength has been shown to identify intergenomic 
trans-complementation of elements such as RNA structures or viral proteins (Herod et al., 
2015, 2016, 2017) 
 
.  
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Figure 3: Schematic representation of methods used to study viral replication. Four methods to 
study viral replication including: a) TCID50 titration b) fluorescent tagging of viruses and c) RT-qPCR. 
All use infectious viruses and require high containments facilities. The replicon system (d) removes all 
or the majority of the capsid proteins of the virus and replaces them with a reporter protein which can 
be enzymatic (e.g. Gluc or Rluc) or fluorescent (GFP, mCherry) in nature. This prevents the production 
of new infectious particles and does not require a high containment facility. Expression of the reporter 
protein is directly proportional to the replication.  
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Replication of FMDV 
 
FMDV life cycle 
FMDV has, like other members of the picornavirus family, a relative short life cycle in cultured 
cells. Depending on the initial virus titre and multiplicity of infection, newly generated 
infectious virus particles are detectable between 4 and 6 hours after infection (Grubman & 
Baxt, 2004). FMDV is cytocidal, resulting in morphological alterations referred to as 
cytopathic effects within infected cells. This includes a rounding of the cells and redistribution 
of internal cellular membranes. The basic components of the infectious cycle of FMDV are: 
• Adsorption and entry 
• Uncoating and genome release into the cytosol 
• Translation of the genomic viral RNA 
• Assembly of RNA replication complexes 
• Genome replication   
• Virion assembly, maturation and release 
 
An overview of the FMDV infectious life cycle can be seen in Figure 4. 
 
Adsorption and entry 
The first step in the virus replication cycle is represented by the initial attachment of the virion 
to the host cell surface. For non-enveloped viruses like FMDV, this process typically involves 
an interaction between the viral capsid proteins and a host cell receptor molecule present on 
the surface of the cell membrane. Binding of the virion to the cell surface will eventually lead 
to several processes whereby the virus enters the cell. It is well established that FMDV 
receptors, as well as other viral receptors, play a part in determining the host range of the virus 
and its tissue tropism defining its pathogenic potential (Evans & Almond, 1998; Schneider-
Schaulies, 2000). The binding of the FMDV particles to the cell surface in cell culture has been 
demonstrated to occur to a limited number of receptor sites (Baxt & Bachrach, 1980). Through 
the use of cross-competition studies it was revealed that all seven serotypes appeared to bind 
to a common primary class of receptor in vitro, whereas some of the serotypes bound to an 
alternate second class of receptors which are found to be present at the cell surface in a higher 
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number (Sekiguchi et al., 1982). Limited trypsin digestion of FMD virions was shown to result 
in non-infectious particles incapable of binding to cells in culture (Moore & Cowan, 1978). 
Additional studies of non-infectious trypsin-inactivated FMDV particles showed a single 
cleavage of the VP1 protein at Arg144 which subsequently has been found to be located within 
the βG-βH surface loop of the VP1 (Robertson et al., 1983b). It was suggested that this region 
of the VP1 interacted with the cellular receptor. Arg144 has since been found to be part of the 
tripeptide sequence Arg-Gly-Asp (RGD), and has been identified to be a recognition sequence 
for the transmembrane glycoproteins called integrins (Fox et al., 1989). Integrins consist of 
two different subunits, α and β, and are involved in cell adhesion, cell migration, thrombosis, 
and lymphocyte interactions. Currently, it is known that integrins are composed of eighteen α 
and eight β subunits, which can combine to generate twenty-four different αβ combinations. 
However, only eight out of these twenty-four integrins use the RGD motif as a recognition 
sequence and four (αvβ1, αvβ3, αvβ6, αvβ8) of these have so far been associated with FMDV 
attachment (Duque & Baxt, 2003; Jackson et al., 2000, 2002, 2004). FMDV strains which have 
adapted for growth in cultured cell lines have been found to acquire a high affinity for heparan 
sulfate proteoglycans (HSPGs) receptors for attachment (Jackson et al., 1996). However, the 
use of HSPGs as a facilitator for host cell entry of field viruses has not been proven. The 
plasmids containing the O1K cDNA (Ellard et al., 1999) are based on a cell-culture-adapted 
B64 strain of the O1 Kaufbeuren virus (O1K B64). Viruses rescued from O1K B64-derived 
infectious cDNA have so far not been reported to cause disease in natural host animals. 
However, replacing the surface-exposed capsid proteins VP2, VP3 and VP1 within this virus 
with the field strain sequences of O-UKG and A-TUR have been shown to restore 
pathogenicity in cattle (Bøtner et al., 2011). Recently, it has also been identified that cell culture 
adaption of FMDV allowed for integrin- and HS-independent infection of CHO cells due to 
the substitution of glutamine (Q) to lysine (K) at amino acid position VP1-110 (Berryman et 
al., 2013). In addition, Chamberlain et al., (2015) have identified a novel site on the capsid 
within VP2 of a FMDV strain where substitutions resulted in cell culture adaptation. 
Interestingly, it remained infectious for cattle, despite having a major deletion in the G-H loop 
of VP1 that results in the loss of the integrin-binding RGD. FMDV binds to the cell surface 
through interaction with these receptors and enters the cell through clathrin mediated 
endocytosis (Burman et al., 2006). This is followed by a decrease in the pH of the endosome 
which breaks down the pH-sensitive capsid releasing the viral RNA into the cytoplasm 
(Carrillo & Giacheiti, 1984).  
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Figure 4: Overview of the FMDV life cycle. The virus enters the host cell through attachment of the 
virion to specific host receptors (e.g. integrins or heparan sulphate) which facilitates internalization 
through clathrin dependent endocytosis. The capsid dissociates and releases the positive-sense single 
stranded RNA genome into the cytoplasm. The cap-independent translation of the single large ORF 
within the FMDV genome is driven by the internal ribosome entry site (IRES) element that recruits the 
ribosomal subunits. This result in a polyprotein which is rapidly processed into structural and non-
structural proteins, 15 in total. The viral proteases Lpro and 3Cpro shut off host cell translation (cap-
dependent). The non-structural proteins form viral replication complexes through the rearrangement of 
the internal cellular membranes. Viral replication is initiated in these complexes and newly formed 
+ssRNA is released and can either be used in translation and replication or be encapsidated to form new 
infectious virions which subsequently are released. Adapted from Whitton et al., (2005). 
 
Translation and polyprotein processing 
Following uncoating of the +ssRNA FMDV genome inside the endosome, it is released into 
the cystosol. The FMDV does not bring any viral proteins capable of replicating the genomic 
RNA inside the cell nor are there any cellular RNA polymerases present to perform this task. 
Accordingly, the first major event for the genomic RNA is to associate with the cellular 
translational system. Unlike most host-cell mRNAs, the FMDV RNA genome is missing a 
standard m7GpppN cap-structure at its 5ʹ-end which eukaryotic cellular translation relies on. 
Cellular cap-dependent translation is initiated when the 5ʹ-cap structure is recognized by eIF4E, 
a cap-binding protein, which  also binds to the N-terminal domain of eIF4G (reviewed in 
Sonenberg & Hinnebusch, 2009). The C-terminal domain of eIF4G also binds to eIF4A and 
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the 40S ribosomal subunit via eIF3. The translation initiation complex then scans along the 
mRNA until it encounters a start codon at which the 60S ribosomal subunit is recruited and 
translation begins. In contrast, cap-independent protein synthesis is dependent on the FMDV 
IRES element and requires almost every cellular translation initiation factors except eIF4E to 
bind to its three-dimensional structures (Martinez-Salas & Belsham, 2017) including the 
poly(rC) binding protein PCBP2. This protein has been found to stimulate the activity of the 
PV IRES and binds to domain I of the FMDV IRES. However, depletion of this protein does 
not block FMDV IRES activity in vitro (Stassinopoulos & Belsham, 2001). Translation of the 
FMDV genome will eventually lead to the shutoff of cap-dependent mRNA translation, since 
the viral encoded Lpro and 3Cpro induce cleavage of eIF4G (Belsham et al., 2000; Devaney et 
al., 1988; Gradi et al., 2004). However, cap-independent translation remains unaffected as 
cleavage of eIF4G only removes the N-terminal portion of the protein which is essential for 
the binding site for the eIF4E. The C-terminal cleavage product of eIF4G, which contains the 
binding sites for eIF4A and eIF3 is still functional for IRES-mediated translation initiation. 
Previously, it has been suggested that the poly(A) tract and the 3ʹ stem-loop help facilitate 
FMDV translation, since deletion of either produced non-infectious FMDV with a lower 
translation efficiency in  in vitro translation reactions (Serrano et al., 2006). Polypeptide chain 
formation can commence at two distinct in-frame start codons (see Genome Organization) 
located in the Lpro coding sequence. The single large ORF encodes a polyprotein which is never 
observed in FMDV infected cells because of a series of co- and post-translationally proteolytic 
cleavages by the viral encoded proteinases (Lpro and 3Cpro) together with the translational 
recoding mechanism (StopGo or ribosomal skipping) at the 2A/2B junction (Donnelly et al., 
2001a). The cleavage products are Lpro (cleaves at its own C- terminus), P1-2A, P2 and P3. 
Each of the P1-2A, P2 and P3 precursor products are processed by the 3Cpro to generate the 
mature structural and non-structural proteins.  
 
Replication of the viral genome 
Replication of positive-stranded RNA viruses occurs within membranous replication 
complexes, derived from host-cellular membranes i.e. the ER and Golgi apparatus. These 
membranous structures have previously been extensively studied in PV (Bienz et al., 1990; 
Schlegel et al., 1996). These membranes are embedded with numerous PV non-structural 
proteins encoded by both the P2 (2B, 2BC, and 2C) and P3 (3A, 3B, 3C, and 3D) regions (Van 
Kuppeveld & Ehrenfeld, 2010). Electron microscopy has demonstrated that the location of the 
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FMDV replication complex forms next to the nucleus and contains membranous structures 
(Monaghan et al., 2004). Knox et al., (2005) showed using immunofluorescence staining that 
FMDV structural and non-structural proteins co-localize in close proximity to the Golgi 
complex. In contrast to other picornaviruses, FMDV-infected cells experience a collapse of the 
cellular organelles to one side of the cell. The membranous replication complexes have been 
reported to appear distinct from those induced by other picornaviruses such as PV, as they 
appear in fewer numbers and do not aggregate into densely packed clusters (Monaghan et al., 
2004). 
A negative-stranded RNA generated from the incoming + ssRNA genome serves a template 
for the replication of additional positive-stranded RNAs (Gamarnik & Andino, 1998). 
Translation of the viral genome proceeds in the 5'-3' direction whereas the replication of the 
genome mediated by the RdRp moves in a 3'-5' direction. The simultaneous events of 
translation and replication are apparently not compatible and translation of the positive-strand 
RNA must presumably cease before negative-strand synthesis can begin. Switching between 
these two mechanisms has in PV been proposed to be initiated by the accumulation of the 3CD 
precursor in the cytoplasm which binds to the cloverleaf structure in the 5ʹ-UTR thereby 
forming a ribonucleoprotein (RNP) complex (Gamarnik & Andino, 1998). This will hinder 
interaction between the PCBP2 and the IRES otherwise required for translation. It remains 
unknown whether 3CD plays a similar role in FMDV RNA replication as 3CD is rapidly 
cleaved to 3Cpro and 3D. In addition, PCBP2 does not appear to affect the activity of the FMDV 
IRES in vitro. At the 3'-terminus of the PV viral RNA, the poly(A) binding protein (PABP) 
binds to the poly(A) tract which subsequently interacts with the RNP complex at the 5'-
terminus essentially circularizing the genome (reviewed in Grubman & Baxt, 2004; Herold & 
Andino, 2000). For FMDV, this interaction has been suggested to include the S-fragment and 
the poly(C) tract (Serrano et al., 2006). Negative-strand RNA synthesis begins with the 
uridylylation of 3B (VPg) which acts as a primer for the RdRp. VPgs bind to the first two A’s 
in the conserved AAACA motif of the cre, serving as a template for the synthesis of VPgpU 
and VPgpUpU catalysed by the 3D (Nayak et al., 2005). It is unclear whether free VPg is 
normally utilized in the initiation step or whether a precursor (either 3AB, 3ABC, or 3BCD) is 
needed. Elongation of the negative-strand catalysed by the FMDV RdRp begins once the 
uridylylated VPg (VPgpU or VPgpUpU) binds to the poly(A) tail located at the 3ʹ-end  of the 
positive-strand template. The elongation of the nascent strands has been suggested to result in 
a double-stranded replicative form (RF) consisting of positive-strand template and newly-
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synthesised negative RNA (Paul & Wimmer, 2015; Wimmer et al., 1993). Free negative-
strands are not detectable in vivo, further supporting this claim. The ratio of positive- to 
negative-strands is about 50:1 (Novak & Kirkegaard, 1991), indicating that a single negative-
strand serves as a template for the synthesis of many positive-strands which occurs through a 
partially double-stranded RNA molecule. The Qβ bacteriophage (another + ssRNA virus) has 
been found to use an alternative model of replication which does not involve a double-stranded 
RF (reviewed in Tomita, 2014). The 3΄-end of the RNA template (either positive- or negative-
sense RNA) is recruited to the active site of the Qβ RdRp (Qβ replicase) though the tunnel-II 
where it initiates RNA replication de novo. The nucleotide triphosphates (NTP) enter through 
the NTP entrance tunnel and base‐pair with the template RNA to form the new elongating RNA 
strand. When the positive:negative duplex exceeds 9 bp, a change in the orientation of the 
interior of the RdRp results in a separation of the positive- and negative-strands. This model is 
independent of a RF intermediate, but it has not been investigated whether it is applicable to 
the picornavirus family.  
 
Assembly and release of the FMDV virion 
In order to generate mature FMD virions capable of infecting new cells, encapsidation of the 
FMDV RNA and the cleavage of VP0 to VP2 and VP4 to form the mature virion must occur. 
The mechanisms involved in FMDV RNA encapsidation and the maturation cleavage are not 
well studied and remain largely unknown. Picornaviruses have been shown only to encapsidate 
VPg-linked positive-strand RNA thereby ensuring that unwanted cellular RNA is not 
incorporated into the mature capsid. Furthermore, it appears that only newly synthesized 
positive-strand RNAs are encapsidated, suggesting that there is a connection between the 
ongoing RNA replication and the encapsidation process (Nugent et al., 1999). It is believed 
that the positive-strand RNA may contain a cis-acting packaging signal which helps to facilitate 
encapsidation (Grubman & Baxt, 2004). Disruption of conserved secondary RNA structures 
within the coding region of the FMDV genome has been shown to results in attenuation of 
virus growth in cell culture as a consequence of fewer available mature virions (Logan et al., 
2017). This was interpreted as evidence for the involvement of these RNA structures in the 
packaging of FMD virions.  
The FMDV capsid is formed from 60 copies of each of the four different capsid proteins (VP1 
to VP4), whereby five protomers, each containing one copy of VP0, VP1, and VP3, assemble 
into a pentamer, and 12 pentamers assemble to make the complete particle. It still remains 
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unknown whether the viral RNA is inserted into the capsid following assembly or if there is 
interaction between the capsid pentamers enabling virus assembly around the RNA genome. 
Mature virions are formed when VP0 is autocatalytically cleaved to VP2 and VP4, which is 
believed to occur upon encapsidation of the RNA but also happens following empty capsid 
assembly (Curry et al., 1995; Gullberg et al., 2013a). Cleavage of VP0 is primarily required 
for particle stability, since the interactions between the newly formed VP2 and VP4 help 
reinforce the connection between capsid subunits. The influence of this cleavage on the FMDV 
virion maturation has been investigated by introducing substitutions within the VP0 precursor 
near the cleavage site. Some substitutions resulted in a loss of infectivity, but the mutant viruses 
were still capable of recognizing the receptor on susceptible cells emphasising the importance 
of this cleavage for the generation of infectious virus (Knipe et al., 1997). Following assembly 
and maturation of the virions, they are released from the infected host cells. 
  
2A mediated ribosomal skipping at the 2A/2B junction  
The separation of the P1-2A precursor from P2 of the FMDV polyprotein occurs at the 2A/2B 
junction (Belsham, 2005). In the majority of picornaviruses, cleavage at the junction between 
the structural and non-structural proteins is mediated by a 2A protein, but the size and function 
of the 2A differs between the different genera (Luke et al., 2008). In entero- and rhinoviruses, 
the 2A protein is a thiol proteinase, designated 2Apro, which cleaves the polyprotein at its own 
N-terminus, i.e. the P1/2A junction (Sommergruber et al., 1989; Toyoda et al., 1986). In 
contrast, the cleavage of the capsid precursor (P1-2A) from P2 (2BC) within the cardio- and 
aphthovirus polyproteins occurs at the 2A/2B junction, i.e. at the C-terminus of 2A. The 2A 
subsequently remains attached to P1 until removed by the 3Cpro. The 2A region of the FMDV 
is only 18 amino acids in length compared to the 150 residues of the 2A protein of 
cardioviruses, but both lack any characteristic protease motifs. In addition, no sequence 
similarity is observed between the 2A of cardio- and aphthoviruses other than the conserved 
C-terminal sequence motif D(V/I)E(x)NPG2A↓P2B at the junction between 2A and 2B (Ryan et 
al., 1989, 1991, Palmenberg et al., 1992). The first residue of the adjacent protein 2B, Proline 
or P, is a key part of the “cleavage” site and is likewise completely conserved. Thus these 2A 
proteins can be defined as having two-parts, one comprising a non-conserved sequence of 
amino acids followed by the conserved D(V/I)E(x)NPG2A↓P2B motif. Early studies into the 
mechanism of this cleavage demonstrated that neither the FMDV encoded proteases Lpro and 
3Cpro nor host cellular proteases were responsible for the rapid cleavage (Palmenberg et al., 
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1992; Ryan et al., 1989, 1991). These results suggested that “cleavage” mediated by the FMDV 
2A occurred co-translationally through a novel protease independent system (this process will 
simply be described as cleavage subsequently, for convenience). Ryan et al., (1991) 
constructed multiple recombinant FMDV polyproteins in which sequences either upstream or 
downstream of the 2A peptide were removed. Only the polyproteins with deletions extending 
into the 2A peptide abrogated cleavage activity. This suggested that the 2A sequence was solely 
responsible for the co-translational cleavage. To demonstrate this, artificial polyprotein 
systems were generated encoding reporter sequences flanking the 2A peptide together with the 
N-terminal proline of 2B (Ryan & Drew, 1994). Analysis of these artificial polyprotein systems 
using rabbit reticulocyte lysates exhibited high-level cleavage activity confirming that cleavage 
at the 2A/2B junction was an autonomous event. The current model for cleavage at the 2A/2B 
junction (see Figure 5) is that the 2A peptide induces an unusual proteolysis-independent co-
translational cleavage event that is referred as “ribosomal skipping” (Donnelly et al., 2001a) 
or, alternatively,  “stop-carry on” or “StopGo” (Atkins et al., 2007; Doronina et al., 2008). 
Prediction of the geometry of the amino acids within 2A suggest that the non-conserved 
upstream amino acids possess a strong propensity to form an α-helix over most of its length 
with a tight reverse turn motif (ESNPG) at its C-terminus (Donnelly et al., 2001a; Ryan et al., 
1999). This particular structure is believed to interact with the exit tunnel of the elongating 
ribosome and bring about a stereo-chemical reorientation of the turn motif thereby influencing 
the events within the peptidyl transferase centre (PTC) of the ribosome. This subtle shift of the 
peptidyl-tRNAGly in the PTC, precludes peptide bond formation to the prolyl-tRNAPro 
(Doronina et al., 2008). Peptide bond formation is achieved by the nucleophilic attack on the 
electrophilic carbonyl group of the tRNAGly located in the P-site by the tRNAPro amino group 
located in the A-site. Proline has a distinctive cyclic structure which results in an exceptional 
conformational rigidity. It has also been documented that proline is a poor nucleophile in 
peptide synthesis compared to other amino acids (Rychlík et al., 1970). It is believed that these 
characteristics are a contributing factor to 2A activity and explains the conservation of a P at 
the C-terminus of the NPG↓P motif in all 2A proteins. These events are believed to bring about 
a pause in translation resulting in inhibition of the formation of a peptide bond between the C-
terminal amino acid, glycine (gly, or G), of 2A and the first residue, proline (P), of 2B. The 
pause in translation leads to dissociation of tRNAPro from the A-site of the ribosome. There are 
two alternative outcomes: I) release of the nascent amino acid chain and reinitiation of 
translation with proline as the first residue or II) dissociation of the ribosome complex 
terminating translation. This is interestingly in accordance with previous results which found a 
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substantial molar excess of the upstream product in several polyproteins comprising two 
reporter proteins linked via the 2A peptide (CAT-2A-GUS, GUS-2A-CAT, GFP-2A-GUS or 
GUS-2A-GFP) (Donnelly et al., 2001a).  
During classical translation, eukaryotic release factors eRF1 and eRF3 are responsible for 
stimulating the hydrolysis (release) of completed proteins from tRNA during termination by 
formation of a complex with the elongating eukaryotic ribosomes. Doronina et al., (2008) 
demonstrated that by depleting eRF1 in yeast, a greater proportion of ribosomes translate 
through the 2A coding sequence without cleavage and thus yield the full-length protein. 
Impaired eRF3 activity lead to many ribosomes failing to translate beyond 2A. These results 
suggested that stalled ribosome-2A complexes promote eRF entry without reading the specific 
mRNA, as the eRFs must recognize the A-site proline codon as, in effect, the termination 
signal. This must be followed by a dissociation of the eRF complex to facilitate the entry of a 
charged tRNA to the A site of the ribosome. The tRNA located in the A-site is then translocated 
to the P-site to become the initiating N-terminus tRNA of the downstream nascent protein 
chain. It is suspected that the level of eukaryotic elongation factors may determine whether, 
after hydrolysis, the ribosome dissociates or continues to translate the downstream context 
(Brown & Ryan, 2010). In contrast, a recent study using a fully reconstituted system, using 
recombinant factors based on human cell extracts, showed that EMCV 2A-mediated 
translational recoding functions in the absence of eRFs (Machida et al., 2014). Thus the role of 
these factors is still controversial.  
Specific amino acid substitutions within the FMDV 2A sequence, and especially within the 
highly conserved D12(V/I)E(S/T)NPG2A↓P192B motif, drastically reduce the cleavage efficiency 
in vitro and can even block it entirely (Donnelly et al., 2001b; Sharma et al., 2012). Gao et al., 
(2014) assayed four different synonymous codons for residue G18 of the 2A peptide in the 
context of an artificial reporter polyprotein within CHO cells. They were all shown to function 
with very similar apparent cleavage efficiencies at the 2A/2B junction. However, it is 
noteworthy that the cleavage efficiency of the system was only 88-89% and thus not optimal. 
These results indicate that it is the amino acid residues and not the nucleotide sequence within 
the 2A region which is instrumental for 2A activity.  
The different 2A sequences can be transposed into new contexts and still remain active 
meaning that they are autonomous elements. However, despite being shown to work in a 
variety of eukaryotic settings (including plant, insect and mammalian cell systems) they do not 
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work in bacteria (Donnelly et al., 1997). The context of the 2A sequence is important. An 
appropriate upstream sequence has been demonstrated to be essential for 2A function. Sharma 
et al., (2012) generated hybrid 2A peptides by replacing the N- or C-terminal portions of the 
2A region from FMDV, TMEV and EMCV with another 2A variant within the context of an 
artificial polyprotein system. The hybrid 2A variants showed low or no activity suggesting that 
each 2A variant is optimized for function in its natural state. By elongating the FMDV 2A, in 
an artificial polyprotein system, with upstream VP1 residues, thereby increasing the chain 
length to up to 30 amino acids, its activity was enhanced (Donnelly et al., 1997, 2001b; 
Minskaia et al., 2013). Similar results were observed for other picornavirus 2As, in which the 
2A peptide was elongated with sequence from their respective polyprotein precursors (Luke et 
al., 2008). Moreover, an extensive alanine (A), glycine (G) and proline (P) scanning 
mutagenesis of the entire FMDV 2A peptide showed that the majority of substitutions and 
especially those within the highly conserved D(V/I)E(S/T)NPG2A↓P192B region reduced the 
cleavage activity  (Donnelly et al., 2001b; Sharma et al., 2012). It is, however, difficult to 
distinguish critical residues which interact with the ribosome tunnel from flanking “space-
filling” residues. Sharma et al., (2012) suggested that the 2A peptides are fine-tuned to function 
as a single unit within their natural polyprotein. 
Much of the research into the function of 2A has been conducted using in vitro experiments 
with mRNAs encoding artificial polyproteins comprising two reporter proteins linked via the 
2A peptide. It has been considered that the cleavage mediated by the 2A peptide was essential 
for the viability of cardioviruses and FMDV. However not much information is available on 
2A modifications in the context of the native polyprotein and its influence on the replication 
and translation. Loughran et al., (2013) studied the effect of substitutions in the 2A coding 
sequences within the context of full-length TMEV and FMDV genomes on virus viability and 
polyprotein processing. Modification of the SNPG↓P2B sequence to SNPL↓V2B at the 2A/2B 
junction blocked polyprotein cleavage. Surprisingly, this modification had no observable effect 
on the growth of TMEV. However, interestingly, it was detrimental for the replication of 
mengovirus (another cardiovirus) and apparently lethal for FMDV. This suggested that the 
StopGo function is not essential for virus viability for certain cardioviruses but is critical for 
FMDV.  
The FMDV 2A peptide is located at the boundary between the structural proteins and the non-
structural proteins involved in RNA replication. It has been speculated the 2A peptide has dual 
functions (Tulloch et al., 2017). Firstly, to achieve cleavage of the polyprotein at the 2A/2B 
26 
 
junction but secondly to act as a translational regulator to down-regulate translation of the non-
structural proteins in the later stages of infection. Such a mechanism has not yet been confirmed 
in FMDV but 2A has been found to act as a translational regulator in the translation of the 
EMCV genome. Recently, it was discovered that a programmed -1 ribosomal frameshifting 
motif was present within the coding region for the 2B protein. It directs a proportion of 
ribosomes into a short overlapping ORF resulting in the production of a “trans-frame” protein, 
2B* (Loughran et al., 2011). The coding sequence for 2B* harbours a stop codon at its C-
terminus. The ribosome slip site (GGUUUUY) is also conserved in TMEV and other 
cardioviruses. Napthine et al., (2017) showed that the 2A protein, at 6-8 hours after infection 
(late stages of infection),  interacts with an RNA structure beginning 14 nt downstream of the 
ribosome slip site, forming a RNA-protein complex that induces highly efficient programmed 
-1 ribosomal frameshifting. As a result, the frameshifting efficiency increases from 0 to 70% 
over the course of infection, thus downregulating the translation of the viral non-structural 
proteins. 
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Figure 5: Model of the 2A mediated translational skipping at the 2A/2B junction. (1) The growing 
nascent polyprotein chain upstream of the 2A/2B junction exits the ribosome through the ribosomal exit 
tunnel. (2) The polyprotein-2A bound to the glycyl-tRNA is translocated from the A- to P-site after 
which proline charged prolyl-tRNA enters the A-site. (3) The 2A region in the growing polyprotein 
interacts with the ribosomal exit tunnel leading to a stereo-chemical reorientation of the turn motif of 
the C-terminal portion (ESNPG) within the peptidyl-transferase centre (PTC) of the ribosome. The 
peptide bond formation (nucleophilic attack) between 2A and the proline attached to the prolyl-tRNA 
in the A-site is inhibited thereby pausing the translation. The prolyl-tRNA leaves the A-site of the 
ribosome. (4) Release factors eRF1/3 binds to the A-site (5) eRF1/3 hydrolyse the ester linkage between 
the polyprotein and the glycyl-tRNA (6) The nascent protein and the eRF1/3 release factors leave the 
ribosome (7) The proline charged prolyl-tRNA enters the A-site (8) The translocation to the P-site is 
mediated by the elongation factor 2 (eEF2)  (9) The next amino-acyl tRNA enters the A-site and protein 
synthesis of the proteins downstream of 2A continues without the need of a new reinitiation event. 
Adapted from Roulston et al., (2016).  
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Functional structural RNA elements within 
the FMDV genome  
 
The multi-functional RNA molecule  
The central dogma has been a cornerstone in molecular biology since it first was defined in 
1958 (Crick, 1970). It states that the irreversible transfer of genetic information from DNA to 
protein flows through RNA. RNA had previously only been considered a messenger for 
translation (mRNA) and had been divided into either coding or non-coding species (Jacob & 
Monod, 1960). The understanding of the role of RNA in biological systems has since expanded 
and today RNA is known to also act as regulatory, enzymatic and structural molecules (Garst 
et al., 2011; Vandivier et al., 2016). This has led to the formulation of the RNA World 
hypothesis (Gilbert, 1986). It postulates that RNA was crucial for the evolutionary history of 
life on Earth and that self-replicating RNA molecules with catalytic properties preceded DNA. 
To accomplish these divergent tasks, RNA forms functional structures through a variety of 
modular, intramolecular interactions through base pairs via Watson-Crick, Hoogsteen or sugar-
edge patterns of hydrogen bonds in conjunction with co-factors and RNA-binding proteins. 
These structures define the catalytic active sites or modulate the function of regulatory motifs. 
RNA can fold into several distinct three-dimensional secondary structures including stem-
loops, bulges, internal loops, hairpins, stems, terminal loop and multiloops (see Figure 6). 
 
RNA structure and function  
The overall structure, which RNA assumes after transcription, is essential for correct function 
of many RNAs. tRNAs are a fundamental component of the translational machinery and the 
most abundant of all small non-coding RNA molecules, constituting 4–10% of all cellular 
RNA. It has been shown that their overall tertiary structure is shared among the different tRNAs 
and that this structure is essential for tRNAs to become charged with their cognate amino acid 
(Giegé et al., 2012). Ribosomal RNA (rRNA) is the most abundant class of RNA in both 
eukaryotic and prokaryotic cells. It is well established that the three-dimensional structure is 
an integral part of the function of ribosomes (Wilson & Cate, 2012). Other RNA molecules 
including non-coding miRNAs or small interfering RNA (siRNAs) also adopt distinct tertiary 
structures which enable them to function as post-transcriptional regulators of gene expression 
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or interfere with the expression of specific genes (Filipowicz et al., 2005). The structures within 
the mRNAs found in both prokaryotes and eukaryotes can also influence translational 
efficiency. Insertion of stable hairpin loops around the Shine-Dalgarno sequence can alter the 
kinetics of translation and reduce expression levels (Kubo & Imanaka, 1989). Svitkin et al., 
(2001) demonstrated that translation of mRNAs with stable secondary structures in the 5ʹ-UTR 
were more sensitive to inhibition by an eIF4A mutant. eIF4A is believed to unwind the 
secondary structures located in the mRNAs 5ʹ-terminus to facilitate ribosome binding (Rogers 
et al., 1999; Sonenberg & Gingras, 1998). Furthermore, it has shown that the IRES elements 
from PV, EMCV and FMDV also were inhibited by the mutant.  
 
Figure 6: Components of RNA secondary structures. The single stranded RNA molecule generates 
elaborate secondary structures formed by base pairing between self-complementary sequences from 
different parts of the RNA chain. Adapted from Fariza et al., 2017. 
 
RNA secondary structure probing 
A better understanding of the fundamental cellular processes, which these RNA are an essential 
part of, will depend on knowledge of the structures of the RNAs. To determine the function of 
either cellular or viral RNA molecules various chemical, physical, and computational methods 
have been developed to investigate their structure. Investigations into RNA folding were 
promoted by the characterization of the tertiary structure of both prokaryotic and eukaryotic 
tRNAs through the use of X-ray crystallography (Kim et al., 1974; Robertus & Ladner, 1974). 
However, this technique requires transcripts to readily form crystals, which limits the technique 
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to the study of a few classes of RNA. There are, to date, a variety of structural probing methods 
available, either chemical or enzymatic in nature. The common feature for many of these 
methods is that they rely on modification of the RNA either through RNase digestion, RNA 
crosslinking, binding of complementing nucleotides to single-stranded RNA regions, nuclease 
treatments to determine scissions specific for single stranded/double stranded regions 
(Vandivier et al., 2016). These methods can have nucleotide biases, preferentially 
cleaving/binding to some nucleotides more than others, potentially generating unreliable RNA 
structures. More accurate probing without nucleotide bias was achieved using selective 2ʹ-
hydroxyl acylation analysed by primer extension (SHAPE) (Deigan et al., 2009) (see Figure 
7). This method uses electrophilic reagents such as isatoic anhydride (IA), N-methyl isatoic 
anhydride (NMIA), 1-methyl-7-nitro-isatoic anhydride (1M7), or benzoyl cyanide (BzCN) 
which react with the 2ʹ-hydroxyl group of the nucleotide resulting in the formation of covalent 
adducts. The methods are therefore independent of the purine or pyrimidine nature of the bases. 
The reactivity is strongly dependent on the nucleotide flexibility since flexible nucleotides are 
more prone to form covalent adducts compared to constrained nucleotides (Weeks & Mauger, 
2011). SHAPE reagents undergo hydrolysis when in contact with water, thus inactivating them 
and making an additional quenching step redundant. Adducts can be detected using reverse 
transcriptase-mediated primer extension. The presence of the 2ʹ-O adduct hinders the 
elongation of the DNA strand and DNA synthesis by reverse transcriptase is terminated one 
nucleotide prior to the position of an adduct. The length of each cDNA reports the site of a 
SHAPE modification in the original RNA. A reaction using unmodified RNA is performed to 
determine the sites of natural reverse transcriptase pausing or pre-existing RNA degradation. 
The cDNA is subsequently sequenced using either conventional Sanger sequencing or next-
generation sequencing (NGS) and peaks from the modified and no-reagent analyses are 
assigned by comparison with sequencing ladders. Subtracting the intensity of the “no-reagent” 
control from the modified RNA intensities results in a reactivity profile. Nucleotides 
constrained by base-pairing and tertiary interactions have low SHAPE reactivities whereas 
single-stranded and unconstrained nucleotides have higher reactivities. 
In the last decade, the introduction of NGS technologies has revolutionized nucleotide 
sequencing and caused a shift away from first generation sequencing, i.e. Sanger sequencing, 
in the study of biological systems (van Dijk et al., 2014). The major advance offered by NGS 
technologies are their abilities to produce, at a low cost, an enormous amount of data (thousands 
to millions of reads) which would otherwise be impossible for traditional DNA sequencing. 
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Recently, the coupling of probing SHAPE with NGS has allowed for higher throughput, 
increased accuracy, and the ability to perform experiments on a mixture of RNAs (multiplex). 
 
 
Figure 7: Schematic representation of the strategy of the Selective 2ʹ-Hydroxyl Acylation analysed 
by Primer Extension probing. (a) The RNA is probed with a suitable SHAPE reagent. Flexible 
nucleotides are more prone to interact with the reagent forming adducts. (b) Reverse transcription 
primers are extended by reverse transcriptase which stops one nucleotide prior to the position of an 
adduct, thus revealing the positions of adduct formation. (c) Each generated cDNA fragment is 
sequenced to determine the site of the SHAPE modification. A no-reagent control and sequencing 
markers is included. (d) Subtraction of the intensity of the no-reagent control from the modified RNA 
yields a normalized reactivity profile. Adapted from Weeks & Mauger, (2011). 
 
Conserved RNA structures in FMDV  
The FMDV genome harbours multiple RNA structures, which have been demonstrated to be 
crucial for both genome replication and translation. These structures are primarily found in the 
5ʹ-UTR and 3ʹ-UTR regions of the genome. In the 5ʹ-UTR (see Figure 8) they are divided into 
the five functional elements termed the S-fragment, poly(C) tract and pseudoknots, cre and 
IRES. The 3ʹ-UTR contains two stem-loops (Belsham, 2005).  
The S-fragment is approximately 360 nucleotides in length and its sequence is predicted to fold 
into a long stem-loop (Clarke et al., 1987; Witwer et al., 2001). The exact function of the S-
fragment is not known. It was been reported that the S-fragment can interact with the cellular 
proteins RNA helicase A, PABP and PCBP, together with the viral proteins 2C, 3A and 3Cpro, 
which are all involved in genome replication (Lawrence & Rieder, 2009). Furthermore, it has 
been established that the S-fragment binds to structural motifs in the 3ʹ-UTR which are 
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presumed to lead to circularization of the viral genome (Lawrence & Rieder, 2009; Serrano et 
al., 2006). Recently, Kloc et al., (2017) have demonstrated that FMDV mutants with deletions 
in the S-fragment triggered an increase in type I interferon mRNA levels (innate immune 
response). Furthermore, the deletion of a 164 nucleotide sequence in the upper S-fragment loop 
proved to be highly attenuated in an FMDV mouse model system. This suggest that the S-
fragment is involved in modulating the host innate immune response.  
Following the S-fragment is a long stretch of C-residues termed the poly(C) tract, which is 
common to the aphthoviruses and most cardioviruses. The poly(C) tract exhibits considerable 
variation in length among the variety of different FMDV isolates, from 80 nt to 450 nt. The 
short tracts are most often found within laboratory strains whereas field strains of FMDV, in 
general, contain poly(C) tracts of around 200 nt in length. The length of this region has 
previously been shown to significantly influence pathogenicity within cardioviruses (Duke et 
al., 1990). Although some early studies suggested that the length of the poly(C) tract was 
associated with virulence of FMDV (Harris & Brown, 1977; Rieder et al., 1993), others have 
not been able to directly associate the two (Costa Giomi et al., 1984). It has been shown that 
the poly(C) lengths of a genetically modified FMDV genome requires a minimum length to 
function optimally. Genetically modified FMDV genomes which contained just six C-residues 
were selected against. The rescued viruses, after a few passages in cell culture, contained 
poly(C) tracts with at least 80 C-residues. In contrast, the tract did not increase in length when 
the modified FMDV genomes only contained two C-residues. This virus remained as 
pathogenic in suckling mice as the wt, albeit with a lower replication efficiency in tissue culture 
(Rieder et al., 1993). Modified mengoviruses with short poly(C) tracts were viable in cell 
culture, but attenuated in mice. The rescued viruses were genetically stable after several 
passages (Duke et al., 1990). In contrast, the function of the poly(C) tract appear to be different 
in the closely related EMCV. Modified EMC viruses with different sized poly(C) tracts were 
shown to possess the same level of pathogenicity in animals as the wt and also demonstrated 
the same replication rate using growth-curves (Hahn & Palmenberg, 1995). Downstream of the 
poly(C) tract in FMDV RNA is a region, which is predicted to fold into a series of RNA 
pseudoknot structures (Escarmís et al., 1995). The function of these elements are still unknown, 
but interestingly the poly(C) tract is located on the 3ʹ side of the pseudoknots within the 
genomes of cardioviruses (Martin & Palmenberg, 1996) thereby making it plausible that these 
elements have some form of interaction.  
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RNA structures, now termed cis-acting replication elements (cre), were first characterized by 
McKnight & Lemon (1996) who demonstrated that a sequence within the P1 coding region of 
the human rhinovirus 14 genome was required for viral RNA replication. The sequence was 
necessary in the form of RNA and is predicted to form a stem-loop structure containing a 
conserved AAAC motif in the loop region. This motif serves as the template for the RdRp 
mediated uridylylation of 3B (VPg) to  produce VPgpU and/or VPgpUpU, collectively termed  
VPgpU(pU) (Paul et al., 1998). VPgpU(pU) serves as a primer for the initiation of viral RNA 
synthesis. Interestingly, the location of the cre within other picornavirus genomes has been 
identified in various different places within the coding region of the respective genomes 
(Goodfellow et al., 2000). FMDV is unique is this regard in having the cre structure embedded 
outside of the coding region and within the 5ʹ-UTR (Mason et al., 2002). The importance of 
this region is demonstrated by the impaired replication of FMDV replicons when the AAACA 
motif in the stem region was modified. Furthermore, it was also shown that the position of the 
cre within the 5ʹ-UTR of the genome was not essential for replication, since insertion of the 
structure into the 3ʹ-UTR could restore replication ability in replicons and viruses lacking the 
original 5ʹ cre. Tiley et al., (2003) demonstrated that the cre can be complemented in trans by 
co-infecting a temperature-sensitive FMDV with a mutation within the cre with another ts 
mutant FMDVs with a defects in other regions of the genome. The cre has, therefore, been 
suggested to be renamed a 3B-uridylylation site (bus).  
The region between the cre and ORF is termed the internal ribosome entry site (IRES) and is 
approximately 450 nt in length and contains a series of highly conserved complex stem-loop 
structures essential for the cap-independent internal initiation of translation on the viral RNA 
(Kühn et al., 1990; Belsham & Brangwyn, 1990). IRES-driven translation initiation depends 
on the recognition of the IRES by both translation initiation factors and other cellular proteins 
necessary for translation of cellular mRNAs. These proteins interact with the five highly 
conserved domain structures, H-L, and with a pyrimidine-rich region at its 3ʹ end immediately 
preceding the first AUG translation initiation codon to promote translation (Pilipenko et al., 
1989). Domain H contains a polypyrimidine tract (UCUUU) that provides a binding site for 
PTB. Domain I has a distinctive cruciform structure that harbours three conserved essential 
motifs, GNRA and RAAA at the apical region, and a conserved C-rich loop. Modifications of 
either the GNRA or RAAA motif led to a reorganization of the entire domain and significantly 
diminished the IRES activity (López de Quinto et al., 2002). Domains J and K are arranged as 
two stem-loop structures in a Y-shape containing A residue-rich internal bulges and act as the 
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binding site for the essential translation initiation factor eIF4G. Domain L consists of a short 
conserved hairpin-loop with a polypyrimidine tract at 20 nt upstream of the initiation codon 
AUG. This provides the binding site for eIF4B, PTB and other cellular proteins necessary for 
IRES driven translation (Belsham, 2005; Belsham & Sonenberg, 1996; Martinez-Salas & 
Belsham, 2017). 
The 3ʹ-UTR of FMDV consists of a unique sequence of ca. 100 nt folded into two separate 
stem-loops (Witwer et al., 2001) followed by a poly(A) tract of varying length. Studies have 
demonstrated the 3ʹ-UTR of FMDV is essential for viral replication, since deletion of this 
region renders viral replication impossible (Sáiz et al., 2001). In contrast, PV replication can 
still proceed without this region, although at a reduced level (Todd et al., 1997). The 3ʹ-UTR 
can bind to both the S-fragment and the IRES domains within the 5ʹ-UTR through long-range 
RNA-RNA interactions (Serrano et al., 2006). Interaction between the 3ʹ-UTR and the IRES 
requires both stem–loop structures of the 3ʹ-UTR whereas only one stem-loop is required for 
the S-fragment interaction. 
 
Figure 8: Schematic representation of the structural elements within the 5ʹ-UTR of FMDV. The 
5ʹ-UTR has been shown to contain five secondary RNA structures termed the S-fragment, poly(C) tract, 
cis-acting replication element (cre) or alternatively the 3B-uridylylation site (bus), pseudoknots (PKs), 
and internal ribosome entry site (IRES). A detailed description of the investigations into the exact 
function of these elements is described in the text. The IRES is further divided into individual domains 
(H-L). The conserved GNRA motif and the polypyrimidine tracts (PPTs) are indicated. The conserved 
and essential AAACA motif in the cre/bus is also indicated. The two different initiation sites (Lab and 
Lb) are shown. Adapted from Belsham, (2005). 
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SHAPE probing of the FMDV genome 
Despite the well-established influence of the previously described functional RNA elements 
on FMDV replication and translation the nature of many of these RNA structures and the 
effects of sequence variation on their structure are poorly understood. Recently, Diaz-Toledano 
et al., 2017 investigated the RNA local flexibility of the FMDV IRES and the 3ʹ-UTR in the 
context of RNA transcripts in vivo. It has been suggested that long-range RNA-RNA 
interactions between the IRES and the 3ʹ-UTR exist, but whether the interaction induces a 
conformational change in the structures has remained unknown. This study used a novel 
approach by using SHAPE in living cells thus providing better and more accurate structure 
models of the RNA in its natural environment. It was demonstrated that the SHAPE results 
using the FMDV IRES in its natural state showed significant differences with in vitro data 
using RNA transcripts, revealing protected or exposed positions within the IRES and the 3ʹ-
UTR. These data have provided new information concerning the local flexibility of the IRES 
and 3ʹ-UTR confirming long-range interactions between these distant elements of the viral 
genome and proving a conformational change during interaction.  
IRES function is tightly linked to the RNA structure and substitutions which affect the structure 
significantly diminish function. The GNRA motif located within region I adopts a tetraloop 
conformation and has been shown to mediate the overall structure of the region by a possible 
RNA-RNA interaction. Fernández et al., (2011) confirmed, using SHAPE probing, that the 
conformation of region I depends on specific nucleotides of the GNRA loop and that this loop 
most likely are involved in tertiary interactions within region I. SHAPE probing of the FMDV 
genome has so far been focused on the IRES and research into the structure of the remaining 
structures in the 5ʹ-UTR are still to be conducted. In addition, little is known about the RNA 
structures in the coding region of the FMDV. Some picornaviruses have been found to also 
harbour RNA structures within the coding sequence of the genome which are essential for viral 
RNA replication and translation. McKnight & Lemon, (1996) demonstrated that a sequence 
within the capsid coding sequence is required for efficient replication of human rhinovirus 14. 
A similar element has been identified in the 2C coding region of PV (Goodfellow et al., 2000). 
A global RNA structure map of the PV genome generated using SHAPE probing has recently 
also demonstrated several conserved RNA structures in the ORF of the viral genome (Burrill 
et al., 2013). In particular, a structure located in the region encoding the RdRp has been shown 
to be required for viral replication and infectivity. The study further suggested a novel 
interaction between an RNA structure in the RdRp coding region and the viral protein(s) 3Cpro 
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and/or its precursor 3CDpro. Similar global RNA structure maps of the FMDV genome have 
also been predicted (Davis et al., 2008; Simmonds et al., 2004), however the functional role of 
these structures has not been determined, but have been suggested to be implicated in the 
evasion of cell defences (Simmonds et al., 2008). Kloc et al., (2017) have recently 
demonstrated that the S-fragment within the 5ʹ-UTR of FMDV is involved in the regulation of 
the host innate immune response.  
 
In silico prediction of RNA secondary structures   
Chemical structure probing analysis can provide reliable structural data, but the methods can 
be laborious. In contrast, computational prediction (in silico) of RNA secondary structures has 
shown to be fast. In silico predications are based on either thermodynamics of the molecules 
(minimum free energy) (Mathews et al., 1999), conservation of RNA structures between 
organisms or a combination of the two (James et al., 1989). The thermodynamic approach 
relies on the principle that the real structure must be the most thermodynamically stable, i.e., 
the one with the minimum free energy. The mfold software for RNA folding was developed in 
the late 1980s (Zuker, 2003), and has been used in numerous papers. The program predicts a 
minimum free energy for an input sequence. However, there are limitations to this model 
including that RNA structures are influenced by the environment such as other macromolecules 
(other RNAs, protein, etc.) which can give rise to new RNA structures with lower energy levels 
through interactions with the original. Additionally, the fidelity of in silico predictions 
decreases as a function of increasing RNA complexity (sequence length). The comparative 
approach is only applied when homologous RNA sequences are available.  
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Abstract 
Foot-and-mouth disease virus (FMDV) has a positive-sense ssRNA genome that includes a 
single, large, open reading frame encoding a polyprotein. The co-translational “cleavage” of 
this polyprotein at the 2A/2B junction is mediated by the 2A peptide (18 residues in length) 
using a non-proteolytic mechanism termed “ribosome skipping” or “StopGo”. Multiple 
variants of the 2A polypeptide with this property among the picornaviruses share a conserved 
C-terminal motif (D(V/I)E(S/T)NPG↓P). The impact of 2A modifications within this motif on 
FMDV protein synthesis, polyprotein processing and virus viability were investigated. Amino 
acid substitutions can be tolerated at residues E14, S15 and N16 within the 2A sequence of 
infectious FMDVs despite their reported “cleavage” efficiencies at the 2A/2B junction of only 
ca. 30-50% compared to wt. In contrast, no viruses were rescued containing substitutions at 
residues P17, G18 or P19 that displayed little or no “cleavage” activity in vitro, but wt revertants 
were obtained. The 2A substitutions impaired the replication of a FMDV replicon. Using 
transient expression assays, it was shown that certain amino acid substitutions at residues E14, 
S15, N16 and P19 resulted in partial “cleavage” of a protease-free polyprotein indicating that 
these specific residues are not essential for co-translational “cleavage”. Immunofluorescence 
studies, using full-length FMDV RNA transcripts encoding mutant 2A peptides, indicated that 
the 2A peptide remained attached to adjacent proteins, presumably 2B. These results show that 
efficient “cleavage” at the 2A/2B junction is required for optimal virus replication. However, 
maximal StopGo activity does not appear to be essential for the viability of FMDV. 
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Importance  
Foot-and-mouth disease virus (FMDV) causes one of the most economically important 
diseases of farm animals. Co-translational “cleavage” of the FMDV polyprotein precursor at 
the 2A/2B junction, termed StopGo, is mediated by the short 2A peptide through a non-
proteolytic mechanism which leads to release of the nascent protein and continued translation 
of the downstream sequence. Improved understanding of this process will not only give a better 
insight into how this peptide influences the FMDV replication cycle but may also assist the 
application of this sequence in biotechnology for the production of multiple proteins from a 
single mRNA. Our data show that single amino acid substitutions in the 2A peptide can have 
a major influence on viral protein synthesis, virus viability and polyprotein processing. It also 
indicates that efficient “cleavage” at the 2A/2B junction is required for optimal virus 
replication. However, maximal StopGo activity is not essential for the viability of FMDV.  
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Introduction 
Foot-and-mouth disease virus (FMDV) is the causative agent of foot-and-mouth disease, a 
highly contagious disease of domestic and wild cloven-hooved animal species. The virus has 
been successfully eradicated from Europe but is still endemic in many regions of the world (in 
Asia, Africa and the Middle East) and can potentially cause major outbreaks in domestic 
livestock elsewhere with severe economic losses (reviewed in [1]). FMDV is the prototypic 
member of the Aphthovirus genus within the family Picornaviridae. These viruses are small 
(ca. 25-30nm) and have a positive-sense ssRNA genome [2]. The FMDV genome is ∼8.5 kb 
in length and includes a single, large, open reading frame (ORF) encoding a long polyprotein 
of over 2300 residues [3]. However, this polyprotein is never observed within infected cells 
due to rapid co- and post-translational processing to produce, initially, the mature Leader 
protein (Lpro) and the precursor proteins P1-2A, P2, and P3. The Lpro is a papain-like protease 
and cleaves the polyprotein at its own C-terminus; that is the junction between Lpro and the 
capsid precursor P1-2A [4, 5]. The 3C protease (3Cpro) is responsible for proteolytic cleavage 
of P1-2A to produce the structural proteins VP0, VP3 and VP1 plus the 2A peptide. The P2 
and P3 precursors are also processed by 3Cpro to generate the non-structural proteins, required 
for the replication of the viral genome. The processing of VP0 to VP4 and VP2 occurs during 
encapsidation of the viral RNA although it can also occur on assembly of empty capsid particles 
[6, 7].  
The separation of the P1-2A precursor from 2B (within P2) is achieved by yet another 
mechanism. There is considerable heterogeneity among the picornaviruses with respect to the 
2A peptide/protein that is located on the C-terminal side of the capsid protein precursor. Both 
the size and the function of the different 2A species differ between different picornavirus 
genera [8]. The entero- and rhinovirus 2A proteins, termed 2Apro, are thiol proteinases of ∼150 
amino acids which catalyse the proteolytic cleavage of the junction between the P1 and P2 
precursors at their own N-termini, i.e. at the P1/2A junction [9, 10]. In contrast, in the 
aphthoviruses and cardioviruses (e.g. encephalomyocarditis virus (EMCV) and Theiler’s 
murine encephalitis virus (TMEV)), the separation of the capsid precursor (P1-2A) from P2 
(2BC) occurs at the 2A/2B junction, i.e. at the C-terminus of 2A. In FMDV, the 2A peptide is 
only 18 amino acids long and lacks any characteristic protease motifs [11–13]. Earlier studies 
have demonstrated that the “cleavage” at the 2A/2B junction is not dependent on the FMDV 
proteases Lpro or 3Cpro nor on host cell proteases [12, 14, 15]. The FMDV 2A peptide contains 
a highly conserved amino acid sequence at its C-terminus, D12(V/I)E(S/T)NPG2A↓P192B. This 
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sequence induces a co-translational “cleavage” event that is referred to as “ribosomal skipping” 
[16] or, alternatively, “stop-carry on” or “StopGo” [17, 18]. The first residue of 2B (pro or P) 
is referred to as P19 as it is a key part of the “cleavage” site. This motif, together with upstream 
amino acids that form an α-helix over most of its length, are believed to interact with the exit 
tunnel of the translating ribosome and prevent the formation of a peptide bond between the C-
terminal amino acid, glycine (gly, or G), of 2A and the first residue, proline (P), of 2B [16, 19]. 
This produces a break in the growing amino acid chain, but the process of protein synthesis 
continues, without the requirement for a new translation initiation event. The same conserved 
motif is also present at the C-terminus of the cardiovirus 2A proteins that are substantially 
larger; the FMDV 2A sequence appears to be the minimal functional entity to break the 
growing polypeptide chain (this process will simply be described as cleavage subsequently, for 
convenience) and other functions have been assigned to the cardiovirus 2A protein as well [20].   
The majority of studies on the function of the FMDV 2A peptide have been conducted using 
in vitro experiments with mRNAs encoding artificial polyproteins comprising two reporter 
proteins linked via the 2A peptide, thus generating two separate translation products (e.g. [16, 
21, 22]). These previous studies have shown that specific amino acid substitutions within the 
FMDV 2A sequence, and especially within the highly conserved D12(V/I)E(S/T)NPG2A↓P192B 
motif, drastically reduce the apparent cleavage efficiency and can even block it entirely. These 
results indicate that these amino acid residues are critical for optimal ribosomal skipping [16, 
22]. Furthermore, in the context of a synthetic reporter polyprotein, assayed within CHO cells, 
four different synonymous codons for residue G18 of the 2A peptide were shown to function 
with very similar apparent cleavage efficiencies at the 2A/2B junction but the cleavage 
efficiency was not optimal, only 88-89% complete, in this system [23]. These results were 
interpreted as showing that it is this amino acid residue rather than the nucleotide sequence 
which is critical for achieving cleavage [23]. The 2A peptide has been shown to mediate 
cleavage in all eukaryotic translation systems tested, whereas a number of artificial 
polyproteins containing this sequence have been examined in prokaryotic systems and no 
detectable cleavage products were observed [22].  
The less conserved part of the 2A sequence, located upstream of the D(V/I)E(S/T)NPG2A↓P2B 
motif, has also been shown to be important for optimal 2A function. Chimeric FMDV, TMEV 
and EMCV 2A peptides were generated by replacing the N- or C-terminal portions with another 
2A variant and then assayed within artificial polyprotein systems where they showed little or 
no activity [24]. In addition, when the FMDV 2A, in an artificial polyprotein system, was 
elongated by the addition of up to 30 amino acids, from the upstream VP1, then its apparent 
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cleavage activity was enhanced [16, 22, 25]. Thus, the context of the 2A sequence is important. 
The 2A peptides from other picornaviruses exhibited similar increases in activity when 
elongated with 30 amino acids from their respective polyprotein precursors [8]. Moreover, an 
extensive alanine (A), glycine (G) and proline (P) scanning mutagenesis of the entire FMDV 
2A peptide showed a decrease in apparent cleavage activity for all mutants [24]. This supports 
the view that the specific identity of the amino acid at nearly all positions within the 2A peptide 
is important for activity and that 2A peptides are fine-tuned to function as a single unit within 
their natural polyprotein.  
In the studies of Loughran et al. [26], a number of  mutations in the 2A coding sequences within 
the full-length TMEV and FMDV genomes were tested for their effects on virus viability and 
polyprotein processing. Modification of the SNPG↓P2B sequence to SNPL↓V2B at the 2A/2B 
junction blocked polyprotein cleavage. However, this modification had no significant effect on 
the growth of Theiler’s murine encephalomyelitis virus (TMEV) whereas it was detrimental 
for the replication of mengovirus (another cardiovirus) and apparently lethal for FMDV. Thus, 
it was concluded that the 2A/P2 cleavage event is not essential for virus viability for certain 
cardioviruses but is critical for FMDV.  
In this study, we have re-investigated the effect of 2A modifications in the context of the native 
FMDV polyprotein and its effect on virus protein synthesis and replication, virus viability and 
on polyprotein processing. In contrast to earlier studies, mutant infectious FMDVs having 
certain amino substitutions within the 2A peptide have been obtained but such changes do 
adversely affect virus replication and polyprotein processing to some degree.  
 
Results 
Effect of single amino acid substitutions in 2A on FMDV viability  
Several studies using artificial polyprotein systems have demonstrated that nearly all positions 
of the 2A peptide are important for the “StopGo” activity and modifications can severely impair 
cleavage [22, 24]. To establish whether the StopGo activity plays a crucial role in FMDV 
viability, this study set out to investigate the constraints on the 2A sequence within the context 
of the full-length FMDV genome (see Fig. 1a). 
To determine the viability of FMD viruses with single amino acid substitutions within the 2A 
peptide, selected modifications that were previously found to impair, to different extents, the 
StopGo activity in artificial polyproteins systems [22, 24] were introduced into the  plasmid, 
pT7S3, that contains the full length FMDV cDNA [27], using site-directed mutagenesis (see 
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Methods). The resultant plasmids were linearized and RNA transcripts, prepared in vitro, were 
introduced into BHK cells by electroporation. Unexpectedly, all of the FMDV 2A mutants 
(Table 1) produced viable progeny viruses, with full CPE detectable after the second passage. 
The rescued viruses were then sequenced to identify possible adaptations or reversions (Table 
1). After three passages of the 2A mutant viruses in cells, the viruses rescued from the 
transcripts encoding the N16H, E14Q, S15F and S15I modifications, had each retained the 
plasmid-derived amino acid substitutions. In contrast, the rescued viruses derived from the 
N16A, G18, P17A, P19G and P19A mutant transcripts all matched the wt sequence (i.e., the 
rescued viruses were not mutant) even when 2 nt changes were required to achieve this (e.g., 
see Fig. 2 for P19A mutant). To determine whether this reflected reversion to the wt sequence 
or some form of contamination/carryover of the wt sequence, three synonymous substitutions 
were inserted ca. 20 nucleotides downstream of the 2A/2B junction in the wt and the N16A, 
P17A, G18A and P19A mutant plasmids (see Fig. 2) after which the “marked” RNA transcripts 
were introduced into BHK cells. After three passages, the rescued mutant viruses had lost the 
2A modification in each case but had, like the “marked” wt virus, each retained the three 
synonymous substitutions in the 2B coding region (see Fig. 2); this provides strong evidence 
that the presence of the wt sequence in the rescued viruses reflects reversion. 
The growth characteristics of the wt and the viable 2A mutant viruses in BHK cells were 
examined in more detail by determining growth curves using a multiplicity of infection (m.o.i.) 
of 0.1. Surprisingly, both the wt and the viable 2A mutants grew with similar kinetics (Fig. 3a). 
Analysis of the FMDV capsid proteins within cells infected with the wt and the viable 2A 
mutant viruses, as determined by immunoblotting using anti-FMDV, is shown in Fig. 3b. As 
expected, the production of the capsid proteins was similar for the wt and the 2A mutants in 
each of the infected cell extracts (Fig. 3b, lanes 1-5).  
 
Requirements for efficient 2A/2B “cleavage” in its native context  
To examine the effects of the 2A mutants on the StopGo cleavage at the 2A/2B junction in its 
natural context and in cells, a plasmid encoding a truncated FMDV polyprotein termed the P1-
2A-2BC-FLAG protein with a FLAG epitope at its C-terminus was generated (see Fig. 1d). 
The transient expression of this truncated viral polyprotein (without any proteases) was 
designed to permit the simultaneous assessment of the production of the uncleaved P1-2A-
2BC-FLAG (ca. 135 kDa) and of the “cleavage” product 2BC-FLAG (ca. 54 kDa). The coding 
sequences for the wt or mutant P1-2A-2BC-FLAG products were under the control of the T7 
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promoter. The plasmids, were transfected into BHK cells that had been infected with the 
recombinant vaccinia virus vTF7-3 [28] which expresses the T7 RNA polymerase. The 
expression and processing of the proteins generated from these plasmids was visualized in 
immunoblots using anti-FLAG antibodies. Expression of the wt cassette led to apparently 
complete cleavage of the P1-2A-2BC-FLAG polyprotein as expected (Fig. 4a, lane 1) and thus 
only the 2BC-FLAG product was observed. In contrast, the E14Q mutant generated a mixture 
of both uncleaved and cleaved products (Fig. 4a, lane 5). Unexpectedly (c.f. [22, 24]), in the 
system used here, the S15A, S15F and S15I mutant proteins were each efficiently cleaved (Fig. 
4a, lanes 6-8). The mutants N16C, N16H, P19A, P19G, P19V and P19S all produced a mixture 
of cleaved and uncleaved products (Fig. 4b, lanes 2, 3 and Fig. 4c, lanes 1-4). However, the 
D12A, V13A, E12A, N16A, N16V, N16W, P17A and G18A substitutions resulted in the 
production of only the uncleaved product and hence these mutant 2A peptides were all inactive 
in this system (Fig. 4a, lanes 2, 3, 4 and Fig. 4b, lanes 1, 4, 5, 6, 7). Overall, there is partial 
agreement between the results described here, using assays of the 2A in its near native context 
within cells, and those described previously [22, 24]. The main discrepancies concern the 
S15A, S15F and S15I mutants which resulted in essentially complete cleavage (≥90%) here 
but gave rather sub-optimal cleavage (42 and 39% of wt, respectively) in vitro [22] while the 
P19A, P19G, P19V and P19S mutants resulted in detectable, but low level, cleavage (8-20%) 
here but completely abrogated cleavage in vitro [22]. The same cell lysates were also analysed 
using an anti-FMDV capsid protein antibody to detect the intact polyprotein and the P1-2A 
product (data not shown). The pattern of results was fully consistent with those obtained using 
the anti-FLAG to detect the intact polyprotein and the 2BC-FLAG product. Thus it seems that 
the efficiency of cleavage detected in this assay system is higher than that observed using cell-
free translation systems in vitro. 
 
Influence of the amino acid substitutions in FMDV 2A on FMDV RNA replication 
efficiency assessed using a replicon that expresses the Gaussia luciferase 
To evaluate the impact of the 2A mutants on the replication of viral RNA, nine different 
substitutions within the 2A coding sequence were introduced into a FMDV replicon (see Fig. 
1b). In this replicon, the coding sequences for the FMDV structural proteins (VP1-VP3) have 
been replaced by the sequence encoding the Gaussia luciferase (Gluc) reporter protein, thus 
allowing replication to be readily monitored via measurement of Gluc expression. RNA 
transcripts were produced in vitro from the linearized plasmids and introduced into BHK cells 
using electroporation. As a negative control, a derivative of the wt-Gluc replicon was produced 
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which lacks a portion of the coding sequence for 3Dpol (the RNA dependent RNA polymerase) 
and is termed wt-GlucΔ3D (see Fig. 1c). Lysates were prepared from cells at various times 
after electroporation with the different transcripts and assayed for Gluc activity (see Fig. 5). 
The wt-Gluc-Δ3D transcript produced Gluc initially, that was already detectable at 1 h post-
electroporation, but no further increase in luciferase activity was observed after 2 h. This 
expression presumably represents the translation of the input RNA. In contrast, the replication-
competent wt-Gluc, while generating an initially similar level of Gluc activity at 2 h, showed 
a sustained increase in expression at later time points. Interestingly, all of the 2A mutants 
expressed low levels of Gluc activity initially, almost 10-fold less than the wt-GlucΔ3D at 2 h. 
However, the expression increased to some degree at later time points; the level of Gluc 
expression first surpassed the polymerase knockout mutant after 6 h. It is noteworthy that the 
mutant transcripts with the E14Q, S15F, S15I and N16H changes, which were retained in the 
rescued viruses, did not have better RNA replication efficiencies than the other 2A mutants. 
This may reflect sub-optimal cleavage at the 2A/2B junction due to the absence of the upstream 
VP1 coding sequences in these replicons (see [25]). 
 
Influence of the StopGo function on the correct processing of the FMDV P1-2A precursor 
Hahn & Palmenberg [29] demonstrated that amino acid substitutions within the conserved 
D(V/I)E(S/T)NPG2A↓P2B motif at the C-terminus of the 2A protein of EMCV not only severely 
reduced or abrogated the StopGo function but also impaired the subsequent cleavage of L-P1-
2A by 3Cpro. The effects of substitutions in 2A on the FMDV P1-2A processing in cells has 
now been assayed using the truncated FMDV polyprotein termed P1-2A-2BC-FLAG (as 
above, see Fig. 1d) which was co-expressed with the FMDV 3Cpro. The wt and mutant P1-2A-
2BC-FLAG plasmids encoding the N16A, P17A, G18A and P19A substitutions (shown in Fig. 
4 to abrogate or impair (P19A) cleavage) were transfected, alone or together with a plasmid 
that expresses the 3Cpro (as in [7]), into vTF7-3-infected BHK cells. Analysis of the FMDV 
P1-2A processing, was determined by immunoblotting using anti-VP2 antibodies and is shown 
in Fig. 6a. Expression of the wt plasmid alone led to complete cleavage at the 2A/2B junction 
of the P1-2A-2BC-FLAG polyprotein, to yield P1-2A, as expected (Fig. 6a, lane 1). 
Furthermore, co-expression of the wt product with the 3Cpro produced VP0 (from the P1-2A) 
also as expected (Fig. 6a, lane 2). When the mutant plasmids, with defective cleavage at the 
2A/2B junction, were expressed alone then the larger, intact, P1-2A-2BC-FLAG product was 
detected (Fig. 6a, lanes 3, 5, 7, 9), as above (see Fig. 3). In the presence of the 3Cpro, the 
production of VP0, derived from P1-2A, was still readily apparent in each case (Fig. 6a, lanes 
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4, 6, 8, 10). These results were confirmed by immunoblotting using anti-FMDV antibodies 
(Fig. 6b). Co-expression of the wt and mutant plasmids with the 3Cpro produced a very similar 
pattern of detectable capsid proteins in each case (Fig. 6b, lanes 2, 4, 6, 8, 10). Thus, abrogating 
cleavage at the 2A/2B junction did not block the processing of the capsid precursor by 3Cpro in 
this system. It should be noted that this is in contrast to some earlier studies [14], which showed 
that a truncated version of FMDV P1-2A (lacking the C-terminus of VP1) could not be 
processed at all by 3Cpro.  
 
Detection of a novel FMDV 2A-2B fusion protein using immunofluorescence  
The FMDV capsid protein precursor, P1-2A, is normally processed by the 3Cpro to VP0, VP3, 
VP1 and 2A. In previous studies, it has been shown that when the cleavage of the VP1/2A 
junction is impaired, then the presence of FMDV 2A (still attached to VP1, as VP1-2A) can be 
detected in BHK cells by immunofluorescence using anti-2A antibodies [7, 30]. When the 2A 
is released from the VP1 then the 2A is no longer detectable (presumably it is either degraded 
or not fixed in the procedure). Thus, it seemed possible that substitutions within the 2A peptide 
that impair the 2A/2B cleavage activity (and prevent formation of viable, mutant, viruses), 
would result in the formation of detectable 2A-2B fusion proteins. Full-length FMDV RNA 
transcripts, with or without modifications in 2A, were introduced into BHK cells by 
transfection and after 8 hrs, the cells were stained with either anti-2A antibodies or anti-FMDV 
capsid protein antibodies. The FMDV VP1 K210E mutant, as previously described [7], which 
produces an uncleaved VP1-2A protein, was included as a positive control for the detection of 
2A attached to an adjacent protein. FMDV capsid proteins could be detected in cells transfected 
with each of the RNA transcripts, as expected (see Fig. 7b-g). In contrast, no signal for the 2A 
peptide was observed in cells transfected with the wt O1K RNA (Fig. 7b) or in untransfected 
cells (Fig. 7a). However, the presence of FMDV 2A (still attached to VP1) was detected in 
cells transfected with the VP1 K210E mutant RNA (Fig. 7c), consistent with previous results 
[7, 30]. Furthermore, using the transcripts with the mutant 2A/2B junctions, the presence of 
FMDV 2A, presumably attached to 2B (and maybe VP1), could be detected in the transfected 
cells (Fig. 7d-g). It should be noted that it is not possible to detect the free 2A peptide by 
immunoblotting due to its small size (ca. 2 kDa) and attempts to identify the presence of the 
2A fused to other proteins in extracts from these RNA transfected cells were unsuccessful (c.f. 
detection of VP1-2A within cells infected with the VP1 K210E mutant virus [7, 30]), 
presumably because the 2A could be attached to a number of different proteins, e.g. within 2A-
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2B, 2A-2BC, VP1-2A-2B and VP1-2A-2BC and not all cells take up and replicate the RNA 
transcripts.   
 
Discussion 
The 2A peptide plays a significant role in the FMDV life cycle as it is required for the co-
translational cleavage of the growing polyprotein into two separate entities at the junction 
between 2A and 2B. Related 2A peptide sequences are found in a variety of other members of 
the picornavirus family; this suggests that they contribute significantly to the correct production 
and function of the viral proteins. 
Using artificial polyprotein systems, it has been well documented [18, 22, 24, 26] that point 
mutations in the highly conserved D12(V/I)E(S/T)NPG2A↓P192B motif, located at the C-terminus 
of FMDV 2A, can either severely reduce or completely abrogate cleavage activity. In this 
study, we have extended these observations and investigated the effects of single amino acid 
substitutions in 2A on FMDV RNA replication, on virus viability and on polyprotein 
processing in its natural context within cells. The results presented here clearly demonstrate 
that certain 2A mutants previously found to greatly impair the StopGo activity in artificial 
polyproteins systems [22, 24] were still able to produce infectious viruses and thus the wt 
sequence and maximal cleavage activity is not essential for virus viability. It was anticipated 
that some mutations might have resulted in lethal phenotypes since earlier mutagenesis studies 
using FMDV and EMCV did not produce any viable progeny when the C-terminal 2A sequence 
was changed from SNPG↓P2B to SNPL↓V2B even after several passages [26]. Interestingly, we 
were able to rescue viruses from all of the RNA transcripts. When the apparent cleavage 
activity of the mutant 2A was low (<31% of wt activity) then it was found that reversions to 
the wild type sequence had occurred. This indicates that some RNA replication must have 
occurred (to allow the formation of wt revertants) despite the presence of a defective 2A 
peptide. In contrast, mutants with a higher level of cleavage activity (≥31% of wt) retained, in 
each case, the introduced amino acid substitutions in the rescued viruses. These results clearly 
indicate that efficient 2A mediated cleavage activity is advantageous for the virus but that 
optimal efficiency is not essential. This raises the question of why the separation of the capsid 
proteins from the non-structural proteins is so advantageous for some picornaviruses? It seems 
necessary for these viruses to have a 3C-independent mechanism to break the polyprotein. 
Some members of the picornavirus family (e.g. enteroviruses) possess a 2A protease to achieve 
the separation of the capsid protein precursor from the rest of the polyprotein and the StopGo 
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mechanism that occurs at the 2A/2B junction is clearly a distinct mechanism but one that is 
used by many members (e.g. aphthoviruses, cardioviruses, sapeloviruses, teschoviruses) of this 
virus family [8]. 
It has been speculated [13] that 2A can act as a translational regulator to modify the amount of 
the different parts of the polyprotein that are produced. In FMDV, the 2A peptide is located at 
the boundary between the upstream capsid proteins and the non-structural proteins involved in 
RNA replication. There could be two distinct functions for the 2A peptide. One primary 
function of 2A could be to achieve the cleavage of the polyprotein but it may also down-
regulate downstream translation. Potentially, this could prove beneficial to the virus as the 
assembly of the FMDV capsid requires up to sixty copies of each of the four structural proteins 
whereas fewer copies of the proteins involved in the replication process are required. On the 
other hand, it could be considered that in the early stages of the virus infection, then it would 
seem advantageous to produce more of the proteins required for replication and processing than 
the capsid proteins. It is also noteworthy that most members of the picornavirus family that use 
a different mechanism for separation of the capsid proteins from the non-structural proteins do 
not apparently have any mechanism for modifying the ratio of proteins produced, thus the need 
for such a mechanism within the picornaviruses, in general, is not established. However, 
recently, Napthine et al.,[32] have demonstrated that in EMCV a programmed -1 ribosomal 
frameshift occurs within the 2B coding region, just downstream of the 2A coding region. This 
frameshift results in the production of a distinct protein, termed 2B*, and then termination of 
translation. The level of ribosomal frame shifting increases dramatically late in infection and 
thus the production of the non-structural proteins involved in virus replication is reduced at this 
time. The process requires the interaction of the EMCV 2A protein (ca. 16 kDa) with a stem-
loop structure some 14 nt downstream of a “slip site” (GGUUUUU) within the 2B coding 
region. Although a U-rich motif (UUCUUUUUCU) is present just downstream of the coding 
region for the 2A/2B junction in the FMDV genome, certain other elements of this process 
appear to be absent. As indicated above, the FMDV 2A is only 18 residues long and it lacks 
the cluster of basic residues (R95-R97) that appear to be important for the interaction of the 
EMCV 2A protein to the stem-loop structure that is critical for the high frameshift efficiency.  
Thus, currently, there is no evidence for such a process within FMDV. 
Assessment of the RNA replication efficiency, using a replicon system, demonstrated that 
alterations in the 2A peptide have a clear, negative, effect on either the replication of the viral 
RNA or on the translation of the polyprotein. Clearly, the processes of translation and 
replication are linked since when translation of the polyprotein is reduced, then the levels of 
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protein available to replicate the RNA are also reduced resulting in a lower level of RNA 
replication. As indicated above, it may be that the detrimental effect of the changes in 2A were 
accentuated by the absence of the VP1 coding sequence in the replicons. In the context of the 
full-length viral polyprotein, it was shown (Fig. 7) that blocking the cleavage at the FMDV 
2A/2B junction produced fusion proteins containing 2A (presumably as 2A-2B or possibly 
VP1-2A-2B, before or after the cleavage of the VP1/2A junction by 3Cpro). However, the 
addition of just 18 amino acids to the N-terminus of the 2B protein may be considered to be 
unlikely to cause this decrease in replication efficiency (indeed it has been shown that leaving 
the 2A peptide fused to the C-terminus of VP1 has no apparent effect on virus viability [7, 30]. 
It should be remembered, however, that the VP1/2A cleavage is the slowest of the 3C-mediated 
processing events within P1-2A [7, 14, 31]. Previously it has been found that cleavage at the 
VP1/2A junction in poliovirus appears to a have a role in processing of the capsid precursors 
since amino acid substitutions that prevented cleavage resulted in a P1 capsid precursor which 
was resistant to 3Cpro processing [10]. Furthermore, Hahn & Palmenberg demonstrated, using 
in vitro translation assays, that a mutation in the EMCV 2A impaired the processing of the L-
P1-2A precursor by 3Cpro [29]. This may suggest a critical role for the 2A cleavage to allow 
proper folding of the (L)-P1-(2A) precursor to permit efficient cleavage by 3Cpro. However, in 
our studies, no adverse effect of blocking cleavage at the 2A/2B junction on processing of P1-
2A by 3Cpro was apparent (see Fig. 6). It was also observed with TMEV that normal capsid 
protein processing occurred in mutant viruses in which the 2A/2B processing was blocked [26]. 
The Gluc replicon, as used here, lacks the coding sequences for the structural proteins except 
for VP4, however, the replication / translation is still impaired in the 2A mutants compared to 
the wild type (Fig. 5). It is, therefore, conceivable that the possible cleavage restrictions that 
could govern the processing of the structural proteins also apply to the non-structural proteins. 
This may mean that correct processing of these proteins, which are required for RNA 
replication, is impaired, thereby resulting in lower RNA synthesis. Although the FMDV P1-
2A processing by 3Cpro appears to be unaffected when the 2A peptide is mutated (Fig. 6), this 
does not rule out the possibility of a negative effect on the 2B-2C (or P3) processing. 
Surprisingly, there was relatively little difference in the growth characteristics between the 
viable 2A mutant viruses (E14Q, S15F, S15I and N16H) and the wt (Fig. 3a), which contrasts 
with the decrease in replication efficiency observed in the context of a FMDV replicon. This 
could suggest that the changes in the 2A peptide influence the initial rate of viral RNA 
replication but not the final virus yield.  
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Investigation of the effect of 2A mutations on the StopGo mechanism revealed that certain 
amino acid substitutions are severely detrimental for the proper function of the 2A whereas 
others only moderately impair the cleavage resulting in a mixture of products (some cleaved 
and others not, see Fig. 4). Previous studies have suggested that the 2A geometry is the 
determining factor for its function [19, 22]. The current hypothesis is that the N-terminal 
portion of 2A (in an α-helical conformation) interacts with the ribosomal exit tunnel to confer 
specific constraints required for the turn motif (ESNPG) to be in a position to influence events 
within the peptidyl transferase centre of the ribosome. Some amino acid substitutions could 
severely change the conformation of the 2A, thereby preventing the disruption of the peptide 
bond formation between the G and P residues, and hence result in an uncleaved polyprotein. 
The substitutions N16C and N16H were found to result in cleavage although with decreased 
efficiency (both cleaved and uncleaved products were observed, see Fig 4). The function of 
residue N16 within 2A has not yet been determined, however it has been suggested that the 
N16 forms a hydrogen bond with E14 to stabilise the right turn [22]. The substitutions S15A, 
S15I and S15F were found to result in essentially complete cleavage in contrast to earlier 
studies [22] that reported a reduction in the cleavage activity. Comparison of the 2A sequence 
from different picornavirus species has shown that a variety of amino acids are allowed at this 
position within the C-terminus of 2A suggesting that this particular amino acid is of low 
importance for the StopGo function. However, Sharma et al. [24] demonstrated that 
substitution of S15 by glycine (G) (in the FMDV sequence), which influenced the peptide 
secondary structure, impaired function more significantly than Ala or Pro substitutions, 
suggesting that increased backbone flexibility imposed by the Gly residue at this position was 
especially detrimental [24]. 
Interestingly, the substitutions P19A, P19G, P19V and P19S greatly reduced the level of 
cleavage but did not abolish it (see Fig. 4). This is in contrast to previous studies [22] which 
have reported that these amino acid substitutions resulted in no apparent cleavage activity in 
an artificial polyprotein system. A model for the mechanism of 2A mediated cleavage 
developed by Donnelly et al. [16] suggests that the P19 residue (at the N-terminus of 2B) is an 
absolute requirement for cleavage as a poor nucleophilic character in this position is an integral 
part of the proposed mechanism. However, our data clearly shows that ala (A), ser (S) and val 
(V) residues are also functional at this position albeit with reduced activity. Rychlík et al. [33] 
demonstrated that A, S, and V are, in fact, also poor nucleophiles in the context of ribosomal 
peptidyl transferase activity, however not to the same extent as P and G. This could explain 
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why these amino acids are able to support the cleavage activity to some degree although not at 
a level compatible with virus viability. Although this does not account for the reduced cleavage 
activity observed for the P19G mutants, suggesting that another, not yet identified, 
characteristic of residue 19 must apply.  
The study by Gao et al. [23] found that the codon usage for the NPGP motif is conserved among 
the seven FMDV serotypes. Through the use of mRNAs encoding artificial polyproteins 
comprising two reporter proteins, assayed within CHO cells, the study investigated the role of 
synonymous codons for the G18. It was concluded that the different synonymous codon usage 
for G18 did not influence the cleavage efficiency in that system. However, in separate studies, 
we have provided evidence that a clear codon bias operates to encode the NPG/P motif at the 
2A/2B junction within FMDV-infected cells [34]. This raises the interesting possibility that the 
RNA sequence itself contributes to the cleavage event at the 2A/2B junction. 
 
Materials and methods 
Construction of plasmids containing full-length mutant FMDV cDNAs 
The plasmid pT7S3 [27] contains the full-length cDNA for the O1Kaufbeuren B64 strain of 
FMDV. Modification of the coding sequence around the 2A/2B junction was achieved by a 2-
step site-directed mutagenesis procedure, a variation of the QuickChange protocol 
(Stratagene), using Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scientific). The 
first round of PCR, using forward mutagenic 2A PCR primers (Table 2) with a single reverse 
primer 10PPN10 (Table 2) and the plasmid pT7S3 as template, generated an amplicon (ca. 450 
bp) specifying particular amino acid substitutions within 2A. The primary PCR products were 
gel purified (GeneJet gel extraction kit, Thermo Fisher Scientific) and used as primers for a 
second round of PCR with plasmid pT7S3 as template. The Dpn-I resistant full-length products 
were selected in chemically competent Escherichia coli (E.coli) TOP10 cells (Thermo Fisher 
Scientific), amplified, then the plasmid DNA was purified (Midiprep kit; QIAGEN) and 
verified by sequencing of the 2A coding region with a BigDye Terminator v. 3.1 Cycle 
Sequencing kit and a 3500 Genetic Analyzer (Applied Biosystems). 
The generation of plasmids with three synonymous mutations ca. 20 bp downstream of the 
modified 2A/2B junction was achieved essentially as described above. The first round of PCRs, 
used the forward mutagenic 2A_Synonymous_Fwd primer (Table 2) with a single reverse 
primer 10PPN10 (Table 2) and plasmid pT7S3 as template. The primary PCR products were 
gel purified (GeneJet gel extraction kit, Thermo Fisher Scientific) and used as primers for a 
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second round of PCR with modified versions of the pT7S3, with the codons for N16, P17, G18 
or P19 changed to encode an alanine (A) residue in each case, as templates.  
 
Construction of plasmids containing a FMDV replicon containing Gaussia Luciferase 
The Gaussia luciferase (Gluc) FMDV replicon was constructed by replacement of the coding 
region for VP2, VP3, VP1 and 2A from pT7S3-NheI [35] with the coding region for Gluc fused 
to FMDV 2A (as used in [36]). The Gluc-2A sequence was amplified by PCR using primers 
13APN1 and 13APN4 (see Table 1) using the rPad2GL BAC (see [34]) as template. The 
amplicon was inserted into the vector pCR-XL-TOPO (Invitrogen), the NheI-ApaI fragment 
was excised and inserted between the same sites within the ca. 5kb XbaI-fragment from pT7S3-
NheI (essentially as described previously [35]). The modified XbaI fragment (now containing 
the Gluc-2A sequence) was reconstructed into the backbone of the O1K FMDV cDNA within 
the XbaI-digested pT7S3 [27] and the orientation established by restriction digestion (using 
EcoRI and HpaI). The Gluc FMDV replicon was termed wt-Gluc.  
The replication-defective Gluc FMDV replicon termed wt-GlucΔ3D was prepared by digesting 
the wt-Gluc plasmid with BamHI and HpaI to liberate a fragment of ca. 770 bp corresponding 
to the 3'-terminus of the FMDV genome (including part of the 3Dpol coding region, see Fig. 
1). The large residual fragment was gel purified, blunt ended, self-ligated and transformed into 
E. coli. The wt-GlucΔ3D plasmid DNA was purified (Midiprep kit; QIAGEN) and verified by 
sequencng of the 3Dpol coding region, as above.  
 
Construction of plasmids containing FMDV P1-2A-2BC-FLAG cDNA cassettes  
The FMDV cDNA cassette, in the plasmid pP1-2A-2BC-FLAG, was prepared by PCR using 
Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scientific). Briefly, the coding region 
for P1-2A-2BC from O1K FMDV cDNA (as in pT7S3, [27]) was amplified with a forward 
primer ATG_P1_fwd which incorporates an initiation codon and the reverse primer 
2C_FLAG_Stop_rev that includes the sequence for a FLAG epitope tag followed by a 
termination codon (see Table 2). The blunt-end amplicon (ca. 3670 bp) was ligated into the 
pJET1.2 vector (Thermo Fisher Scientific) according to the manufacturer’s instructions. 
Sequencing revealed an unwanted initiation codon between the T7 promoter and the insert, 
which was then removed. A 2-step site-directed mutagenesis PCR using Phusion High-Fidelity 
DNA Polymerase as previously described with mutagenic PCR 2A primers (Table 2) and 
10PPN10 was used to produce the following plasmids encoding the indicated single amino acid 
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substitutions within 2A: pP1-2C-FLAG D12A, V13A, E14A, E14Q, S15A, S15F, S15I, N16A, 
N16C, N16W, P17A, G18A, P19A, P19G, P19V and P19S. All plasmids were propagated in 
E. coli TOP10 cells (Thermo Fisher Scientific), purified (Midiprep kit; QIAGEN), and verified 
by sequencing. 
 
In vitro transcription 
Briefly, 5 µg of replicon plasmid or full-length FMDV plasmid were linearized by digestion 
with HpaI (Thermo Fisher Scientific), purified (GeneJET PCR Purification Kit, Thermo Fisher 
Scientific) and eluted in RNase-free water. Both replicon and full-length FMDV RNA 
transcripts were prepared using the Megascript T7 kit (Ambion). Reaction mixtures were 
incubated at 37°C for 4 h and treated with 2 units of TURBO DNase for 30 min after which 
the RNA was purified using the MEGAclear Transcription Clean-Up Kit according to the 
manufacturer’s instructions. RNA integrity was assessed by electrophoresis using an ethidium 
bromide-stained agarose gel (1%), in TBE buffer, and quantified by spectrophotometry 
(NanoDrop 1000, Thermo Fisher Scientific). 
 
Rescue of virus from full-length cDNA plasmids 
For rescue and passage of infectious FMDV, 5 µg full-length FMDV RNA was introduced into 
BHK cells by electroporation (as described previously [37]). The cells were then transferred to 
one well of a 6-well plate and incubated for 1-3 days at 37°C after which the viruses were 
harvested by freezing. The rescued viruses were then amplified using additional passages (P2 
and P3) using fresh BHK cells. After the third passage (P3), viral RNA was extracted (RNeasy 
Mini Kit, Qiagen) and converted to cDNA using ready-to-go you-prime first-strand beads (GE 
Healthcare Life Sciences) with random hexamer primers. Amplicons (ca. 660 bp), including 
the 2A coding region, were amplified by PCR (AmpliTaq Gold DNA polymerase, Thermo 
Fischer Scientific) using the primers 8APN206 and 8APN203 (see Table 2). Control reactions, 
without RT, were used to ensure that the analysed products were derived from RNA and not 
from the presence of carryover plasmid DNA template. The amplicons were visualized in 1% 
agarose gels, purified (GeneJET gel extraction kit, Thermo Fischer Scientific) and sequenced 
as above. Sequences were analysed using Geneious 7.2 (Biomatters, Auckland, New Zealand). 
 
Gaussia luciferase assay 
BHK cells suspended in cold PBS were transferred to a 4 mm cuvette after which 2 µg replicon 
RNA was added, briefly mixed, and the cells were electroporated (25 ms and 240 V; one pulse) 
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on a Gene Pulser X-Cell (Bio-Rad). Following incubation for 10 min at room temperature, the 
cells were transferred to 5 wells of a 24-well plate (140 µl per well with 500 µl DMEM 
containing 5% FCS). Following incubation, at 37°C for the required time, the medium was 
removed and the BHK cells were lysed by adding 100 µl of Renilla luciferase assay lysis buffer 
(Promega) to the cells in each well (24-plate well) and incubated at room temperature for 15 
min. The luciferase activity was quantified in a Luminometer (Titertek-Berthold) by addition 
of this lysate (20 µl) to Renilla Luciferase Assay reagent (100 µl) according to the 
manufacturer’s instructions.  
 
Virus growth kinetics 
Virus titres for the wt and the 2A mutant viruses: E14Q, S15I, S15F and N16H were determined 
in BHK cells as TCID50/ml, as described previously [38]. Monolayers of BHK cells, grown in 
96-well plates were infected with either wt or mutant FMDV at an m.o.i of 0.1 at 37°C. At 0, 
2, 5, 10 and 24 hours post infection the infected cells were harvested by freezing (at -80°C) to 
determine the virus yield as TCID50/ml. 
 
Transient expression assays 
BHK cells (in 35mm wells) were grown to 90 % confluency and infected with vTF7-3, a 
recombinant vaccinia virus that expresses the T7 RNA polymerase [28], as described 
previously [38]. Briefly, following the infection, plasmid DNA (pP1-2A-2BC-FLAG and its 
derivatives, 2µg) was transfected alone or, when indicated, with pSKRH3C (50 ng) [38] that 
expresses FMDV 3Cpro, using FuGene6 (Roche), into the infected BHK cells and incubated 
overnight at 37°C. 
 
Western blotting 
Cell lysates for immunoblotting were prepared by addition of cold Buffer C (0.125 M NaCl, 
20 mM Tris/HCl (pH 8.0), 0.5% NP-40) to the cells. After incubation (on ice, for at least 5 
mins), the cell extracts were clarified by centrifugation (20000 g for 10 min) and Laemmli 
sample buffer (with 25 mM DTT) was added (as described previously [39]) . Following heating 
to 98°C for 5 min, samples were resolved by SDS-PAGE (4-15% polyacrylamide) and 
transferred to a PVDF membrane (Bio-Rad) and blocked for 1 h in 5% PBS-Tween (PBS, 0.1% 
Tween) with 5% non-fat milk. The membranes were incubated overnight at 4°C with either 
goat anti-FLAG antibodies (Abcam), guinea pig anti-FMDV O1 Manisa serum (to detect 
FMDV capsid proteins) or mouse anti-FMDV VP2 (4B2) monoclonal antibody [40], as used 
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previously [7]. The membranes were washed 3x with PBS-Tween and incubated for 3 hours at 
room temperature with either HRP-conjugated anti-goat IgG (Dako), HRP-conjugated anti- 
guinea pig IgG (Dako) or HRP-conjugated anti-mouse IgG (Dako), respectively. The 
membranes were then washed 3x with PBS-Tween and bound proteins were detected using a 
chemiluminescence detection kit (ECL Prime, Amersham) with a Chemi-Doc XRS system 
(Bio-Rad). The intensities of the signals for the FLAG-tagged polyproteins were, when 
necessary, quantitated using ImageJ software (v1.50).  
 
Immunofluorescence assay  
Monolayers of BHK cells were grown on glass coverslips in 6 well plates and immediately 
prior to transfection, cells were washed briefly in PBS and the medium replaced with DMEM 
without serum. FMDV RNA transcripts were introduced into BHK cells using Lipofectin 
transfection reagent (Thermo Fisher Scientific) according to the manufacturer’s instructions.  
After 8 h, the cells were fixed, stained and mounted as described previously [31] using rabbit 
anti-FMDV O serum or rabbit anti-2A (ABS31, Merck) followed by a donkey Alexa Fluor 
568-labelled anti-rabbit IgG (A10042, Life Technologies). The slides were washed in PBS after 
which they were mounted with Vectashield (Vector Laboratories) containing DAPI and images 
were captured using an epifluorescence microscope. 
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Tables 
 
Table 1: Amino acid sequences in the encoded 2A peptide within rescued viruses following 
three passages in BHK cells. Sequence differences from wt are shown whereas identical 
amino acids are indicated by a (.). The wt and mutant 2A cleavage activities previously 
determined by Donnelly et al. [22] and Sharma et al.[24], in vitro, are indicated. 
Plasmid “Cleavage”  
in vitro (%)1 
Residue encoded in rescued viruses 
2A 2B 
wt 90 E14 S15 N16 P17 G18 P19 
E14Q 56 Q · · · · · 
S15F 39 · F · · · · 
S15I 42 · I · · · · 
N16A 0 · · · · · · 
N16H 31 · · H · · · 
P17A 0 · · · · · · 
G18A 0 · · · · · · 
P19A 0 · · · · · · 
P19G 11 · · · · · · 
 
1: Data from Donnelly et al. and Sharma et al. [22, 24]. 
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Table 2: PCR primers used to create and sequence mutant FMDV cDNAs. Mutagenic 
nucleotides are shown underlined. 
Primer name Sequence (5ʹ-3ʹ) 
Fwd_2A_D12A AAGTTGGCGGGAGCCGTCGAGTCCAACCCTGG 
Fwd_2A_V13A AAGTTGGCGGGAGACGCCGAGTCCAACCCTGG 
Fwd_2A_E14A AAGTTGGCGGGAGACGTCGCGTCCAACCCTG 
Fwd_2A_E14Q GATGTCCAGTCCAACCCTGG 
Fwd_2A_S15A TTGGCGGGAGACGTCGAGGCCAACCCTG 
Fwd_2A_S15F GATGTCGAGTTTAACCCTGC 
Fwd_2A_S15I GATGTCGAGATTAACCCTGG 
Fwd_2A_N16A GTC CGC CCC TGG GCC CTT C 
Fwd_2A_N16C CGAGTCCTGCCCTGGGCCCTTCTTTTTCTCCGA 
Fwd_2A_N16H CGAGTCCCACCCTGGGCCCTTCTTTTTCTCCGA 
Fwd_2A_N16V CGAGTCCGTCCCTGGGCCCTTCTTTTTCTCCGA 
Fwd_2A_N16W CGAGTCCTGGCCTGGGCCCTTCTTTTTCTCCGA 
Fwd_2A_P17A GTCCAACGCTGGGCCCTTC 
Fwd_2A_G18A GTCCAACCCTGCGCCCTT C 
Fwd_2A_P19A CAACCCTGGGGCTTTCTT 
Fwd_2A_P19G CAACCCTGGGGGCTTCTT 
Fwd_2A_P19S CGAGTCCAACCCTGGGTCCTTCTTTTTCTCCGA 
Fwd_2A_P19V CGAGTCCAACCCTGGGGTCTTCTTTTTCTCCGA 
8APN203 CTCCTTCAACTACGGTGCC 
8APN206 CACCCGAAGACCTTGAGAG 
10PPN10 CTTTGACCAACCCGGCCA 
13APN1 CCGGGCCCAGGGTTGGACTCGAC 
13APN4 CCGGATCCGCTAGCCATGGGAGTCAAAGTTCTGTTTGC 
ATG_P1_fwd ATGAATACTGGCAGCATAATAAACAACTAC 
2C_FLAG_Stop
_rev 
CTATTACTTGTCGTCATCGTCTTTGTAGTCCTGCTTGAAGATC
GGGTGACTCGACAC 
2A_Synonomous
_Fwd 
TCTCCGACGTAAGATCAAACTTCTCCA 
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Figures 
 
Fig. 1: Structure of the plasmids used in this study. These include: (a) full-length FMDV 
O1K cDNA, (b) Gluc replicon cDNA and (c) RNA polymerase defective Gluc replicon cDNA. 
The plasmids were linearized using HpaI or BlpI prior to in vitro transcription. Panel (d): 
Schematic representation of the P1-2A-2BC-FLAG cDNA cassette expressed in transient 
expression assays (as described in Material and Methods).  
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Fig. 2: FMDVs rescued from mutants N16A, P17A, G18A and P19A had reverted to the 
wt sequence. Three synonymous mutations downstream of the 2A/2B junction were 
introduced into the wt and mutant N16A, P17A, G18A and P19A plasmids. The resultant RNA 
transcripts were introduced into BHK cells. The rescued viruses were analysed after 3 passages 
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in BHK cells. The region of the FMDV genome including that encoding the 2A peptide was 
amplified by RT-PCR and the PCR products were sequenced. The chromatograms are shown, 
note the retained synonymous mutations ca. 20 nt downstream of the 2A/2B junction, that had 
been introduced as a marker. 
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Fig. 3: Growth curves and assessment of the production of FMDV capsid proteins in BHK 
cells infected with wt and viable 2A mutant viruses. (a) BHK cells were infected with wt 
and the indicated 2A mutants at an m.o.i. of 0.1 and virus was harvested by freezing at 0, 2, 5, 
10 and 24 hours post-infection. Virus yields were determined as TCID50 by titration in BHK 
cells. (b) Uninfected or FMDV-infected BHK (m.o.i. 0.1) cell lysates were analysed by SDS-
PAGE and immunoblotting with antibodies specific for FMDV capsid proteins (anti-FMDV 
sera). Uninfected cells were used as a negative control. Molecular mass markers (kDa) are 
indicated on the left. 
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Fig. 4: Transient expression assays to determine 2A/2B “cleavage” induced by the wt and 
mutant FMDV cDNAs. The indicated plasmids were transfected into vTF7-3 infected BHK 
cells as described in Materials and Methods. After 24 hours, cell extracts were prepared and 
analysed by SDS-PAGE and immunoblotting using an anti-FLAG antibody. The uncleaved 
P1-2A-2BC-FLAG and the cleavage product (2BC-FLAG) are marked. Molecular mass 
markers (kDa) are indicated on the left. The cleavage activities (percentage of cleaved product) 
of the wt and each 2A mutant were determined by quantifying the intensity of the signal for 
the FMDV capsid proteins using ImageJ (v1.50) and are indicated above each lane.  
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Fig. 5: Expression of the luciferase reporter protein, Gluc, by a FMDV replicon. BHK 
cells were electroporated with wt or mutant RNA transcripts derived from the indicated cDNAs 
and, at the indicated times, cell lysates were prepared and assayed for Gluc activity. RLUs = 
Relative light units. Data are presented as mean ± standard deviation (SD) RLUs from samples 
(n=3) harvested at the indicated times.  
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Fig. 6: Transient expression assays to determine the influence of 2A substitutions on the 
processing of the FMDV capsid precursor P1-2A. The wt and mutant P1-2A-2BC-FLAG 
plasmids were transfected alone or with pSKRH3C [40] (which expresses FMDV 3Cpro), as 
indicated, into vTF7-3 infected BHK cells as described in Methods. After 24 h, cell extracts 
were prepared and analysed by SDS-PAGE and immunoblotting using anti-FMDV VP2 (panel 
a) and anti-FMDV antisera (to detect all FMDV capsid proteins) (panel b) as indicated. 
Molecular mass markers (kDa) are indicated on the left. 
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Fig. 7: Detection of FMDV 2A fusion proteins by IF staining within cells. BHK cells were 
untreated or transfected with wt or mutant FMDV RNA transcripts. At 8 h post-transfection, 
the cells were fixed. FMDV capsid proteins or the FMDV 2A peptide were detected using anti-
FMDV O1K polyclonal antibodies (upper panels) or anti-2A antibodies (lower panels), 
respectively, plus a secondary antibody labelled with Alexa Fluor 568 (red). The 2A 
substitutions are indicated. Untransfected cells were used as a negative control whereas the 
O1K VP1 K210E mutant, described previously [7], in which the 2A remains joined to VP1, 
served as a positive control. The cellular nuclei were visualized with DAPI (blue). Bar, 50 µm. 
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Abstract 
Foot-and-mouth disease virus (FMDV) has a positive-sense ssRNA genome including a single, 
large, open reading frame. Splitting of the encoded polyprotein at the 2A/2B junction is 
mediated by the 2A peptide (18 residues long) which induces a non-proteolytic, co-
translational, “cleavage” at its own C-terminus. A conserved feature among variants of 2A is 
the C-terminal motif N16P17G18/P19 where P19 is the first residue of 2B. It has been shown 
previously that certain amino acid substitutions can be tolerated at residues E14, S15 and N16 
within the 2A sequence of infectious FMDVs but no variants at residues P17, G18 or P19 have 
been identified. In this study, using highly degenerate primers, we analysed if any other 
residues can be present at each position of the NPG/P motif within infectious FMDV. No 
alternative forms of this motif were found to be encoded by rescued FMDVs after 2, 3 or 4 
passages. However, surprisingly, a clear codon preference for the wt nucleotide sequence 
encoding the NPGP motif within these viruses was observed. Indeed, the codons selected to 
code for P17 and P19 within this motif were distinct; thus the synonymous codons are not 
equivalent. 
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Introduction 
Foot-and-mouth disease virus (FMDV) is the prototypic member of the genus Aphthovirus 
within the family Picornaviridae. This virus is the causative agent of the highly contagious and 
economically important disease of cloven-hoofed animals, foot-and-mouth disease. The 
positive-sense ssRNA genome of around 8400 nt includes a single, large, open reading frame 
(ORF), ca. 7000 nt, encoding a polyprotein (Belsham, 2005). The full-length viral polyprotein 
is never observed since it is rapidly processed during and after synthesis mainly by the virus-
encoded proteases (primarily 3Cpro) to produce 15 distinct mature proteins plus multiple 
precursors (reviewed in Martinez-Salas and Belsham 2017). Interestingly, FMDV, like many 
(but by no means all) other picornavirus (e.g. cardioviruses, erboviruses, teschoviruses etc.) 
employs a co-translational, protease-independent mechanism for the “cleavage” of the 
polyprotein at the 2A/2B junction  (the boundary between the capsid proteins and the non-
structural proteins) (Donnelly et al., 2001a). This mechanism has been referred-to as 
“ribosomal skipping” or, alternatively,  “stop-carry on” or “StopGo” (Atkins et al., 2007; 
Donnelly et al., 2001a; Doronina et al., 2008; Tulloch et al., 2017). The 2A peptide lacks 
characteristic protease motifs and only mediates “cleavage” during translation. It has been 
demonstrated that the 2A sequence is able to mediate “cleavage” in all eukaryotic translation 
systems tested whereas a number of artificial polyproteins containing this sequence have been 
examined in prokaryotic systems and no detectable cleavage products were observed (Donnelly 
et al., 1997). 
The 2A peptide contains a highly conserved D12(V/I)E(S/T)NPG2A↓P192B motif at its C-
terminus which is critical for its function (Donnelly et al., 1997; Ryan & Drew, 1994). This 
motif, together with upstream amino acids, is believed to interact with the ribosomal exit 
tunnel. This prevents the formation of a peptide bond between the C-terminal glycine (G18) of 
2A and the N-terminal proline of 2B, referred to here, as P19 since it is an important part of the 
cleavage mechanism (see also Donnelly et al. 2001a; Ryan et al. 1999). However, remarkably, 
protein synthesis continues without the requirement for a re-initiation event. 
Investigations into the activity of the 2A sequence have mainly been performed using in vitro 
experiments. Typically, these have either used mRNAs with single ORFs encoding artificial 
polyproteins comprising two reporter proteins linked via the 2A peptide (Donnelly et al., 
2001b; Ryan et al., 1991; Ryan & Drew, 1994) or by expressing cDNAs encoding a truncated 
viral polyprotein including the StopGo coding region (Palmenberg et al., 1992). Alterations to 
78 
 
the conserved D12(V/I)E(S/T)NPG2A↓P192B motif reduced or abrogated the StopGo function 
(Donnelly et al., 2001b; Sharma et al., 2012), thereby showing that these amino acids are 
important for the correct StopGo “cleavage”. Furthermore, Hahn and Palmenberg (1996) 
demonstrated that alterations to this motif also influenced the viability of encephalomyocarditis 
virus (EMCV, a cardiovirus) as they resulted in lethal phenotypes. Subsequently, Loughran et 
al. (2013) reported a similar observation for FMDV, as modification of the S15NPG182A↓P192B 
sequence to S15NPL182A↓V192B or S15NPA182A ↓P192B also gave rise to a lethal phenotype.  
However, recently, certain amino acid substitutions (e.g. 2A S15 to F/I and 2A N16 to H) that 
have been shown to severely (60-70%) impair “cleavage” at the 2A/2B junction, using in vitro 
assays (Donnelly et al., 2001b), have been found to be tolerated within infectious FMDVs 
(Kjær J and Belsham GJ, submitted). In contrast, other substitutions (e.g. P19 to A and P19 to 
G) that inhibit cleavage more severely (by 89-100%) in vitro, were not found within rescued 
viruses. Indeed, viruses rescued from these mutant transcripts had sequences that exactly 
matched the wt sequence (i.e. the rescued viruses were not mutant). In these studies, we also 
determined a critical role for the StopGo mechanism for the overall level of 
replication/translation of FMDV RNA. FMDV replicons with a defective 2A sequence had a 
markedly lower replication efficiency compared to the wt replicon (Kjær J and Belsham GJ, 
submitted).  
It is, therefore, apparent that some amino acid substitutions can be tolerated within the FMDV 
2A peptide whereas other changes are not compatible with viability. To identify if any 
alternative residues can be accepted within the critical N16P17G182A↓P192B motif, degenerate 
sequences, encoding all possible amino acid substitutions at each of these positions 
individually, were introduced into a full-length FMDV cDNA, as used previously (Gullberg et 
al., 2013b; Kristensen et al., 2017). In principle, this should result in the production of RNA 
transcripts encoding 2A peptides with a wide spectrum of “cleavage” activities. This was 
achieved by generating a large pool of plasmids, using site-directed mutagenesis with highly 
degenerate oligonucleotides, to change each of the individual codons corresponding to the 
amino acid residues within this conserved motif to NNN (where N is a mixture of all 4 bases). 
Using each pool of plasmids, RNA transcripts were prepared, in vitro, and introduced into baby 
hamster kidney (BHK) cells. Infectious viruses were rescued and characterized.  
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Results and Discussion 
The expected generation of a pool of StopGo cDNA mutants that could potentially result in all 
possible single amino substitutions in place of the N16, P17, G18 and P19 residues (see Figure 
1A) was analysed by sequencing  (see Figure 1B). The heterogeneity at the expected positions 
was clear in each case (this does not prove that each of the possible codons was present but 
indicates it is likely). 
Full-length RNA transcripts were produced, in vitro, and introduced into BHK cells. Infectious 
virus was generated and passaged in fresh cells. RNA was then extracted from the virus 
harvests and the sequence encoding the 2A peptide was amplified by RT-PCR. The pool of 
amplicons was introduced into the pCR-XL-TOPO vector and then the sequence of the inserts 
in 20 individual colonies was determined for each virus harvest. It was found that all of the 
rescued viruses analysed after passages p2, p3 and p4 encoded the wt amino acid sequence at 
the NPGP motif in 2A. Interestingly, the complete spectrum of the possible synonymous 
codons for each of the residues N16, P17, G18 and P19 was present in the rescued viral genomes 
at p2 (see Table 1). These results indicated that the approach had indeed generated a diverse 
pool of codons within the viruses. Furthermore, the very restricted range of nucleotide 
sequences encoding 2A observed within the rescued viruses strongly suggests that the specific 
amino acid sequence (NPGP), encoded by these nucleotide sequences, is critical for FMDV 
viability.  
However, it was also apparent that the utilization of the different codons for the conserved 
amino acid residues varied. At p2, 55% of the sequences analysed had the wt codon for residue 
N16 (AAC) while the synonymous AAT codon was present in the remaining 45% of the rescued 
sequences. In the subsequent passages, the proportion of the AAC codon within the sequences 
increased to 75% and 95% by p3 and p4 respectively while the incidence of the AAT codon 
declined (Table 1). For residue P17, at p2, the codon CCT was present in 55% of the colonies 
analysed and increased to 100% by p4. Each of the three other possible codons for P17 (CCC, 
CCA and CCG) were also observed at p2 but each declined as the wt codon became dominant. 
For residues G18 and P19, the wt codons (GGG and CCC respectively) were in the minority (10 
or 20%) at p2 and each of the synonymous codons were also present. However, interestingly, 
by p3 the wt codons had markedly increased to 50% abundance and by p4 were dominant 
(≥90% abundance). For G18, the GGA codon was the most abundant at p2 but declined during 
further passages to be only 10% of the sequences at p4. Similarly, for P19 the CCT codon was 
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present in 50% of the sequences at p2 but declined to just 5% by p4. Strikingly, by p3, the wt 
codon was present in 50-75% of the population at each of the 4 residues and by p4 the wt codon 
was present in 90-100% of the virus population in each case (Table 1). Thus, it appears that 
selection occurs for the wt nucleotide sequence during passage of the rescued viruses in cell 
culture.  
The wt GGGCCC nt sequence encoding residues G18 and P19 is recognized in DNA by the 
restriction enzyme ApaI (see Figure 1A). Hence, it was possible to deplete the cDNA amplicons 
generated by RT-PCR, of the wt sequence from the rescued viruses by digesting them with 
ApaI prior to the cloning step (it was anticipated that this should enhance the detection of non-
wt nucleotide sequences). The residual, full-length, 650bp amplicons were inserted into the 
pCR-XL-TOPO vector, as described above, and the plasmid DNA from individual colonies 
was sequenced. As expected, the wt codons for G18 and P19 were no longer observed in the 
cloned fragments (Table 2) and the G18 (GGA) and P19 (CCT) codons were predominant in 
these enriched populations. These results are consistent with those obtained without the ApaI 
digestion (since the GGA and CCT codons were also present in 50% of the fragments at p2 
without this treatment, see Table 1) but clearly the apparent abundance of these non-wt codons 
is enhanced following the ApaI digestion (Table 2), as anticipated. The enrichment for non-wt 
sequences did not result in the detection of codons for alternative amino acids within the virus 
population. It had been anticipated that some amino acid substitutions at residue N16 might be 
rescued since a mutant (with N16 changed to H) has been shown to be viable (Kjær J and 
Belsham GJ, submitted) but, presumably, it was outcompeted by the wt virus.  
It is interesting to note that the G18  (GGA) and P19 (CCT) codons have previously been found 
to be the second most abundant codons found in FMDV genomes from all seven serotypes (see 
Gao et al. 2014). This comparison of FMDV sequences also indicated that the alternate codon 
for N16 (AAC) is present in only a small minority of FMDV genomes and CCC is also a minor 
population of the codons used for residue P17. The results presented in Table 1 clearly indicate 
that infectious FMDVs with these synonymous changes can be obtained but these viruses do 
not appear to be stably maintained in cell culture and are apparently selected against.     
The evidence presented here strongly suggests that there is a distinct selection, within the virus 
when grown in cell culture, for codon AAC for N16, CCT for P17, GGG for G18 and CCC for 
P19; thereby indicating that synonymous codon usage for this conserved motif is biased in these 
rescued viruses. It is particularly noteworthy that the codon preference for P17 and P19 is 
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different (CCT and CCC respectively). This raises the question of why does the virus select 
some codons over others? Various studies have demonstrated that synonymous codon usage 
bias plays an important role in the translation of certain mRNAs (Akashi 2001; Bulmer 1991; 
Novoa and Ribas de Pouplana 2012; Mauro and Chappell 2014). It is therefore conceivable 
that synonymous codons may influence the cleavage efficiency through the FMDV StopGo 
mechanism. As indicated above, a marked codon bias within the FMDV genome is apparent 
from the alignment of diverse FMDV 2A sequences as described by Gao et al. (2014). 
However, in the context of a synthetic reporter polyprotein, assayed within CHO cells, use of 
the four different synonymous codons for residue G18 of the 2A peptide resulted in very similar 
apparent “cleavage” efficiencies at the 2A/2B junction. This was interpreted as showing that it 
is the amino acid residue rather than the nt sequence which is critical for achieving cleavage 
(Gao et al., 2014). However, using that assay system, the “cleavage” efficiency was only about 
88-89% while essentially 100% cleavage occurs within the native context, as in the virus. The 
results obtained here (see Table 1) indicate that two separate selection effects may be operating. 
There is a clear selection for the NPGP motif at the amino acid level. However, in addition, 
there is a distinct codon bias within the context of the rescued infectious viruses and a 
significant selection pressure appears to exist for the wt sequence. This effect is fully consistent 
with the codon bias observed in the analysis of natural FMDV genomic sequences (Gao et al. 
2014). This suggests that the FMDV RNA sequence itself (rather than just the encoded amino 
acid sequence) affects the “cleavage” process (StopGo mechanism) at the 2A/2B junction. Such 
an effect could be achieved through a direct interaction of the RNA sequence itself or 
potentially through interactions with the specific charged tRNAs involved in the translation 
process. In the case of the P17 and P19 codons, it is interesting to note that the same type of 
prolyl tRNA (with an IGG anticodon) has been reported to be used for decoding of the CCC 
and CCU codons in human cells (no gene for a tRNA that is cognate for CCC was identified, 
see Mauro and Chappell, 2014). However, in the current database of tRNA sequences from the 
Lowe laboratory, it appears that in humans, 1 of 23 genes for prolyl tRNAs has a GGG 
anticodon with 10 copies having an AGG anticodon. In the mouse genome, 1 of 20 genes for 
the prolyl tRNAs has the GGG anticodon and 8 genes have the AGG anticodon (see the 
gtrnadb.ucsc.edu database described in Chan and Lowe (2009)). Interestingly, in cattle and pigs 
(major hosts for FMDV) and also in the rat, there is no gene for a prolyl tRNA with a GGG 
anticodon. Thus, it is not clear whether a single, post-transcriptionally modified prolyl tRNA 
recognizes these two Pro codons (at least some of the time) or if different tRNAs are involved 
in the hamster cells used here. If a single tRNA is involved in recognizing both codons (as in 
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cattle, pigs and rats), then it seems that the RNA sequence itself must be influencing the StopGo 
process; it seems unlikely that this effect is mediated through some secondary or tertiary RNA 
structure, as this would presumably be lost on the ribosome during the process of translation. 
It will clearly be important to analyse the effect of the presence of the non-optimal synonymous 
codons on “cleavage” at the 2A/2B junction in its native context.  
 
Materials and Methods 
Construction of plasmids containing full-length mutant FMDV cDNAs 
Pools of StopGo cDNA mutants that potentially result in all possible single amino substitutions 
in place of the N16, P17, G18 and P19 residues, respectively, were constructed. This was achieved 
using a 2-step site-directed mutagenesis procedure. This is a variation of the QuickChange 
protocol (Stratagene), using Phusion High-Fidelity DNA Polymerase (Thermo Scientific) with 
modified versions of the plasmid pT7S3 (Ellard et al., 1999) as template. The wt pT7S3 
contains the full-length cDNA for the O1Kaufbeuren B64 strain of FMDV. To eliminate the 
possibility of carrying over some residual wt template from the PCR, the templates used were 
modified versions of the pT7S3 with the codons for N16, P17, G18 or P19 changed to encode an 
alanine (A) residue in each case (see Figure 1A). These substitutions have been reported 
previously to result in a complete loss of apparent cleavage activity (Donnelly et al., 2001b; 
Sharma et al., 2012) and it has not been possible to rescue infectious virus containing these 
substitutions  (Kjær J and Belsham GJ, submitted). The first round of PCRs used the forward 
mutagenic 2A PCR primers (Table 3), with a single reverse primer 8APN206 (Table 3) plus 
the four different modified pT7S3 plasmids as templates and generated amplicons of ca. 450 
bp. These primary PCR products were then used as megaprimers for a second round of PCR 
with the respective mutant pT7S3 plasmids as templates to produce full-length plasmids. 
Following DpnI digestion, the products from each reaction were introduced into E. coli and 
grown as separate pools. The plasmid pools were sequenced using a BigDye Terminator v. 3.1 
Cycle Sequencing Kit and a 3500 Genetic Analyzer (Applied Biosystems). 
 
Rescue of virus from full-length cDNA plasmids 
Plasmid DNA isolated from each pool was linearized by digestion with HpaI and RNA 
transcripts were prepared using T7 RNA polymerase (Ambion T7 MEGAscript) at 37°C for 4 
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hours. The integrity of the transcripts was assessed on agarose gels and quantified by 
spectrophotometry (NanoDrop 1000, Thermo Scientific) after which they were introduced into 
BHK cells by electroporation, as described previously (Nayak et al., 2005). The BHK cells 
were maintained in Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 5% 
fetal calf serum, and incubated at 37°C with 5% CO2. At 2 days post-electroporation, the 
viruses were harvested by freezing and then amplified through three passages (p2, p3 and p4) 
in BHK cells. 
 
Characterization of viruses following multiple passages 
After each passage, viral RNA was extracted from a sample of the virus harvest (using the 
RNeasy Mini Kit, Qiagen) and converted to cDNA using ready-to-go you-prime first-strand 
beads (GE Healthcare Life Sciences). FMDV cDNA, which included the whole 2A coding 
region, was amplified in PCRs (AmpliTaq Gold DNA polymerase, Thermo Scientific) using 
primers 8APN206 and 8APN203 (see Figure 1 and Table 3). Control reactions, without RT, 
were used to ensure that the analysed products were derived from RNA and not from the 
presence of carryover plasmid DNA template. The amplicons (ca. 650 bp) were visualized on 
1% agarose gels and purified (GeneJET gel extraction kit, Thermo Scientific). These amplicons 
should be representative of the heterogeneity present in the rescued virus populations. The 
resulting collections of fragments were inserted into pCR-XL-TOPO (Thermo Scientific) and 
the sequence of the cDNA fragment present in individual bacterial clones (20 colonies for each 
of the 4 residues) was determined using the same reverse primer as used for the PCR. The 
fragments from codon mutants G18 and P19 were also enriched for the non-wt sequence 
populations by digestion of the cDNA with ApaI prior to gel purification and insertion into the 
pCR-XL-TOPO vector as described above.  
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Tables 
Table 1: Codon utilization encoding the “NPGP” motif at the 2A/2B junction within 
rescued FMDVs. 
Residue Codon  p2 p3 p4 
%1 %1 %1 
N16 AAT  45 25 5 
N16 AAC wt 55 75 95 
P17 CCT wt 55 70 100 
P17 CCC  10 15 0 
P17 CCA  20 5 0 
P17 CCG  15 10 0 
G18 GGT  15 5 0 
G18 GGC  15 5 0 
G18 GGA  50 40 10 
G18 GGG wt 20 50 90 
P19 CCT  50 25 5 
P19 CCC wt 10 50 95 
P19 CCA  10 5 0 
P19 CCG  30 20 0 
 
1: From sequencing of plasmid DNA isolated from separate 20 colonies in each case, the 
proportion (%) of each codon present in the rescued FMDVs is indicated at the different 
passage (p) numbers. Codon frequency values of 50-70% are highlighted in light grey whereas 
values from 75-100% are highlighted in dark grey. 
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Table 2: Enrichment for non-wt sequences encoding residues G18 and P19 within the 
“NPGP” motif within rescued FMDVs. 
Residue 
 
Codon  Pretreatment p2 p3 
%2 %2 
G18 GGT  ApaI1 5 0 
G18 GGC  ApaI1 15 5 
G18 GGA  ApaI1 80 95 
G18 GGG wt ApaI1 0 0 
P19 CCT  ApaI1 60 55 
P19 CCC wt ApaI1 0 0 
P19 CCA  ApaI1 15 0 
P19 CCG  ApaI1 25 45 
 
1: Following RT-PCR, the 650bp amplicons were digested with ApaI to enrich the population 
in non-wt sequences and the residual intact products were inserted into the pCR-XL-TOPO 
vector (see text). 
2: From sequencing of plasmid DNA isolated from separate 20 colonies in each case, the 
proportion (%) of each codon present in the rescued FMDVs is indicated at the different 
passage (p) numbers. Codon frequency values of 50-70% are highlighted in light grey whereas 
values from 75-100% are highlighted in dark grey. 
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Table 3: Primers used to create and sequence mutant FMDV cDNAs. 
Primer Sequence (5'-3') 
Fwd_2A_N16A_degen GGAGTCCNNNCCTGGGCCCTTC 
Fwd_2A_P17A_ degen GTCCAACNNNGGGCCCTTC 
Fwd_2A_G18A_ degen GACGTCGAGTCCAACCCTNNNCCCTTCTTTTTCTCCGA
CGTTA 
Fwd_2A_P19G_ degen TCG 
AGTCCAACCCTGGGNNNTTCTTTTTCTCCGACGTTAGG 
8APN206 CACCCGAAGACCTTGAGAG 
8APN203 CTCCTTCAACTACGGTGCC 
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Figure 
 
Figure 1: Structure of the FMDV O1 Kaufbeuren (O1K) cDNA and its derivatives.  (A) 
The plasmid-encoded amino acids and the corresponding nucleotide sequences at the 2A/2B 
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junction are shown. The FMDV O1K degenerate codon mutants were produced as described 
in the text using the mutant pT7S3 plasmids encoding the N16A, P17A, G18A and P19A 
substitutions as templates. The full-length plasmid pools were linearized using HpaI prior to in 
vitro transcription and virus rescue. The locations of the HpaI and ApaI restriction sites that 
were used are marked. N = a mixture of the 4 nucleotides. (B) Chromatograms and sequences 
of the FMDV cDNA corresponding to the NPGP motif at the 2A/2B junction. Degenerate 
positions showing the presence of multiple nucleotides are marked with an N (in bold type). 
The colour code in the chromatograms is as follows: A (red), T (green), G (yellow), C (blue).  
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Abstract  
The positive-sense ssRNA genome of foot-and-mouth disease virus (FMDV) has multiple 
conserved RNA secondary and higher-order structures which play fundamental roles in the life 
cycle of the virus. A previous study using SHAPE probing found three conserved RNA 
structures within the coding region for 2B, 3C and 3D with significantly lower synonymous 
substitution rates compared to the remainder of the genome. In this study, we aimed to 
investigate the influence of these structures on viral protein synthesis and virus viability. It was 
found that introduction of synonymous nucleotide sequence changes that disrupt the structures 
but do not result in amino acids changes can be tolerated and are retained after three passages 
in BHK cells. The same substitutions did not impair the replication of a FMDV replicon in 
these cells. These results show that the RNA structures located in the coding region of 2B, 3C 
and 3D are not essential for RNA replication or viability of FMDV in BHK cells.  
 
Introduction 
Foot-and-mouth disease virus (FMDV) is the causative agent of foot-and-mouth disease, a 
highly economically important infectious disease of cloven- hooved animals. The virus is the 
prototypic member of the genus Aphthovirus within the family Picornaviridae and exists in 
seven different serotypes (O, A, C, SAT 1–3 and Asia-1) (Knowles & Samuel, 2003). The 
FMDV particle includes a single copy of the positive-sense RNA genome (~8300 nt) which 
has a single large ORF (~7000 nt) encoding a large polyprotein generating 15 distinct mature 
proteins (Belsham, 2005). The genome is encapsidated by an icosahedral capsid composed of 
60 copies of four different capsid proteins (VP1, VP2, VP3, and VP4). The ORF is flanked by 
untranslated regions (UTRs) termed the 5ʹ-UTR and the 3ʹ-UTR which contain multiple 
secondary structures. The long 5ʹ-UTR contains five distinct elements, including a type II 
internal ribosome entry site (IRES) and the cis-acting replicative element (cre) in addition to 
the S-fragment, a polypyrimidine tract of variable length and multiple copies of a pseudoknot 
(Escarmís et al., 1995). The smaller 3ʹ-UTR (ca. 90 nt) contains two RNA stem-loops upstream 
of a 3ʹ-poly(A) tail (Witwer et al., 2001). These structures can participate in inter- and 
intramolecular interactions such as RNA/RNA interactions but also binding to viral and cellular 
proteins. Besides the local folding displayed by the some of these regions, long-range 
interactions between distantly separated RNA elements are also suggested to regulate FMDV 
replication (Diaz-Toledano et al., 2017; Sáiz et al., 2001). Studies have demonstrated that the 
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structured 3ʹ-UTR directly binds to the S-fragment and IRES elements at two distinct positions 
in the 5ʹ-UTR through specific long-range RNA–RNA contacts (Diaz-Toledano et al., 2017). 
Elaborate RNA structures are not limited to the UTRs of the genome. Functional structures 
embedded within protein-coding sequence have been found in rhinovirus and poliovirus (PV) 
genomes, both within the picornavirus family (McKnight & Lemon, 1996; Yang et al., 2008). 
Such structures are crucial for replication of the viral genome and may play additional roles in 
other processes e.g. genome packaging and alterations of the host antiviral defence. Capsid 
assembly and the encapsidation of the viral genome are suggested to involve interactions 
between capsid proteins and secondary structures in the viral genome as found for the 
bacteriophage MS2 (Stockley et al., 2007). Recently, Logan et al., (2017) identified several 
predicted RNA secondary structures located within the ORF of FMDV that may be involved 
in genome packaging. Synonymous substitutions which disrupted the structures did not 
influence viral replication but resulted in attenuation of virus growth in cell culture. 
Selective 2ʹ-hydroxyl acylation analysed by primer extension (SHAPE) has previously been 
successfully used to identify new potential RNA structures within the genomes of important 
human pathogens as PV and HIV (Watts et al., 2009). Burrill et al., (2013) used SHAPE 
probing to generate a global RNA structure map of the PV genome and found a conserved 
structure with the coding region of the 3D, the RNA-dependent RNA polymerase (RdRp), 
which was involved in viral replication and infectivity. Poulsen, (2015) used a similar approach 
with a modified version of SHAPE (Poulsen et al., 2015) to probe the RNA structure of the 
entire FMDV genome in order to identify regions with stable secondary RNA structures. This 
study aimed to investigate whether these structures play an essential role in viral protein 
synthesis, viral RNA replication and viability of FMDV.  
 
Materials and methods 
Construction of plasmids containing full-length mutant FMDV cDNAs and FMDV 
replicons containing Gaussia Luciferase.  
The structures of the plasmids containing full-length FMDV cDNAs used in this study are 
indicated in Figure 1. The pT7S3 plasmid (Ellard et al., 1999) containing the full-length cDNA 
corresponding to the O1Kaufbeuren B64 strain of FMDV was used as a template in a 2-step 
site-directed mutagenesis procedure, a variation of the QuickChange protocol (Stratagene), to 
generate full-length mutant FMDV cDNAs with synonymous mutations in the 2B, 3C and 3D 
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coding regions. Briefly, amplicons specifying particular synonymous mutations in the 2B, 3C 
and 3D coding regions were generated in a first round of PCR using forward mutagenic PCR 
primers (Table 1) with appropriate reverse primers (Table 1) and the plasmid pT7S3 as 
template. The primary PCR products of varying size (2B: 212 bp, 2C: 605 bp and 3D: 326 bp) 
were gel purified (GeneJet gel extraction kit, Thermo Fisher Scientific) and used as primers for 
a second round of PCR with plasmid pT7S3 as template. The Dpn-I resistant full-length 
products (plasmids) were amplified in Escherichia coli (E.coli) TOP10 cells (Thermo Fisher 
Scientific), purified (Midiprep kit; Thermo Scientific) and verified by sequencing of the 2B, 
3C and 3D coding region respectively with a BigDye Terminator v. 3.1 Cycle Sequencing kit 
and a 3500 Genetic Analyzer (Applied Biosystems). 
The FMDV replicon plasmid and RNA polymerase knockout control have been described 
previously (Kjær & Belsham, submitted, see Manuscript 1) and the mutants were generated as 
described above.  
 
In vitro transcription 
Replicon plasmid or full-length FMDV plasmid (5µg) DNA was linearized with HpaI (Thermo 
Fisher Scientific), purified (GeneJET PCR Purification Kit, Thermo Fisher Scientific) and 
eluted in RNase-free water. The linear DNA was used in a 20 µl in vitro transcription reaction 
using the Megascript T7 kit (Ambion). Reaction mixtures were incubated at 37°C for 4 h and 
with 2 units of TURBO DNase for 30 min after which the RNA was purified using the 
MEGAclear Transcription Clean-Up Kit according to the manufacturer’s instructions. All 
transcripts were quantified by NanoDrop 1000 spectrophotometry (Thermo Scientific), and 
RNA integrity was assessed by electrophoresis using an ethidium bromide-stained agarose gel 
(1%) in TBE buffer.  
 
Rescue of virus from full-length cDNA plasmids 
Full-length linearized FMDV RNA transcripts (5 µg) were introduced into BHK cells by 
electroporation as described previously (Nayak et al., 2005). At 48 h after electroporation, the 
rescued viruses were harvested by freezing and amplified in two subsequent passages (P2 and 
P3) in fresh BHK cells at 37°C. After these passages, RNA was extracted (RNeasy Mini Kit, 
Qiagen) and reverse transcribed into cDNA using Ready-To-Go You-Prime First-Strand Beads 
with random hexamer primers. Amplicons including either the 2B, 3C or 3D coding region, 
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were amplified by PCR (AmpliTaq Gold DNA polymerase, Thermo Fischer Scientific) using 
appropriate primers (see Table 1). Control reactions, lacking reverse transcriptase, were used 
to ensure that the PCR products were derived from RNA and not from residual DNA template. 
The amplicons were visualized in 1% agarose gels, purified (GeneJET gel extraction kit, 
Thermo Fischer Scientific) and sequenced as previously described. Sequences were analysed 
using Geneious 7.2 (Biomatters, Auckland, New Zealand). 
 
Gaussia luciferase assay 
The replicon replication assay was performed in 24-well plates using monolayers of BHK cells. 
Replicon RNA (2 µg) was introduced into BHK cells by transfection using the Lipofectin 
transfection reagent (Thermo Fisher Scientific) according to the manufacturer’s instructions. 
The plates were then incubated at 37°C in 5 % CO2 . After 1, 2, 3, 4, 6 and 8 hours, the medium 
was removed and the BHK monolayers were washed twice. The cells were then harvested by 
adding 100 µl of Renilla luciferase assay lysis buffer (Promega) to each well and incubated at 
room temperature for 15 min. The luciferase expression was quantified in a Luminometer 
(Titertek-Berthold) by addition of this lysate (20 µl) to Renilla Luciferase Assay reagent (100 
µl) according to the manufacturer’s instructions.  
 
RT-PCR and full-genome sequencing 
cDNA was generated from extracted RNA (RNeasy Mini Kit, Qiagen) using SuperScript III 
(Invitrogen) with a T27 reverse primer according to the manufacturer’s protocol. Two PCR 
products were amplified from the viral cDNA using Phusion DNA polymerase (Thermo Fisher) 
with the primers 13NPN2 and 10PPN30 (Table 1) and separately 8APN200 +13NPN3 (Table 
1). The two fragments of ca. 4 and 4.2 kb respectively are overlapping and correspond to most 
of the FMDV genome (downstream of the poly(C) tract). The fragments were visualized on an 
agarose gel, purified (GeneJET gel extraction kit, Thermo Fischer Scientific and analysed by 
NGS essentially as described previously (Kristensen et al., 2017). Geneious 7.2 (Biomatters, 
Auckland, New Zealand) was used for mapping the reads to the sequence of the FMDV strain 
O1K sequence (accession no. X00871).  
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RNA secondary structure prediction 
Thermodynamic RNA structural predictions were carried out using the Zuker energy 
minimization algorithm (Zuker, 2003) implemented in the Mfold program using default 
settings through the web interface at http://unafold.rna.albany.edu/?q=mfold/RNA-Folding-
Form.  
 
Results 
Production of modified FMDVs with synonymous substitutions within the coding region 
for 2B, 3C and 3D  
A recent study by Poulsen, (2015) conducted a genome-wide SHAPE probing of the FMDV 
genome. The SHAPE probing identified 17 novel secondary structures within the protein 
coding region. Interestingly, three of these structures, which are located within the coding 
regions for 2B, 3C and 3D (see Figure 1 and 2), were found to have synonymous substitution 
rates significantly lower than the rest of the genome suggesting that the nucleotide structure in 
addition to the amino acid sequence is of importance. 
To investigate whether these structures are important for viral RNA replication and viability, 
specific substitutions within the coding regions for 2B, 3C and 3D which would disrupt the 
secondary structures without altering the encoded amino acid sequence were introduced into a 
FMDV replicon and a full-length FMDV cDNA respectively (see Figure 1). Three mutants 
with synonymous substitutions covering the entire sequence length of the 2B, 3C and 3D 
structures termed 2Bsyn_mut, 3Csyn_mut and 3Dsyn_mut respectively were generated. The 2B 
structure also has non-paired nucleotides in the terminal loop and bulge (see Figure 2). Such 
non-paired nucleotides have previously been reported to be involved in long-range RNA-RNA 
interactions. Two further mutants, termed 2Bsyn_mut_loop (terminal loop) and 2Bsyn_mut_bugle 
(bugle) were generated in which the motif in both elements was changed. The structure 
identified by SHAPE within the coding region of 3D spans 128 nt and is larger and more 
elaborate compared to those identified within the coding sequence of 2B and 3C. To identify 
the regions within this structure which potentially were of significance for virus replication, 
synonymous substitutions were designed, in addition, to disrupting the entire structure also 
aimed at disrupting just the 5ʹ and 3ʹ regions of this structure termed 3Dsyn_mut_5ʹ and 3Dsyn_mut_3ʹ. 
The 5ʹ and 3ʹ substitutions were also both incorporated in the same construct and termed 
3Dsyn_mut_5ʹ+3ʹ. Modifications to the FMDV Gluc replicon and the full-length cDNA 
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corresponding to the O1 Kaufbeuren strain of FMDV were performed and an illustration of the 
modifications is shown in Figure 2.  
 
The effect of synonymous substitutions within the conserved structures found in 2B, 3C 
and 3D on RNA replication assessed using a FMDV replicon 
A FMDV replicon encoding a reporter protein provides a quantitative measurement of FMDV 
RNA replication. To monitor the influence of the RNA structure modifications on replication 
of viral RNA, eight different changes within the coding regions for 2B, 3C and 3D were 
introduced into a FMDV replicon. This replicon has the coding sequences for the FMDV 
structural proteins (VP1-VP3) replaced by the sequence encoding the Gaussia luciferase (Gluc) 
reporter protein. The plasmids were linearized and RNA transcripts were prepared in vitro and 
introduced into BHK cells (see Methods). Lysates were prepared from cells at various times 
after electroporation with the different transcripts and assayed for Gluc activity. At early times 
post-transfection of BHK cells with wt-Gluc RNA transcripts, Gluc expression increased and 
reached maximal expression by 8 hours (see Figure 3). In contrast, wt-GlucΔ3D, a mutant 
replicon which lacks a portion of the coding sequence for 3D expressed Gluc maximally only 
at 2 hours post-transfection (Figure 3), consistent with translation of the input RNA followed 
by RNA turnover. Unexpectedly, all of the RNA structure mutants expressed the same level of 
Gluc activity as the wt-Gluc at each time point. The same mutants also exhibited the same level 
of replication efficiency when tested in a GFP replicon system as previously described (Herod 
et al., 2016; Tulloch et al., 2014) (data not shown).  
 
Effect of synonymous substitutions in 2B, 3C and 3D on viral viability and genetic 
stability  
To determine the viability and genetic stability of FMD viruses with disrupted RNA structures 
within the 2B, 2C and 3D coding regions, the mutant plasmids were linearized and RNA 
transcripts, prepared in vitro, were introduced into BHK cells by electroporation. All eight 
FMDV mutants were indeed viable within BHK cells with the production of progeny viruses 
and full CPE detectable after the third passage. Full CPE for the wt was detectable at the second 
passage. The rescued viruses were sequenced to identify possible adaptations or reversions. 
After three passages in BHK cells, the rescued viruses had each retained the plasmid-derived 
synonymous nucleotide substitutions. To determine whether adaptation to overcome the 
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defects had appeared elsewhere in the genomes of the 2B mutants, we examined the rescued 
viral genomes throughout the near-complete genome sequence. To achieve this, RNA was 
extracted from the rescued 2B mutant viruses (see Methods) at the third passage. Two separate, 
but overlapping, cDNA fragments including the near-complete genome (downstream of the 
poly(C) tract) were produced by reverse transcription (RT)-PCR, mixed and then sequenced 
using next-generation sequencing (NGS). No adaptations were observed within the modified 
2B coding region or in the remainder of the genome.  
 
Discussion  
The genomes of RNA viruses contain RNA structures that are crucial for translation and RNA 
replication and may play additional, uncharacterized roles during the viral replication cycle. In 
recent years, advances been made in identifying and charactering such RNA structures in 
positive-sense RNA viruses through the use of SHAPE probing. Within the field of FMDV 
biology, SHAPE has given new insights into the dynamic RNA–RNA interactions between the 
IRES and the 3ʹ-UTR (Diaz-Toledano et al., 2017). Recently, Poulsen, (2015) probed the RNA 
structures within the entire FMDV genome, also using SHAPE probing, thereby generating a 
genome-wide RNA structure model. Three structures present in the coding sequences for 2B, 
3C and 3D showed significantly lower synonymous substitution rates than observed in the 
remainder of the genome, suggesting a selective pressure to maintain these structures. 
Synonymous mutations were designed to disrupt the structures in these regions without altering 
the encoded amino acid sequence and these were introduced into a FMDV replicon and full-
length FMDV cDNAs. The site-directed mutagenesis of these structures within a replicon 
system revealed that none of the RNA elements played an important role in viral replication in 
BHK cells as the mutants exhibited about the same level of RNA replication as wt  in this 
system, as judged by the reporter protein expression. The mutants were likewise also able to 
produce infectious viruses in the context of the full-length FMDV suggesting that the structures 
are not essential for virus viability. Interestingly, the synonymous mutations proved to be 
genetically stable after three passages in BHK cells. In addition, no other adaptations were 
present elsewhere in the genome of the 2B mutants suggesting that the structure was not 
involved in long-range RNA interaction with other parts of the genome. Previous studies of 
other picornavirus RNA structures have found cre’s which are essential for the viral life cycle, 
within the coding region (McKnight & Lemon, 1996; Yang et al., 2008). The understanding of 
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the role RNA structures play in biological systems has expanded in recent years and although 
the structures tested in the FMDV genome appear to have no observable influence on either 
translation or replication of the FMDV genome in BHK cells they can still possess additional, 
uncharacterized roles during the viral replication cycle, e.g. within the context of the host 
response to infection as seen by Kloc et al., (2017) with the S-fragment. Logan et al., (2017) 
recently demonstrated a novel technique to identify possible RNA secondary structures 
involved in packaging of the FMDV genome. Through the use of NGS and structure prediction 
software they identified several RNA structures with a common motif at the terminal loops 
which are suggested to be involved in FMDV packaging. Disruption of these structures through 
synonymous substitutions resulted in attenuation of virus growth in BHK cells probably due to 
a reduction in assembly of mature virions. In this connection, the conserved loop sequences 
(AAUCCA) that are presumed to be part of the packaging mechanism were not found in any 
of the three structures tested here. Simmonds et al., (2004) suggested that RNA structure could 
be implicated in the evasion of host cell defences by facilitating escape from innate responses 
induced by certain structured RNAs. Large cellular RNA structures such as rRNA and tRNA 
have been found not to induce a dsRNA defence response. It is speculated that RNA structures 
within the viral genome have evolved as a way to mimic cellular structured RNAs thereby 
circumventing the cellular dsRNA response. It could be interesting to study the growth kinetics 
of all the structural mutant viruses within primary bovine thyroid cells (pBTY) as they have an 
intact interferon system in contrast to BHK cells.  
Certain RNA structures are important for optimal function of the virus and SHAPE probing 
has provided an excellent way for determining RNA structures at a single nucleotide resolution. 
The combination of SHAPE analysis of a viral genome along with evolutionary analysis and 
functional biochemical assays should help to find additional structures located inside or outside 
of the coding sequence which influence the life cycle of FMDV. Further investigations into the 
influence of these structures on the viral life cycle are needed.  
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Table 1: Oligonucleotides used to create and sequence mutant FMDV cDNAs. 
Primer name Sequence (5ʹ-3ʹ) Function  
2Bsyn_mut_loop_fwd GTCCAAGGACCCGGTCCTTGTGG Forward 2B mutagenesis  
2Bsyn_mut_bugle_fwd CTTGTGGCCATTATGCTGGCCGACACC Forward 2B mutagenesis  
2Bsyn_mut_few 
AGCTCCTAAGCCGCCTGTCGTGCATGGCAG
CGGTAGCGGCGCGATCAAAAGATCCGGTA
CTAGTAGCAATAATGCTGGCCGACACCGGT
CTCGAGATTCT 
Forward 2B 
mutagenesis  
3Csyn_mut_fwd 
CGGTAGCCATCTGCTGCGCTACTGGAGTCT
TCGGAACGGCGTATCTAGTACCGCGGCACC
TATTTGCGGAAAAATACGATAAGATCATGG
TGGACGGCAGAGCCAT 
Forward 3C 
mutagenesis  
3Dsyn_mut_fwd 
AGATACATACACAATGATTTCATATGGCGA
TGATATAGTTGTAGCGAGCGACTACGACTT
AGATTTTGAAGCGCTAAAACCTCATTTCAA
GTCGCTGGGA 
Forward 3D 
mutagenesis  
3Dsyn_mut_5ʹ 
CCACCACGATGTCGTCTCCGTATGAAATCA
TTGTGTATGTATCTAGTTCTACTCCCTCATA
GTGTCTACG 
Forward 3D 
mutagenesis  
3Dsyn_mut_3ʹ 
GTCAGCTGGAGTGATGGTTTGGCCAAGGGA
CTTGAAATGAGGTTTTAGAGCCTCGAAGTC
CAAATC 
Forward 3D 
mutagenesis  
1-I TBR2 ACGAGTACCGGCGTCTCTT Reverse 3D mutagenesis  
8APN206 CACCCGAAGACCTTGAGAG Reverse 2B mutagenesis  
10PPN4 CGGTGGGTGCAAGCTTGG Reverse 3C mutagenesis 
13-NPN2 AAGTTTTACCGTCGTTCCCGACGTAAAAGGGAGGTAACCACAAGCTTGAA 
Forward NGS 
primer 
10-PPN30 TCTGGACAGCACCTTTGTCG Reverse NGS primer 
8-APN200 GAGACGTTGAGTCCAACCC Forward NGS primer 
13-NPN3 CCGTAGGAGTGAAAATCCCGAAAGGGTTTTTCCCGCTTCCTTAATCCAAA 
Reverse NGS 
primer 
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Figure 1: Schematic representation of the plasmids used in this study. These include: (a) 
full-length FMDV O1K cDNA, (b) Gluc replicon cDNA and (c) RNA polymerase defective 
Gluc replicon cDNA. All plasmids contain the T7 promoter and were linearized using either 
HpaI or BlpI prior to in vitro transcription and virus rescue. The locations of restriction sites 
used are marked HpaI and BlpI. The location of the three conserved RNA structures within the 
coding region of 2B, 3C and 3D (marked in grey) are indicated.  
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Figure 2: Previously predicted RNA structures, following SHAPE analysis, with low 
synonymous substitution rates (Poulsen, 2015) showing the introduced synonymous 
substitutions. These are located within the protein coding region of a) 2B, b) 3C and c) 3D. 
The SHAPE predicted model for each structure is shown with the nucleotide position in the 
genome (accession no. X00871). The nucleotides are coloured compared to their individual 
SHAPE selection reactivity. The arrows indicate the synonymous substitutions in the terminal 
loop (blue) and bulge (red) of the 2B structure and in the 5ʹ- (green) and 3ʹ-terminal end 
(orange) of 3D structure. 2Bsyn_mut, 3Csyn_mut and 3Dsyn_mut introduced synonymous substitutions 
covering the entire sequence length of each structure and are not marked. The nucleotides are 
coloured by SHAPE selection reactivity. Adapted from Poulsen, (2015).  
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Figure 3: Expression of the secreted luciferase reporter protein, Gluc, by a FMDV 
replicon. BHK cells were transfected with RNA transcripts derived from the indicated cDNAs 
and, at the indicated times, lysates were prepared and assayed for Gluc activity. RLU = Relative 
light units. Data are represented as mean RLUs from a subset of samples (n=3) ± standard 
deviations (SD) over 8 hours. 
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Conclusions and perspectives  
 
The FMDV has a relatively small positive-sense single-stranded RNA genome like the other 
members of the Picornaviridae family. Many aspects of the FMDV viral life cycle remain 
unknown, but it has similarities to that of PV and relies on interactions with many cellular and 
viral elements (e.g. proteins and RNA structures). The FMDV genome includes a single, large, 
ORF encoding a polyprotein that is rapidly processed by the viral proteinases Lpro and 3Cpro 
and the StopGo inducing peptide 2A to generate multiple precursors and the mature proteins. 
This is a strategy which enables the virus to facilitate regulation of the polyprotein processing 
and several aspects of the FMDV life cycle. The RNA genome of FMDV folds into distinct 
three dimensional RNA structures, e.g. the IRES, which also have been found to regulate the 
life cycle of the virus. Many, if not all of these regulatory elements, are highly conserved due 
to their important role. Several conserved elements within the genome of FMDV have been 
identified. The aim of this thesis has been to investigate the influence of the conserved 2A 
peptide and three conserved RNA structures within the coding region for 2B, 3C and 3D on 
viral RNA replication and virus viability.  
The FMDV 2A peptide located at the boundary between the structural proteins (capsid 
proteins) and the non-structural proteins (involved in RNA replication and polyprotein 
processing) is only 18 amino acid in length but is found to induce an unusual co-translational 
“cleavage” of the two regions. The majority of the reported work regarding the 2A peptide has 
been focused on characterizing the function of the peptide and identifying the residues essential 
for cleavage. This has primarily been achieved using mRNAs encoding artificial polyproteins 
proteins comprising two reporter proteins linked via the 2A sequence. Recently it has been 
established that for certain cardioviruses this cleavage event is not essential (Loughran et al., 
2013). The modification of the conserved S15N16PG18↓P19 motif to SNPL18V19 at the 2A/2B 
junction blocks the cleavage but, surprisingly, it has no effect on the growth of TMEV while it 
is highly deleterious for replication of mengovirus (another cardiovirus) and lethal for FMDV. 
Manuscript 1 investigated the influence of the 2A peptide on polyprotein processing and virus 
replication of FMDV. Using a reverse genetics system based on using a full-length FMDV 
cDNA, it was established that certain amino acids substitutions in the 2A peptide that severely 
(60-70%) inhibit cleavage at the 2A/2B junction, as measured in in vitro assays (Donnelly et 
al., 2001b; Sharma et al., 2012), are tolerated within infectious FMDVs. In contrast, other 
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substitutions, previously found to inhibit cleavage by 89-100% in vitro, were not found in 
rescued viruses as they had reverted to the wt sequence. This was confirmed by marking the 
RNA transcripts with synonymous substitutions downstream of the 2A/2B junction. These 
results indicate that there is a selection pressure towards efficient cleavage activity at the 2A/2B 
junction. Furthermore, the absolute conservation of the 2A/2B cleavage motif in FMDV is not 
essential for viability as previously reported. The replication or translation of the FMDV 
genome was also found to be impaired in all the tested 2A mutants in the context of a FMDV 
replicon. The analysis of the 2A/2B “cleavage” in a transient expression assay within BHK 
cells using cDNA that encodes a truncated FMDV polyprotein, P1-2A-2BC-FLAG, thus free 
of the viral proteases showed that the 2A wt, S15A, S15I and S15F sequence results in complete 
cleavage at the 2A/2B junction. Some mutants were severely defective in “cleavage” by 
allowing the P1-2A-2BC-FLAG product to be detected while others generated a mix of cleaved 
and uncleaved product. 
Manuscript 2 investigated which codons were tolerated at each of the four positions encoding 
the NPG↓P motif. Using highly degenerate primers, pools of modified plasmids were generated 
with all possible codons present for each of the amino acids in the NPG↓P motif individually. 
RNA transcripts were made from these pools and introduced into BHK cells and subsequently 
infectious virus was rescued. Sequencing of the recued viruses showed that they all encoded 
the NPG↓P motif, thus confirming the importance of this amino acid sequence. However, 
viruses with each of the 14 possible codons encoding these four residues were found within the 
rescued pool. Interestingly during subsequent passages in BHK cells, a distinct codon bias 
became apparent. This was in accordance with the codon bias previously identified within 
naturally occurring FMDVs (Gao et al., 2014). Surprisingly, the codons selected are different 
for the two P residues; P17 is preferentially encoded by CCU while P19 is preferentially encoded 
by CCC. Interestingly, a single tRNA species recognizes both of these two codons, in both 
cattle and pigs which are the major hosts for FMDV. In addition, no gene for a prolyl tRNA 
with a GGG anticodon has found in the rat (close relationship with hamster). Gao et al., (2014) 
demonstrated that the synonymous codon usage for G18 did not influence the cleavage 
efficiency at the 2A/2B junction in an artificial polyprotein construct. It has been shown that 
the rate of peptide bond formation differs significantly depending on the Pro codon. The 
kinetics at codons CCA, CCU (P17) and CCG are similar, but dipeptide synthesis at CCC (P19) 
is twice as slow (Pavlov et al., 2009) and could explain, at least in part, the codon bias. The 
generation of constructs with all four codons having synonymous (non wt) substitutions in the 
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context of a full-length FMDV cDNA and a P1-2A-2BC-FLAG expression cassette would help 
reveal whether the nucleotide composition at the 2A/2B junction also influences the cleavage 
activity and virus viability.  
The eukaryotic translation factor eIF5A (eukaryotic initiation factor 5A) which contains the 
unique amino acid hypusine was originally identified as stimulating the peptide bond formation 
between a methionine charged tRNA and puromycin. It was thus concluded that eIF5A acted 
as a translation initiation factor. More recently, studies have identified eIF5A that facilitates 
polypeptide elongation, more precisely as a factor that overcomes stalling of ribosomes during 
synthesis of polyproline stretches (Gutierrez et al., 2013; Schuller et al., 2016). Furthermore, 
eIF5A has also been linked to a range of different processes such as tumorigenesis, cancer and 
virus replication. Some amino acids, proline in particular, are poor substrates for peptide bond 
formation and thus result in a lower rate of peptide bond formation (Pavlov et al., 2009; 
Wohlgemuth et al., 2008). It has been established that ribosomes stall when translating 
polyproline sequences and certain other “stalling motifs”. eIF5A have been found to be 
important for the translation of proline rich motifs, e.g. PPP, (c.f. the NPG↓P motif in the 2A). 
The eIF5A serves to promote polypeptide elongation on stalled ribosomes that occurs when P- 
rich or G-rich sequences are being synthesized. It is suggested that eIF5A stimulates 
the peptidyl transferase activity of the ribosome and facilitates the reactivity of poor substrates 
like Pro. Hence, it can be hypothesized that eIF5A may be involved in the continuation of 
protein synthesis at the NPG↓P motif at the junction of FMDV 2A/2B. Doronina et al., (2008) 
demonstrated that the eukaryotic release factors eRF1 and eRF3 are essential for the StopGo 
function in a yeast system. However, Machida et al., (2014) showed using a translation system 
reconstituted with human factors that the cleavage at the 2A/2B junction in EMCV does not 
require eRF1 and eRF3. Thus the role of these factors is still unclear. It could be interesting to 
investigate the effect of depleting cells of specific cellular proteins on the 2A/2B cleavage. In 
particular the level of eIF5A, eRF1 and eRF3 could be reduced within cells through the use of 
appropriate siRNAs or by the CRISPR/Cas9 method. Alternatively, the level of the functional 
eIF5A protein can be reduced by blocking the production of hypusine, a critical and unique 
component of eIF5A. Schuller et al., (2016) also identified various tripeptide motifs associated 
with ribosome pausing in eIF5A depleted cells. Some 29 tripeptide motifs were calculated to 
have high propensity for ribosomal stalling in eIF5A depleted cells, but surprisingly, Pro or 
Asp were favoured in the E and the P sites and Pro in the A site, which is accordance with the 
PGP motif found in the conserved 2A NPG↓P motif. Clearly, the amino acid composition at 
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the NPG↓P motif is important. But it has been established in this thesis that some changes still 
permit cleavage. It would be interesting to investigate whether any of the other identified stall 
frameshifting motifs could induce cleave in the context of the 2A peptide. 
Loughran et al., (2011) have demonstrated a programmed -1 ribosomal frameshift into a 
conserved overlapping ORF within the 2B region of EMCV, just downstream of the 2A coding 
region. This result in the use of a distinct “trans-frame” protein termed 2B* and then termination 
of translation. Recently, Napthine et al., (2017) showed that the frameshifting efficiency 
increases significantly during the later stages of infection and as such the production of the 
non-structural proteins associated with the virus replication is reduced. It was demonstrated 
that the EMCV 2A protein (ca. 16 kDa) serves as a trans-activator of this frameshifting by 
interacting with a stem-loop structure some 14 nt downstream of a slip site (GGUUUUU). 
Indeed, a U-rich motif (UUCUUUUUCU) can be found downstream of the 2A/2B junction in 
the FMDV genome, however other requirements necessary for this process to function appear 
to be absent. The EMCV is 150 amino acids long and possess a cluster of positively charged 
residues (R95-R97) which is suggested to bind to the stem-loop structure that is critical for the 
high frameshift efficiency. In contrast, the FMDV 2A peptide is only 18 amino acids long and 
lacks any such basic cluster. At present, there is no evidence for such a process within FMDV. 
Interestingly, is has previously been suggested that the 2A in FMDV could serve as a regulator 
to decrease the production of the non-structural proteins (Tulloch et al., 2017). Sixty copies of 
each of the four structural proteins (VP1-VP4) are needed for the generation of a mature virion, 
albeit the FMDV genome only encodes a single copy of each capsid protein. An excess of the 
capsid proteins could prove beneficial to the virus during the late stages of the viral infection 
where new infectious virions assemble. Ribosomal profiling (as used by Napthine et al., 2017) 
which identifies translated RNA regions of wt and 2A mutant FMDV genomes could help to 
determine whether the FMDV 2A  functions as a regulator of the expression levels of the 
structural and non-structural proteins.   
For the past two decades over 100 recombinant proteins with therapeutic application have been 
successfully approved by the United States Food and Drug Administration (FDA) for the 
treatment of several human diseases (Zhu, 2012). The majority of these protein include 
immunoglobulins, cell receptors, interleukins, enzymes and transcription factors which 
primarily all consist of multimeric complexes which require the need for co-expression of 
multiple proteins from a single mRNA. This can be achieved through several approaches e.g. 
use of alternative initiation codons, proteolytic processing, ribosomal frame shifting, multiple 
115 
 
internal promoters, fusion proteins or the use of dicistronic mRNAs containing an internal 
ribosome entry site (IRES). These methods are each associated with several limitations and 
disadvantages. The use of multiple promoters can result in interference decreasing the level of 
expressed protein, whereas fused proteins can lead to loss of function due to steric effects. Post-
translational cleavage can help remedy this, but the protease must be co-expressed in the same 
subcellular site. IRES elements vary in length and efficiency, within different cell types, due 
to their requirements for specific cellular trans-acting proteins. The presence of such cellular 
factors varies amongst different cell types. The two proteins produced can have their native 
sequences but they may not be made in equimolar amounts. In some IRES elements the 
downstream product is only expressed to ~10% of that of the upstream. The small FMDV 2A 
peptide could bypass this as it allows the near stoichiometric production of multiple, discrete, 
protein products from a single mRNA.  
It has become increasingly evident that viral RNA genomes, like that of FMDV, form elaborate 
three dimensional structures through base pairing between complementary sequences. These 
structures can influence important aspects of the viral life cycle through long-range RNA-RNA 
interactions or through binding sites for viral or cellular proteins. The influence of three distinct 
RNA structures within the coding regions for 2B, 3C and 3D which previously has been 
determined through the use of SHAPE probing has been investigated in Manuscript 3. It was 
shown that synonymous substitutions within these sequences, designed to modify the 
structures, did not affect the replication of a FMDV replicon within BHK cells. The structure 
mutants were able to form viable infectious viruses and sequencing of rescued viruses (third 
passage in BHK cells) showed that the mutants had retained their mutations. Furthermore, NGS 
of the near complete genome of the 2B mutants did not show any secondary mutations 
indicating that the structures are not involved in RNA-RNA interactions.  
Various distinct functional RNA structures within the genomes of viruses from different viral 
families have been described during the last two decades. The majority have so far been 
identified within the untranslated region of the genome where they are involved in intra-
genomic interactions. Extensive RNA structures have also been identified within the coding 
regions. However, the exact function of these structures are still unknown. Some could be 
required for virus replication, like the cis-acting replication element, or for RNA packaging 
within new virus particles. Others could be important for protein binding to either separate 
RNA structures, for bringing the RNA structures together or to maintain RNA structure 
stability. Recently Logan et al., (2017) found secondary structures within the coding region of 
FMDV with a similar conservation of the structure and a common motif at the loop. Disruption 
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of these structures resulted in attenuation of virus growth in BHK cells due to a reduction in 
assembly of mature virions, thus suggesting that these predicted RNA structures are involved 
in FMDV packaging. Simmonds et al., (2004) suggested that RNA structures could be 
implicated in the evasion of cell defences and Kloc et al., (2017) have provided evidence that 
changes in the FMDV S-fragment exert an effect in this way. Viability and replication studies 
in Manuscript 3 have been carried out in BHK cells which lack an intact interferon signalling 
system. Growth kinetics and the study of additional mutations using pBTY cells could reveal 
if these structures are important in this regard.  
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Abbreviations 
 
BHK Baby Hamster Kidney 
bp Base pair 
CAT Chloramphenicol acetyl-transferase  
cDNA Complimentary DNA 
CHO Chinese hamster ovary 
cre Cis-acting RNA element 
DNA Deoxyribonucleic acid 
eIF4A  Eukaryotic translation initiation factor 4 A 
eIF4E Eukaryotic translation initiation factor 4E 
eIF4G Eukaryotic translation initiation factor 4 G 
eIF5A  Eukaryotic translation initiation factor 5A-1 
EMCV Encephalomyocarditis virus  
ER Endoplasmic reticulum 
eRF1  Eukaryotic release factor 1 
eRF3 Eukaryotic release factor 3 
Foot-and-mouth disease FMD 
Foot-and-mouth disease virus FMDV 
GFP Green fluorescent protein 
Gluc Gaussia luciferase 
HSPG Heparan sulfate proteoglycan 
HIV Human immunodeficiency virus 
IRES Internal ribosome entry site 
Kb Kilobase 
mRNA Messenger RNA 
NGS Next generation sequencing 
Nucleotide triphosphates  NTP 
ORF Open reading frame 
PCR Polymerase Chain Reaction  
pfu Plaque forming units 
PCBP2 Poly(rC) binding protein 2 
PV Poliovirus 
RdRp  RNA-dependent RNA polymerase  
Ribonucleoprotein  RNP 
Ribosomal RNA  rRNA 
RLU Relative light units  
RNA Ribonucleic acid 
RT-qPCR  Reverse transcription quantitative PCR 
SHAPE Selective 2'-hydroxyl acylation analysed by primer extension 
siRNA Small interfering RNA 
TCID50 Tissue culture Infective Dose 50% 
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TMEV Theiler’s murine encephalitis virus  
tRNA Transfer RNA 
UK United Kingdom 
UTR Untranslated region 
wt wild type 
(+) ssRNA Positive single stranded RNA 
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Selection of functional 2A sequences within foot-and-mouth
disease virus; requirements for the NPGP motif with
a distinct codon bias
JONAS KJÆR and GRAHAM J. BELSHAM
DTU National Veterinary Institute, Technical University of Denmark, Lindholm, DK-4771 Kalvehave, Denmark
ABSTRACT
Q1 Foot-and-mouth disease virus (FMDV) has a positive-sense ssRNA genome including a single, large, open reading frame. Splitting
of the encoded polyprotein at the 2A/2B junction is mediated by the 2A peptide (18 residues long), which induces a
nonproteolytic, cotranslational, “cleavage” at its own C terminus. A conserved feature among variants of 2A is the C-terminal
motif N16P17G18/P19, where P19 is the first residue of 2B. It has been shown previously that certain amino acid substitutions
can be tolerated at residues E14, S15, and N16 within the 2A sequence of infectious FMDVs, but no variants at residues P17,
G18, or P19 have been identified. In this study, using highly degenerate primers, we analyzed if any other residues can be
present at each position of the NPG/P motif within infectious FMDV. No alternative forms of this motif were found to be
encoded by rescued FMDVs after 2, 3, or 4 passages. However, surprisingly, a clear codon preference for the wt nucleotide
sequence encoding the NPGP motif within these viruses was observed. Indeed, the codons selected to code for P17 and P19
within this motif were distinct; thus the synonymous codons are not equivalent.
Keywords: picornavirus; synonymous codon; codon bias; translation
INTRODUCTION
Foot-and-mouth disease virus (FMDV) is the prototypic
member of the genus Aphthovirus within the family
Picornaviridae. This virus is the causative agent of the highly
contagious and economically important disease of cloven-
hoofed animals, foot-and-mouth disease. The positive-sense
ssRNA genome of around 8400 nt includes a single, large,
open reading frame (ORF),∼7000 nt, encoding a polyprotein
(Belsham 2005). The full-length viral polyprotein is never ob-
served since it is rapidly processed during and after synthesis
mainly by the virus-encoded proteases (primarily 3Cpro) to
produce 15 distinct mature proteins plus multiple precursors
(for review, see Martinez-Salas and Belsham 2017). Interest-
ingly, FMDV, like many (but by no means all) other picorna-
virus (e.g., cardioviruses, erboviruses, teschoviruses etc.) uses
a cotranslational, protease-independent mechanism for the
“cleavage” of the polyprotein at the 2A/2B junction (the
boundary between the capsid proteins and the nonstructural
proteins) (Donnelly et al. 2001a). This mechanism has been
referred to as “ribosomal skipping” or, alternatively, “stop-
carry on” or “StopGo” (Donnelly et al. 2001a; Atkins et al.
2007; Doronina et al. 2008; Tulloch et al. 2017). The 2A pep-
tide lacks characteristic protease motifs and only mediates
“cleavage” during translation. It has been demonstrated
that the 2A sequence is able to mediate “cleavage” in all eu-
karyotic translation systems tested whereas a number of arti-
ficial polyproteins containing this sequence have been
examined in prokaryotic systems and no detectable cleavage
products were observed (Donnelly et al. 1997).
The 2A peptide contains a highly conserved D12(V/I)E(S/
T)NPG2A
↓P192B motif at its C terminus, which is critical for
its function (Ryan and Drew 1994; Donnelly et al. 1997).
This motif, together with upstream amino acids, is believed
to interact with the ribosomal exit tunnel. This prevents the
formation of a peptide bond between the C-terminal glycine
(G18) of 2A and the N-terminal proline of 2B, referred to
here, as P19 since it is an important part of the cleavage mech-
anism (see also Ryan et al. 1999; Donnelly et al. 2001a).
However, remarkably, protein synthesis continues without
the requirement for a reinitiation event.
Investigations into the activity of the 2A sequence have
mainly been performed using in vitro experiments.
Typically, these have either used mRNAs with single ORFs
encoding artificial polyproteins comprising two reporter pro-
teins linked via the 2A peptide (Ryan et al. 1991; Ryan and
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Drew 1994; Donnelly et al. 2001b) or by expressing cDNAs
encoding a truncated viral polyprotein including the
StopGo coding region (Palmenberg et al. 1992). Alterations
to the conserved D12(V/I)E(S/T)NPG2A
↓P192B motif reduced
or abrogated the StopGo function (Donnelly et al. 2001b;
Sharma et al. 2012), thereby showing that these amino
acids are important for the correct StopGo “cleavage”.
Furthermore, Hahn and Palmenberg (1996) demonstrated
that alterations to this motif also influenced the viability of
encephalomyocarditis virus (EMCV, a cardiovirus) as they
resulted in lethal phenotypes. Subsequently, Loughran et al.
(2013) reported a similar observation for FMDV, as modifi-
cation of the S15NPG 182A
↓ P192B sequence to S
15NPL 182A
↓ V192B
or S15NPA 182A
↓ P192B also gave rise to a lethal phenotype.
However, recently, certain amino acid substitutions (e.g.,
2A S15 to F/I and 2A N16 to H) that have been shown to se-
verely (60%–70%) impair “cleavage” at the 2A/2B junction,
using in vitro assays (Donnelly et al. 2001b), have been found
to be tolerated within infectious FMDVs (J Kjær and GJ
Belsham, in prep.). In contrast, other substitutions (e.g.,
P19 to A and P19 to G) that inhibit cleavage more severely
(by 89%–100%) in vitro, were not found within rescued vi-
ruses. Indeed, viruses rescued from these mutant transcripts
had sequences that exactly matched the wt sequence (i.e., the
rescued viruses were not mutant). In these studies, we also
determined a critical role for the StopGo mechanism for
the overall level of replication/translation of FMDV RNA.
FMDV replicons with a defective 2A sequence had a marked-
ly lower replication efficiency compared to the wt replicon (J
Kjær and GJ Belsham, in prep.).
It is, therefore, apparent that some amino acid substitu-
tions can be tolerated within the FMDV 2A peptide whereas
other changes are not compatible with viability. To identify if
any alternative residues can be accepted within the critical
N16P17G 182A
↓ P192B motif, degenerate sequences, encoding all
possible amino acid substitutions at each of these positions
individually, were introduced into a full-length FMDV
cDNA, as used previously (Gullberg et al. 2013; Kristensen
et al. 2017). In principle, this should result in the production
of RNA transcripts encoding 2A peptides with a wide spec-
trum of “cleavage” activities. This was achieved by generating
a large pool of plasmids, using site-directed mutagenesis with
highly degenerate oligonucleotides, to change each of the in-
dividual codons corresponding to the amino acid residues
within this conserved motif to NNN (where N is a mixture
of all four bases). Using each pool of plasmids, RNA tran-
scripts were prepared, in vitro, and introduced into baby
hamster kidney (BHK) cells. Infectious viruses were rescued
and characterized.
RESULTS AND DISCUSSION
The expected generation of a pool of StopGo cDNA mutants
that could potentially result in all possible single amino sub-
stitutions in place of the N16, P17, G18, and P19 residues (see
F1 Fig. 1A) was analyzed by sequencing (see Fig. 1B). The het-
erogeneity at the expected positions was clear in each case
(this does not prove that each of the possible codons was pre-
sent but indicates it is likely).
Full-length RNA transcripts were produced, in vitro, and
introduced into BHK cells. Infectious virus was generated
and passaged in fresh cells. RNA was then extracted from
the virus harvests and the sequence encoding the 2A peptide
was amplified by RT-PCR. The pool of amplicons was intro-
duced into the pCR-XL-TOPO vector and then the sequence
of the inserts in 20 individual colonies was determined for
each virus harvest. It was found that all of the rescued viruses
analysed after passages p2, p3, and p4 encoded the wt amino
acid sequence at the NPGP motif in 2A. Interestingly, the
complete spectrum of the possible synonymous codons for
each of the residues N16, P17, G18, and P19 was present in
the rescued viral genomes at p2 (see T1Table 1). These results
indicated that the approach had indeed generated a diverse
pool of codons within the viruses. Furthermore, the very re-
stricted range of nucleotide sequences encoding 2A observed
within the rescued viruses strongly suggests that the specific
amino acid sequence (NPGP), encoded by these nucleotide
sequences, is critical for FMDV viability.
However, it was also apparent that the utilization of the
different codons for the conserved amino acid residues var-
ied. At p2, 55% of the sequences analysed had the wt codon
for residue N16 (AAC) while the synonymous AAT codon was
present in the remaining 45% of the rescued sequences. In
the subsequent passages, the proportion of the AAC codon
within the sequences increased to 75% and 95% by p3 and
p4 respectively while the incidence of the AAT codon de-
clined (Table 1). For residue P17, at p2, the codon CCT was
present in 55% of the colonies analysed and increased to
100% by p4. Each of the three other possible codons for
P17 (CCC, CCA, and CCG) were also observed at p2 but
each declined as the wt codon became dominant. For resi-
dues G18 and P19, the wt codons (GGG and CCC, respective-
ly) were in the minority (10 or 20%) at p2 and each of the
synonymous codons were also present. However, interesting-
ly, by p3 the wt codons hadmarkedly increased to 50% abun-
dance and by p4 were dominant (≥90% abundance). For
G18, the GGA codon was the most abundant at p2 but de-
clined during further passages to be only 10% of the sequenc-
es at p4. Similarly, for P19 the CCT codon was present in 50%
of the sequences at p2 but declined to just 5% by p4.
Strikingly, by p3, the wt codon was present in 50%–75% of
the population at each of the four residues and by p4 the
wt codon was present in 90%–100% of the virus population
in each case (Table 1). Thus, it appears that selection occurs
for the wt nucleotide sequence during passage of the rescued
viruses in cell culture.
The wt GGGCCC nt sequence encoding residues G18 and
P19 is recognized in DNA by the restriction enzyme ApaI (see
Fig. 1A). Hence, it was possible to deplete the cDNA ampli-
cons generated by RT-PCR, of the wt sequence from the
Kjær and Belsham
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rescued viruses by digesting themwith ApaI prior to the clon-
ing step (it was anticipated that this should enhance the
detection of non-wt nucleotide sequences). The residual,
full-length, 650-bp amplicons were inserted into the pCR-
XL-TOPO vector, as described above, and the plasmid
DNA from individual colonies was sequenced. As expected,
the wt codons for G18 and P19 were no longer observed in
the cloned fragments (T2 Table 2) and the G18 (GGA) and P19
(CCT) codons were predominant in these enriched popula-
tions. These results are consistent with those obtained with-
out the ApaI digestion (since the GGA and CCT codons were
also present in 50% of the fragments at p2 without this treat-
ment, see Table 1) but clearly the apparent abundance of
these non-wt codons is enhanced following the ApaI diges-
tion (Table 2), as anticipated. The en-
richment for non-wt sequences did not
result in the detection of codons for alter-
native amino acids within the virus pop-
ulation. It had been anticipated that some
amino acid substitutions at residue N16
might be rescued since a mutant (with
N16 changed to H) has been shown to
be viable (J Kjær and GJ Belsham, in
prep.) but, presumably, it was outcom-
peted by the wt virus.
It is interesting to note that the G18
(GGA) and P19 (CCT) codons have pre-
viously been found to be the second
most abundant codons found in FMDV
genomes from all seven serotypes (see
Gao et al. 2014). This comparison of
FMDV sequences also indicated that the
alternate codon for N16 (AAC) is present
in only a small minority of FMDV ge-
nomes and CCC is also a minor popula-
tion of the codons used for residue P17.
The results presented in Table 1 clearly
indicate that infectious FMDVs with
these synonymous changes can be ob-
tained but these viruses do not appear
to be stably maintained in cell culture
and are apparently selected against.
The evidence presented here strongly
suggests that there is a distinct selection,
within the virus when grown in cell cul-
ture, for codon AAC for N16, CCT for
P17, GGG for G18, and CCC for P19;
thereby indicating that synonymous co-
don usage for this conserved motif is
biased in these rescued viruses. It is par-
ticularly noteworthy that the codon pref-
erence for P17 and P19 is different (CCT
and CCC, respectively). This raises the
question of why does the virus select
some codons over others? Various stud-
ies have demonstrated that synonymous codon usage bias
plays an important role in the translation of certain
mRNAs (Bulmer 1991; Akashi 2001; Novoa and Ribas de
Pouplana 2012; Mauro and Chappell 2014). It is therefore
conceivable that synonymous codons may influence the
cleavage efficiency through the FMDV StopGo mechanism.
As indicated above, a marked codon bias within the FMDV
genome is apparent from the alignment of diverse FMDV
2A sequences as described by Gao et al. (2014). However,
in the context of a synthetic reporter polyprotein, assayed
within CHO cells, use of the four different synonymous co-
dons for residue G18 of the 2A peptide resulted in very similar
apparent “cleavage” efficiencies at the 2A/2B junction. This
was interpreted as showing that it is the amino acid residue
FIGURE 1. Structure of the FMDV O1 Kaufbeuren (O1K) cDNA and its derivatives. (A) The
plasmid-encoded amino acids and the corresponding nucleotide sequences at the 2A/2B junction
are shown. The FMDV O1K degenerate codon mutants were produced as described in the text
using the mutant pT7S3 plasmids encoding the N16A, P17A, G18A, and P19A substitutions as tem-
plates. The full-length plasmid pools were linearized using HpaI prior to in vitro transcription and
virus rescue. The locations of the HpaI and ApaI restriction sites that were used are marked. (N) A
mixture of the 4 nucleotides. (B) Chromatograms and sequences of the FMDV cDNA corre-
sponding to the NPGP motif at the 2A/2B junction. Degenerate positions showing the presence
of multiple nucleotides are marked with an N (in bold type). The color code in the chromato-
grams is as follows: A (red), T (green), G (yellow), C (blue).
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rather than the nt sequence which is critical for achieving
cleavage (Gao et al. 2014). However, using that assay system,
the “cleavage” efficiency was only about 88%–89% while es-
sentially 100% cleavage occurs within the native context, as in
the virus. The results obtained here (see Table 1) indicate that
two separate selection effects may be operating. There is a
clear selection for the NPGP motif at the amino acid level.
However, in addition, there is a distinct codon bias within
the context of the rescued infectious viruses and a significant
selection pressure appears to exist for the wt sequence. This
effect is fully consistent with the codon bias observed in the
analysis of natural FMDV genomic sequences (Gao et al.
2014). This suggests that the FMDV RNA sequence itself
(rather than just the encoded amino acid sequence) affects
the “cleavage” process (StopGo mechanism) at the 2A/2B
junction. Such an effect could be achieved through a direct
interaction of the RNA sequence itself or potentially through
interactions with the specific charged tRNAs involved in the
translation process. In the case of the P17 and P19 codons, it is
interesting to note that the same type of prolyl tRNA (with an
IGG anticodon) has been reported to be used for decoding of
the CCC and CCU codons in human cells (no gene for a
tRNA that is cognate for CCC was identified, see Mauro
and Chappell 2014). However, in the current database of
tRNA sequences from the Lowe laboratory, it appears that
in humans, 1 of 23 genes for prolyl tRNAs has a GGG anti-
codon with 10 copies having an AGG anticodon. In the
mouse genome, 1 of 20 genes for the prolyl tRNAs has the
GGG anticodon and 8 genes have the AGG anticodon (see
the gtrnadb.ucsc.edu database described in Chan and Lowe
(2009)). Interestingly, in cattle and pigs (major hosts for
FMDV) and also in the rat, there is no gene for a prolyl
tRNA with a GGG anticodon. Thus, it is not clear whether
a single, post-transcriptionally modified prolyl tRNA recog-
nizes these two Pro codons (at least some of the time) or if
different tRNAs are involved in the hamster cells used here.
If a single tRNA is involved in recognizing both codons (as
in cattle, pigs, and rats), then it seems that the RNA sequence
itself must be influencing the StopGo process; it seems un-
likely that this effect is mediated through some secondary
or tertiary RNA structure, as this would presumably be lost
on the ribosome during the process of translation. It will
clearly be important to analyse the effect of the presence of
the non-optimal synonymous codons on “cleavage” at the
2A/2B junction in its native context.
MATERIALS AND METHODS
Construction of plasmids containing full-length mutant
FMDV cDNAs
Pools of StopGo cDNAmutants that potentially result in all possible
single amino substitutions in place of the N16, P17, G18, and P19 res-
idues, respectively, were constructed. This was achieved using a two-
step site-directed mutagenesis procedure. This is a variation of the
QuickChange protocol (Stratagene), using Phusion High-Fidelity
DNA Polymerase (Thermo Scientific) with modified versions of
the plasmid pT7S3 (Ellard et al. 1999) as template. The wt pT7S3
contains the full-length cDNA for the O1Kaufbeuren B64 strain of
FMDV. To eliminate the possibility of carrying over some residual
wt template from the PCR, the templates used were modified ver-
sions of the pT7S3 with the codons for N16, P17, G18, or P19 changed
to encode an alanine (A) residue in each case (see Fig. 1A). These
substitutions have been reported previously to result in a complete
loss of apparent cleavage activity (Donnelly et al. 2001b; Sharma
TABLE 1. Codon utilization encoding the “NPGP” motif at the 2A/
2B junction within rescued FMDVs
Residue Codon
p2 p3 p4
%a %a %a
N16 AAT 45 25 5
N16 AAC wt 55 75 95
P17 CCT wt 55 70 100
P17 CCC 10 15 0
P17 CCA 20 5 0
P17 CCG 15 10 0
G18 GGT 15 5 0
G18 GGC 15 5 0
G18 GGA 50 40 10
G18 GGG wt 20 50 90
P19 CCT 50 25 5
P19 CCC wt 10 50 95
P19 CCA 10 5 0
P19 CCG 30 20 0
aFrom sequencing of plasmid DNA isolated from separate 20 colo-
nies in each case, the proportion (%) of each codon present in the
rescued FMDVs is indicated at the different passage (p) numbers.
Codon frequency values of 50%–70% are highlighted in light
gray, whereas values from 75%–100% are highlighted in dark
gray.
TABLE 2. Enrichment for non-wt sequences encoding residues
G18 and P19 within the “NPGP” motif within rescued FMDVs
Residue Codon Pretreatment
p2 p3
%b %b
G18 GGT ApaIa 5 0
G18 GGC ApaIa 15 5
G18 GGA ApaIa 80 95
G18 GGG wt ApaIa 0 0
P19 CCT ApaIa 60 55
P19 CCC wt ApaIa 0 0
P19 CCA ApaIa 15 0
P19 CCG ApaIa 25 45
aFollowing RT-PCR, the 650-bp amplicons were digested with
ApaI to enrich the population in non-wt sequences and the residu-
al intact products were inserted into the pCR-XL-TOPO vector (see
text).
bFrom sequencing of plasmid DNA isolated from separate 20 colo-
nies in each case, the proportion (%) of each codon present in the
rescued FMDVs is indicated at the different passage (p) numbers.
Codon frequency values of 50%–70% are highlighted in light
gray, whereas values from 75%–100% are highlighted in dark
gray.
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et al. 2012) and it has not been possible to rescue infectious virus
containing these substitutions (J Kjær and GJ Belsham, in prep.).
The first round of PCRs used the forward mutagenic 2A PCR prim-
ers (T3 Table 3), with a single reverse primer 8APN206 (Table 3) plus
the four different modified pT7S3 plasmids as templates and gener-
ated amplicons of approximately 450 bp. These primary PCR prod-
ucts were then used as megaprimers for a second round of PCR with
the respective mutant pT7S3 plasmids as templates to produce full-
length plasmids. Following DpnI digestion, the products from each
reaction were introduced into E. coli and grown as separate pools.
The plasmid pools were sequenced using a BigDye Terminator
v. 3.1 Cycle Sequencing Kit and a 3500 Genetic Analyzer (Applied
Biosystems).
Rescue of virus from full-length cDNA plasmids
Plasmid DNA isolated from each pool was linearized by digestion
with HpaI and RNA transcripts were prepared using T7 RNA poly-
merase (Ambion T7 MEGAscript) at 37°C for 4 h. The integrity of
the transcripts was assessed on agarose gels and quantified by spec-
trophotometry (NanoDrop 1000, Thermo Scientific) after which
they were introduced into BHK cells by electroporation, as described
previously (Nayak et al. 2005). The BHK cells were maintained in
Dulbecco’s Modified Eagles Medium (DMEM) supplemented
with 5% fetal calf serum, and incubated at 37°C with 5% CO2. At
2 d post-electroporation, the viruses were harvested by freezing
and then amplified through three passages (p2, p3, and p4) in
BHK cells.
Characterization of viruses following multiple passages
After each passage, viral RNA was extracted from a sample of the vi-
rus harvest (using the RNeasy Mini Kit, QIAGEN) and converted to
cDNA using ready-to-go you-prime first-strand beads (GE
Healthcare Life Sciences). FMDV cDNA, which included the whole
2A coding region, was amplified in PCRs (AmpliTaq Gold DNA po-
lymerase, Thermo Scientific) using primers 8APN206 and 8APN203
(see Table 3; Fig. 1). Control reactions, without RT, were used to en-
sure that the analysed products were derived from RNA and not
from the presence of carryover plasmid DNA template. The ampli-
cons (approximately 650 bp) were visualized on 1% agarose gels and
purified (GeneJET gel extraction kit, Thermo Scientific). These
amplicons should be representative of the heterogeneity present in
the rescued virus populations. The resulting collections of fragments
were inserted into pCR-XL-TOPO (Thermo Scientific) and the se-
quence of the cDNA fragment present in individual bacterial clones
(20 colonies for each of the 4 residues) was determined using the
same reverse primer as used for the PCR. The fragments from codon
mutants G18 and P19 were also enriched for the non-wt sequence
populations by digestion of the cDNA with ApaI prior to gel purifi-
cation and insertion into the pCR-XL-TOPO vector as described
above.
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